record_id,Reference,,,,,,,
Abadie_2018,"Abadie, R., Gelpi-Acosta, C., Davila, C., Rivera, A., Welch-Lazoritz, M., & Dombrowski, K. (2018). “It Ruined My Life”: The effects of the War on Drugs on people who inject drugs (PWID) in rural Puerto Rico. International Journal of Drug Policy, 51, 121–127.",,,,,,,
Abouk_2019,"Abouk, R., Pacula, R. L., & Powell, D. (2019). Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose. JAMA Intern Med, 179(6), 805–811. https://doi.org/10.1001/jamainternmed.2019.0272",,,,,,,
Abramson_2009,"Abramson, K. (2009). Unfairly Condemned to Disease: The Argument for Needle-Exchange Programs in United States Prisoner Note. Geo. J. on Poverty L. & Pol’y, 16, 695–720.",,,,,,,
Accurso_2016,"Accurso, A. J., & Rastegar, D. A. (2016). The Effect of a Payer-Mandated Decrease in Buprenorphine Dose on Aberrant Drug Tests and Treatment Retention Among Patients with Opioid Dependence. Journal of Substance Abuse Treatment, 61, 74–79.",,,,,,,
Aguiar_2016,"Aguiar, C. M., & Leavell, S. (2017). A Statewide Parenting Alternative Sentencing Program: Description and Preliminary Outcomes. Smith College Studies in Social Work, 87(1), 78–93. https://doi.org/10.1080/00377317.2017.1248629",,,,,,,
Ahammer_2019,"Ahammer, A. (2019). A novel supply-side measure to combat abuse of addictive prescription drugs. https://EconPapers.repec.org/RePEc:jku:econwp:2019_11",,,,,,,
Aitken_2002,"Aitken, C., Moore, D., Higgs, P., Kelsall, J., & Kerger, M. (2002). The impact of a police crackdown on a street drug scene: Evidence from the street. International Journal of Drug Policy, 13(3), 189–198.",,,,,,,
Al Achkar_2018,"Al Achkar, M., Grannis, S., Revere, D., MacKie, P., Howard, M., & Gupta, S. (2018). The effects of state rules on opioid prescribing in Indiana. BMC Health Services Research, 18(1), 29.",,,,,,,
Alburaih_2018,"Alburaih, A., & Witting, M. D. (2018). Effectiveness of a Rural Emergency Department (ED)-Based Pain Contract on ED Visits Among ED Frequent Users. Journal of Emergency Medicine, 55(3), 327-332.e321. https://doi.org/10.1016/j.jemermed.2018.04.056",,,,,,,
Aletraris_2017,"Aletraris, L., Roman, P. M., & Pruett, J. (2017). Integration of Care in the Implementation of the Affordable Care Act: Changes in Treatment Services in a National Sample of Centers Treating Substance Use Disorders. Journal of Psychoactive Drugs, 49(2), 132–140.",,,,,,,
Alexander_2014,"Alexander, M. B. (2014). Denying the Dyad: How Criminalizing Pregnant Use Harms the Baby, Taxpayers and Vulnerable Women. Tennessee Law Review, 82, 745–790.",,,,,,,
Alexandridis_2018,"Alexandridis, A. A., McCort, A., Ringwalt, C. L., Sachdeva, N., Sanford, C., Marshall, S. W., Mack, K., & Dasgupta, N. (2018). A statewide evaluation of seven strategies to reduce opioid overdose in North Carolina. Injury Prevention, 24(1), 48–54.",,,,,,,
Alexandridis_2019,"Alexandridis, A. A., Dasgupta, N., McCort, A. D., Ringwalt, C. L., Rosamond, W. D., Chelminski, P. R., & Marshall, S. W. (2019). Associations between implementation of Project Lazarus and opioid analgesic dispensing and buprenorphine utilization in North Carolina, 2009-2014. Inj Epidemiol, 6(1), 2. https://doi.org/10.1186/s40621-018-0179-2",,,,,,,
Ali_2017,"Ali, M. M., Dowd, W. N., Classen, T., Mutter, R., & Novak, S. P. (2017). Prescription drug monitoring programs, nonmedical use of prescription drugs, and heroin use: Evidence from the National Survey of Drug Use and Health. Addict Behav, 69, 65–77. https://doi.org/10.1016/j.addbeh.2017.01.011",,,,,,,
Allen_2016,"Allen, S. T., Ruiz, M. S., Jones, J., & Turner, M. M. (2016). Legal space for syringe exchange programs in hot spots of injection drug use-related crime. Harm Reduction Journal, 13, 16.",,,,,,,
Allen_2019,"Allen, B., Harocopos, A., & Chernick, R. (2019). Substance Use Stigma, Primary Care, and the New York State Prescription Drug Monitoring Program. Behavioral medicine (Washington, D.C.), 46(1), 52–62. https://doi.org/10.1080/08964289.2018.1555129",,,,,,,
Almarsdottir_2000,"Almarsdottir, A. B., & Grimsson, A. (2000). Over-the-counter codeine use in Iceland: The impact of increased access. Scandinavian Journal of Public Health, 28(4), 270–274. MEDLINE.",,,,,,,
Alpert_2017,"Alpert, A., Powell, D., & Pacula, R. L. (2017). Supply-Side Drug Policy in the Presence of Substitutes. NBER
Working Paper Series, No. 23031. https://www.rand.org/pubs/external_publications/EP67579.html ",,,,,,,
Alsirafy_2011,"Alsirafy, S. A., El-Mesidi, S. M., El-Sherief, W. A., Galal, K. M., Abou-Elela, E. N., & Aklan, N. A. (2011). Opioid needs of patients with advanced cancer and the morphine dose-limiting law in Egypt. Journal of Palliative Medicine, 14(1), 51–54.",,,,,,,
Anders_2019,"Anders, J. (2019). Medicaid, marijuana and opioids: Is prescription access to blame? (SSRN Scholarly Paper ID 3247989). Social Science Research Network. https://papers.ssrn.com/abstract=3247989",,,,,,,
Andraka-Christou_2016,"Andraka-Christou, B. (2016b). Improving Drug Courts through Medication-Assisted Treatment for Addiction. Virginia Journal of Social Policy & the Law, 23, 179–230.",,,,,,,
Andraka-Christou_2016a,"Andraka-Christou, B. (2016a). America Needs the TREAT Act: Expanding Access to Effective Medication for Treating Addiction. Health Matrix: Journal of Law-Medicine, 26, 309–362.",,,,,,,
Andraka-Christou_2017,"Andraka-Christou, B. (2017). What Is Treatment for Opioid Addiction in Problem-Solving Courts: A Study of 20 Indiana Drug and Veterans Courts. Stanford Journal of Civil Rights & Civil Liberties, 13, 189–254.",,,,,,,
Andresen_2009,"Andresen, M. A., & Boyd, N. (2010). A cost-benefit and cost-effectiveness analysis of Vancouver’s supervised injection facility. Int J Drug Policy, 21(1), 70–76. https://doi.org/10.1016/j.drugpo.2009.03.004",,,,,,,
Andrews_2014,"Andrews, Christina M. (2014). The Relationship of State Medicaid Coverage to Medicaid Acceptance Among Substance Abuse Providers in the United States. The Journal of Behavioral Health Services & Research, 41(4), 460–472. https://doi.org/10.1007/s11414-013-9387-2",,,,,,,
Andrews_2018,"Andrews, C. M., Grogan, C. M., Westlake, M. A., Abraham, A. J., Pollack, H. A., D’Aunno, T. A., & Friedmann, P. D. (2018). Do benefits restrictions limit Medicaid acceptance in addiction treatment? Results from a national study. J Subst Abuse Treat, 87, 50–55. https://doi.org/10.1016/j.jsat.2018.01.010",,,,,,,
Andrews_2019,"Andrews, C. M., Abraham, A. J., Grogan, C. M., Westlake, M. A., Pollack, H. A., & Friedmann, P. D. (2019). Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs. Am J Public Health, 109(3), 434–436. https://doi.org/10.2105/ajph.2018.304856",,,,,,,
Andrews_2019_2,"Andrews, C. M., Pollack, H. A., Abraham, A. J., Grogan, C. M., Bersamira, C. S., D’Aunno, T., & Friedmann, P. D. (2019). Medicaid coverage in substance use disorder treatment after the affordable care act. J Subst Abuse Treat, 102, 1–7. https://doi.org/10.1016/j.jsat.2019.04.002",,,,,,,
Angelotta_2016,"Angelotta, C., Weiss, C. J., Angelotta, J. W., & Friedman, R. A. (2016). A Moral or Medical Problem? The Relationship between Legal Penalties and Treatment Practices for Opioid Use Disorders in Pregnant Women. Womens Health Issues, 26(6), 595–601.",,,,,,,
Angelotta_2017,"Angelotta, C., & Appelbaum, P. S. (2017). Criminal Charges for Child Harm from Substance Use in Pregnancy. Journal of the American Academy of Psychiatry & the Law, 45(2), 193–203.",,,,,,,
Anglin_2013,"Anglin, M. D., Nosyk, B., Jaffe, A., Urada, D., & Evans, E. (2013). Offender diversion into substance use disorder treatment: The economic impact of California’s proposition 36. Am J Public Health, 103(6), 1096–1102. https://doi.org/10.2105/ajph.2012.301168",,,,,,,
Anglin_2013_2,"Anglin, D. M., Jaffee, A., Nysok, B., Urada, D., & Evans, E. (2013). Offender Diversion into Substance Use Disorder Treatment: Demographic Variation in the Economic Impact of California’s Proposition 36. Journal of Alcoholism & Drug Dependence, 1(7), 1000140. https://doi.org/10.4172/2329-6488.1000140",,,,,,,
Arredondo_2018,"Arredondo, J., Gaines, T., Manian, S., Vilalta, C., Banuelos, A., Strathdee, S. A., & Beletsky, L. (2018). The law on the streets: Evaluating the impact of Mexico’s drug decriminalization reform on drug possession arrests in Tijuana, Mexico. Int J Drug Policy, 54, 1–8. https://doi.org/10.1016/j.drugpo.2017.12.006",,,,,,,
Asher_2013,"Asher, H. (2013). Methadone prescribing in local prisons in England. Drugs & Alcohol Today, 13(4), 234-243 10p.",,,,,,,
Atkins_2018,"Atkins, D. N., Durrance, C. P., & Kim, Y. (2019). Good Samaritan harm reduction policy and drug overdose deaths. Health Serv Res, 54(2), 407–416. https://doi.org/10.1111/1475-6773.13119",,,,,,,
Aubrun_2007,"Aubrun, F., Chretien, E., Letrilliart, L., Ginoux, M., Belhassen, M., Lanteri-Minet, M., Van Ganse, E., & Beloeil, H. (2017). What are the therapeutic alternatives to dextropropoxyphene in France? A prescribers’ survey. Anaesth Crit Care Pain Med, 36(1), 15–19. https://doi.org/10.1016/j.accpm.2016.01.007",,,,,,,
Auerhahn_2004,"Auerhahn, K. (2004). California’s Incarcerated Drug Offender Population, Yesterday, Today, and Tomorrow: Evaluating the War on Drugs and Proposition 36. Journal of Drug Issues, 34(1), 95–120. https://doi.org/10.1177/002204260403400105",,,,,,,
Ayres_2018,"Ayres, I., & Jalal, A. (2018). The Impact of Prescription Drug Monitoring Programs on U.S. Opioid Prescriptions. The Journal of Law, Medicine & Ethics, 46(2), 387–403. https://doi.org/10.1177/1073110518782948",,,,,,,
Azrin_2007,"Azrin, S. T., Huskamp, H. A., Azzone, V., Goldman, H. H., Frank, R. G., Burnam, M. A., Normand, S. L., Ridgely, M. S., Young, A. S., Barry, C. L., Busch, A. B., & Moran, G. (2007). Impact of full mental health and substance abuse parity for children in the Federal Employees Health Benefits Program. Pediatrics, 119(2), e452-9. https://doi.org/10.1542/peds.2006-0673",,,,,,,
Azzone_2011,"Azzone, V., Frank, R. G., Normand, S. L., & Burnam, M. A. (2011). Effect of insurance parity on substance abuse treatment. Psychiatr Serv, 62(2), 129–134. https://doi.org/10.1176/ps.62.2.pss6202_0129",,,,,,,
Bachhuber_2014,"Bachhuber, M. A., Saloner, B., Cunningham, C. O., & Barry, C. L. (2014). Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Internal Medicine, 174(10), 1668–1673.",,,,,,,
Bachhuber_2018,"Bachhuber, M. A., Mehta, P. K., Faherty, L. J., & Saloner, B. (2017). Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty Treatment. Med Care, 55(12), 985–990. https://doi.org/10.1097/mlr.0000000000000803",,,,,,,
Bachhuber_2019,"Bachhuber, M. A., Tuazon, E., Nolan, M. L., Kunins, H. V., & Paone, D. (2019). Impact of a prescription drug monitoring program use mandate on potentially problematic patterns of opioid analgesic prescriptions in New York City. Pharmacoepidemiol Drug Saf, 28(5), 734–739. https://doi.org/10.1002/pds.4766",,,,,,,
Baicker_2017,"Baicker, K., Allen, H. L., Wright, B. J., & Finkelstein, A. N. (2017). The Effect Of Medicaid On Medication Use Among Poor Adults: Evidence From Oregon. Health Aff (Millwood), 36(12), 2110–2114. https://doi.org/10.1377/hlthaff.2017.0925",,,,,,,
Bammer_2000,"Bammer, G., Battisson, L., Ward, J., & Wilson, S. (2000). The impact on retention of expansion of an Australian public methadone program. Drug and Alcohol Dependence, 58(1–2), 173–180. https://doi.org/10.1016/s0376-8716(99)00084-8",,,,,,,
Bao_2016,"Bao, Y., Pan, Y., Taylor, A., Radakrishnan, S., Luo, F., Pincus, H. A., & Schackman, B. R. (2016). Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians. Health Affairs, 35(6), 1045–1051.",,,,,,,
Bao_2018,"Bao, Y., Wen, K., Johnson, P., Jeng, P. J., Meisel, Z. F., & Schackman, B. R. (2018). Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions. Health Aff (Millwood), 37(10), 1596–1604. https://doi.org/10.1377/hlthaff.2018.0512",,,,,,,
Barber_2017,"Barber, C., Gagnon, D., Fonda, J., Cho, K., Hermos, J., & Miller, M. (2017). Assessing the impact of prescribing directives on opioid prescribing practices among Veterans Health Administration providers. Pharmacoepidemiology & Drug Safety, 26(1), 40–46.",,,,,,,
Barnes_2013,"Barnes, M. C., & Arndt, G. (2013). The Best of Both Worlds: Applying Federal Commerce and State Police Powers to Reduce Prescription Drug Abuse. Journal of Health Care Law and Policy, 16, 271–308.",,,,,,,
Barnett_2018,"Barnett, M. L., Olenski, A. R., Thygeson, N. M., Ishisaka, D., Wong, S., Jena, A. B., & Mehrotra, A. (2018). A Health Plan’s Formulary Led To Reduced Use Of Extended-Release Opioids But Did Not Lower Overall Opioid Use. Health Aff (Millwood), 37(9), 1509–1516. https://doi.org/10.1377/hlthaff.2018.0391",,,,,,,
Bartelson_2017,"Bartelson, B. B., Le Lait, M. C., Green, J. L., Cepeda, M. S., Coplan, P. M., Maziere, J. Y., Wedin, G. P., & Dart, R. C. (2017). Changes in misuse and abuse of prescription opioids following implementation of Extended-Release and Long-Acting Opioid Analgesic Risk Evaluation and Mitigation Strategy. Pharmacoepidemiol Drug Saf, 26(9), 1061–1070. https://doi.org/10.1002/pds.4257",,,,,,,
Barthwell_2016,"Barthwell, A. G., Young, J. M., Barnes, M. C., & Kulkarni, S. R. (2016). What’s in a number? Recommending practicality in the DATA 2000 patient limits. Journal of Opioid Management, 12(4), 243–250.",,,,,,,
Beaudoin_2016,"Beaudoin, F. L., Banerjee, G. N., & Mello, M. J. (2016). State-level and system-level opioid prescribing policies: The impact on provider practices and overdose deaths, a systematic review. Journal of Opioid Management, 12(2), 109–118.",,,,,,,
Becquemont_2014,"Becquemont, L., Delespierre, T., Bauduceau, B., Benattar-Zibi, L., Berrut, G., Corruble, E., Danchin, N., Derumeaux, G., Doucet, J., Falissard, B., Forette, F., Hanon, O., Pasquier, F., Pinget, M., Ourabah, R., Bucher, S., Lazkani, A., Piedvache, C., & Bertin, P. (2014). Consequences of dextropropoxyphene market withdrawal in elderly patients with chronic pain. Eur J Clin Pharmacol, 70(10), 1237–1242. https://doi.org/10.1007/s00228-014-1722-x",,,,,,,
Beheshti_2018,"Beheshti, D. (2019). Adverse health effects of abuse-deterrent opioids: Evidence from the reformulation of OxyContin. Health Economics, 28(12), 1449-1461. https://doi.org/10.1002/hec.3944",,,,,,,
Beletsky_2008,"Beletsky, L., Davis, C. S., Anderson, E., & Burris, S. (2008). The law (and politics) of safe injection facilities in the United States. American Journal of Public Health, 98(2), 231–237.",,,,,,,
Ben-Joseph_2014,"Ben-Joseph, R., Chen, C. C., De, A. P., Wade, R. L., & Shah, D. (2014). Consequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plans. Journal of Medical Economics, 17(10), 708–718.",,,,,,,
Bernhardt_2017,"Bernhardt, M. B., Taylor, R. S., Hagan, J. L., Patel, N., Chumpitazi, C. E., Fox, K. A., & Glover, C. (2017). Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products. American Journal of Health-System Pharmacy, 74(24), 2046–2053.",,,,,,,
Bernstein_2013,"Bernstein, S. E., & Bennett, D. (2013). Zoned Out: “NIMBYism”, addiction services and municipal governance in British Columbia. International Journal of Drug Policy, 24(6), e61-5.",,,,,,,
Best_2010,"Best, D., Walker, D., Aston, E., Pegram, C., & O’Donnell, G. (2010). Assessing the impact of a high-intensity partnership between the police and drug treatment service in addressing the offending of problematic drug users. Policing & Society, 20(3), 358–369.",,,,,,,
Biddulph_2011,"Biddulph, S., & Xie, C. (2011). Regulating Drug Dependency in China: The 2008 PRC Drug Prohibition Law. British Journal of Criminology, 51, 978–996.",,,,,,,
Bird_2015,"Bird, S. M., Fischbacher, C. M., Graham, L., & Fraser, A. (2015). Impact of opioid substitution therapy for Scotland’s prisoners on drug-related deaths soon after prisoner release. Addiction, 110(10), 1617–1624.",,,,,,,
Bird_2016,"Bird, S. M., McAuley, A., Perry, S., & Hunter, C. (2016). Effectiveness of Scotland’s National Naloxone Programme for reducing opioid-related deaths: A before (2006-10) versus after (2011-13) comparison. Addiction, 111(5), 883–891.",,,,,,,
Birk_2017,"Birk, E., & Waddell, G. R. (2017). The mitigating role of prescription drug monitoring programs in the abuse of prescription drugs (SSRN Scholarly Paper ID 3037875). Social Science Research Network. https://papers.ssrn.com/abstract=3037875",,,,,,,
Black_2019,"Black, J. C., Bau, G. E., Rosen, T., Cepeda, M. S., Wedin, G. P., Green, J. L., & Dart, R. C. (2019). Changes in Mortality Involving Extended-Release and Long-Acting Opioids After Implementation of a Risk Evaluation and Mitigation Strategy. Pain Med 21(1), 92-100. https://doi.org/10.1093/pm/pnz031",,,,,,,
Blanchard_2016,"Blanchard, J., Hunter, S. B., Osilla, K. C., Stewart, W., Walters, J., & Pacula, R. L. (2016). A Systematic Review of the Prevention and Treatment of Prescription Drug Misuse. Military Medicine, 181(5), 410–423.",,,,,,,
Blanchard_2018,"Blanchard, J., Weiss, A. J., Barrett, M. L., McDermott, K. W., & Heslin, K. C. (2018). State variation in opioid treatment policies and opioid-related hospital readmissions. BMC Health Serv Res, 18(1), 971. https://doi.org/10.1186/s12913-018-3703-8",,,,,,,
Bleyer_2019,"Bleyer, A., & Barnes, B. (2019). Contribution of Marijuana Legalization to the U.S. Opioid Mortality Epidemic: Individual and Combined Experience of 27 States and District of Columbia. MedRxiv. https://doi.org/10.1101/19007393",,,,,,,
Bluthenthal_2018,"Bluthenthal, R. N., Heinzerling, K. G., Anderson, R., Flynn, N. M., & Kral, A. H. (2008). Approval of syringe exchange programs in California: Results from a local approach to HIV prevention. Am J Public Health, 98(2), 278–283. https://doi.org/10.2105/ajph.2005.080770",,,,,,,
Bobashev_2018,"Bobashev, G., Goree, S., Frank, J., & Zule, W. (2018, 2018//). Pain Town, an Agent-Based Model of Opioid Use Trajectories in a Small Community. Social, Cultural, and Behavioral Modeling, Cham.",,,,,,,
Boehnke_2016,"Boehnke, K. F., Litinas, E., & Clauw, D. J. (2016). Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. Journal of Pain, 17(6), 739–744.",,,,,,,
Bohnert_2011,"Bohnert, A. S. B., N., i, A., Tracy, M., Cerda, M., Tardiff, K. J., Vlahov, D., & Galea, S. (2011). Policing and risk of overdose mortality in urban neighborhoods. Drug and Alcohol Dependence, 113(1), 62–68.",,,,,,,
Bohnert_2018,"Bohnert, A. S. B., Guy, G. P., Jr., & Losby, J. L. (2018). Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention’s 2016 Opioid Guideline. Ann Intern Med, 169(6), 367–375. https://doi.org/10.7326/m18-1243",,,,,,,
Borquez_2018,"Borquez, A., Beletsky, L., Nosyk, B., Strathdee, S. A., Madrazo, A., Abramovitz, D., Rafful, C., Morales, M., Cepeda, J., Panagiotoglou, D., Krebs, E., Vickerman, P., Claude Boily, M., Thomson, N., & Martin, N. K. (2018). The effect of public health-oriented drug law reform on HIV incidence in people who inject drugs in Tijuana, Mexico: An epidemic modelling study. Lancet Public Health, 3(9), e429–e437. https://doi.org/10.1016/s2468-2667(18)30097-5",,,,,,,
Boyer_2008,"Boyer, E. W., & Wines, J. D., Jr. (2008). Impact of Internet pharmacy regulation on opioid analgesic availability. Journal of Studies on Alcohol & Drugs, 69(5), 703–708.",,,,,,,
Bradbury_2014a,"Bradbury, G. (2014a). Overdose prevention services upon release from prison: Best practices from Scotland, Denmark, Italy and Spain . https://www.drugsandalcohol.ie/22777/",,,,,,,
Bradbury_2014b,"Bradbury, G. (2014b). Overdose prevention services upon release from prison: Estonia, Lithuania, Hungary, Poland and Romania . https://idpc.net/publications/2014/07/overdose-prevention-services-upon-release-from-prison-estonia-lithuania-hungary-poland-and-romania",,,,,,,
Bradford_2016,"Bradford, A. C., Bradford, W. D., Abraham, A., & Bagwell Adams, G. (2018). Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population. JAMA Internal Medicine, 2, 02.",,,,,,,
Bradford_2018,"Bradford, Ashley C., & Bradford, W. D. (2018). The Impact of Medical Cannabis Legalization on Prescription Medication Use and Costs under Medicare Part D. The Journal of Law and Economics, 61(3), 461–487. https://doi.org/10.1086/699620",,,,,,,
Brady_2014,"Brady, J. E., Wunsch, H., DiMaggio, C., Lang, B. H., Giglio, J., & Li, G. (2014). Prescription drug monitoring and dispensing of prescription opioids. Public Health Rep, 129(2), 139–147. https://doi.org/10.1177/003335491412900207",,,,,,,
Brands_2003,"Brands, B., Blake, J., & Marsh, D. (2003). Impact of Methadone Program Philosophy Changes on Early Treatment Outcomes. Journal of Addictive Diseases, 22(3), 19–38. https://doi.org/10.1300/J069v22n03_03",,,,,,,
Branham_2017,"Branham, D. K. (2018). Time-Series Analysis of the Impact of Prescription Drug Monitoring Programs on Heroin Treatment Admissions. Subst Use Misuse, 53(4), 694–701. https://doi.org/10.1080/10826084.2017.1363232",,,,,,,
Bravo_2007,"Bravo, M. J., Royuela, L., Barrio, G., de la Fuente, L., Suarez, M., & Brugal, M. T. (2007). More free syringes, fewer drug injectors in the case of Spain. Social Science & Medicine, 65(8), 1773–1778.",,,,,,,
Brighthaupt_2019,"Brighthaupt, S. C., Stone, E. M., Rutkow, L., & McGinty, E. E. (2019). Effect of pill mill laws on opioid overdose deaths in Ohio & Tennessee: A mixed-methods case study. Prev Med, 126, 105736. https://doi.org/10.1016/j.ypmed.2019.05.024",,,,,,,
Brownsberger_2004,"Brownsberger, W. N., Aromaa, S. E., Brownsberger, C. N., & Brownsberger, S. C. (2004). An empirical study of the school zone anti-drug law in three cities in Massachusetts. Journal of Drug Issues, 34(4), 933–949.",,,,,,,
Brown_2010,"Brown, R. T. (2010). Systematic review of the impact of adult drug-treatment courts. Translational Research, 155(6), 263–274.",,,,,,,
Brown_2017,"Brown, R., Riley, M. R., Ulrich, L., Kraly, E. P., Jenkins, P., Krupa, N. L., & Gadomski, A. (2017). Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity. Drug & Alcohol Dependence, 178, 348–354.",,,,,,,
Bruce_2009,"Bruce, R. D., Govindasamy, S., Sylla, L., Kamarulzaman, A., & Altice, F. L. (2009). Lack of Reduction in Buprenorphine Injection After Introduction of Co-Formulated Buprenorphine/Naloxone to the Malaysian Market. American Journal of Drug & Alcohol Abuse, 35(2), 68–72.",,,,,,,
Buchmueller_2018,"Buchmueller, T. C., & Carey, C. (2017). The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare (Working Paper No. 23148). National Bureau of Economic Research. http://www.nber.org/papers/w23148",,,,,,,
Buer_2014,"Buer, L. M., Havens, J. R., & Leukefeld, C. (2014). Does the new formulation of OxyContin(R) deter misuse? A qualitative analysis. Subst Use Misuse, 49(6), 770–774. https://doi.org/10.3109/10826084.2013.866963",,,,,,,
Buhl_2004,"Buhl, L., Saelan, H., & Sorensen, T. M. (2004). Adverse events due to change in organization of problem drug users’ treatment? Scandinavian Journal of Public Health, 32(2), 130–135.",,,,,,,
Bunting_2019,"Bunting, A. M., Victor, G., Pike, E., Staton, M., Winston, E., & Pangburn, K. (2020). The Impact of Policy Changes on Heroin and Nonmedical Prescription Opioid Use Among an Incarcerated Population in Kentucky, 2008 to 2016. Criminal Justice Policy Review, 31(5), 746–762. https://doi.org/10.1177/0887403419838029",,,,,,,
Burger_2017,"Burger, J., & Kapron, M. J. D. (2017). Drug Policy and Indigenous Peoples. Health and Human Rights, 19(1), 269.",,,,,,,
Burns_2016,"Burns, R. M., Pacula, R. L., Bauhoff, S., Gordon, A. J., Hendrikson, H., Leslie, D. L., & Stein, B. D. (2016). Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013. Substance Abuse, 37(1), 63–69.",,,,,,,
Busch_2014,"Busch, S. H., Epstein, A. J., Harhay, M. O., Fiellin, D. A., Un, H., Leader, D., Jr., & Barry, C. L. (2014). The effects of federal parity on substance use disorder treatment. Am J Manag Care, 20(1), 76–82.",,,,,,,
Butler_2013,"Butler, S. F., Cassidy, T. A., Chilcoat, H., Black, R. A., Landau, C., Budman, S. H., & Coplan, P. M. (2013). Abuse rates and routes of administration of reformulated extended-release oxycodone: Initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment. J Pain, 14(4), 351–358. https://doi.org/10.1016/j.jpain.2012.08.008",,,,,,,
Cady_2019,"Cady, A. (2019). 50 Shades of Data Sharing: How a Uniform Fifty-State Prescription Drug Monitoring Program Can Restore Discretion to Opioid Prescribers and Autonomy to Chronic Pain Patients. Health Matrix, 29(1), 464–500.",,,,,,,
Cahill_2003,"Cahill, R., Keenan, E., Clarke, A., Bol, M, & Barry, J. (2003). Consequences of legislative changes to methadone prescribing in Ireland. International Journal of Drug Policy, 14(3), 241–245.",,,,,,,
Cairns_2016,"Cairns, R., Brown, J. A., & Buckley, N. A. (2016). The impact of codeine re-scheduling on misuse: A retrospective review of calls to Australia’s largest poisons centre. Addiction, 111(10), 1848–1853.",,,,,,,
Calsyn_2003,"Calsyn, D. A., DeMarco, F. J., Saxon, A. J., Sloan, K. L., & Gibbon, K. E. (2003). Evaluation of a minimal services treatment track for noncompliant patients in opioid substitution treatment. American Journal of Public Health, 93(7), 1086–1088.",,,,,,,
Capoccia_2012,"Capoccia, V. A., Grazier, K. L., Toal, C., Ford, J. H., 2nd, & Gustafson, D. H. (2012). Massachusetts’s experience suggests coverage alone is insufficient to increase addiction disorders treatment. Health Aff (Millwood), 31(5), 1000–1008. https://doi.org/10.1377/hlthaff.2011.0326",,,,,,,
Cassidy_2014,"Cassidy, T. A., DasMahapatra, P., Black, R. A., Wieman, M. S., & Butler, S. F. (2014). Changes in prevalence of prescription opioid abuse after introduction of an abuse-deterrent opioid formulation. Pain Med, 15(3), 440–451. https://doi.org/10.1111/pme.12295",,,,,,,
Cassidy_2017,"Cassidy, T. A., Thorley, E., Black, R. A., DeVeaugh-Geiss, A., Butler, S. F., & Coplan, P. (2017). Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder. J Opioid Manag, 13(6), 425–440. https://doi.org/10.5055/jom.2017.0419",,,,,,,
Castillo-Carniglia_2019,"Castillo-Carniglia, A., Ponicki, W. R., Gaidus, A., Gruenewald, P. J., Marshall, B. D. L., Fink, D. S., Martins, S. S., Rivera-Aguirre, A., Wintemute, G. J., & Cerda, M. (2019). Prescription Drug Monitoring Programs and Opioid Overdoses: Exploring Sources of Heterogeneity. Epidemiology, 30(2), 212–220. https://doi.org/10.1097/ede.0000000000000950",,,,,,,
Casturi_2013,"Casturi, N. (2012). A Modern Day Apocalypse: The Pill Mill Epidemic, How It Took Texas by Storm, and How Texas Is Fighting Back Comment. Tex. Tech. Admin. L.J., 14, 445–466.",,,,,,,
CDC_nd,"Prevention, Center for Disease Control and. (2015a). Doctor Shopping Laws. https://www.cdc.gov/phlp/docs/menu-shoppinglaws.pdf",,,,,,,
CDC_nd_2,"Prevention, Center for Disease Control and. (2015b). Menu of Pain Management Clinic Regulation. https://www.cdc.gov/phlp/docs/menu-pmcr.pdf",,,,,,,
CDC_nd_3,"Prevention, Center for Disease Control and. (2015c). Menu of State Laws Related to Prescription Drug Overdose Emergencies. https://www.cdc.gov/phlp/docs/menu-pdoe.pdf",,,,,,,
CDC_nd_4,"Prevention, Center for Disease Control and. (2015d). Menu of State Prescription Drug  Identification Laws. https://www.cdc.gov/phlp/docs/menu-pdil.pdf",,,,,,,
CDC_nd_5,"Prevention, Center for Disease Control and. (2015e). Tamper-Resistant Prescription Form Requirements. https://www.cdc.gov/phlp/docs/menu-prescriptionform.pdf",,,,,,,
CDC_nd_6,"Prevention, Centers for Disease Control and. (2015a). Prescription Drug Physical Examination Requirements. https://www.cdc.gov/phlp/docs/pdpe-requirements.pdf",,,,,,,
CDC_nd_7,"Prevention, Centers for Disease Control and. (2015b). Prescription Drug Time and Dosage Limit Laws. https://www.cdc.gov/phlp/docs/menu_prescriptionlimits.pdf",,,,,,,
Cerda_2018,"Cerda, M., Sarvet, A. L., Wall, M., Feng, T., Keyes, K. M., Galea, S., & Hasin, D. S. (2018). Medical marijuana laws and adolescent use of marijuana and other substances: Alcohol, cigarettes, prescription drugs, and other illicit drugs. Drug & Alcohol Dependence, 183, 62–68.",,,,,,,
Chacko_2017,"Chacko, J., Greenstein, J., Ardolic, B., & Berwald, N. (2017). Effect of an emergency department opioid prescription policy on prescribing patterns. American Journal of Emergency Medicine, 35(9), 1327–1329.",,,,,,,
Chambers_2015,"Chambers, J., Gleason, R. M., Kirsh, K. L., Twillman, R., Webster, L., Berner, J., Fudin, J., & Passik, S. D. (2016). An Online Survey of Patients’ Experiences Since the Rescheduling of Hydrocodone: The First 100 Days. Pain Med, 17(9), 1686–1693. https://doi.org/10.1093/pm/pnv064",,,,,,,
Chang_2016,"Chang, H. Y., Lyapustina, T., Rutkow, L., Daubresse, M., Richey, M., Faul, M., Stuart, E. A., Alex, & er, G. C. (2016). Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis. Drug & Alcohol Dependence, 165, 1–8.",,,,,,,
Chang_2018,"Chang, H. Y., Murimi, I., Faul, M., Rutkow, L., Alex, & er, G. C. (2018). Impact of Florida’s prescription drug monitoring program and pill mill law on high-risk patients: A comparative interrupted time series analysis. Pharmacoepidemiology & Drug Safety, 27(4), 422–429.",,,,,,,
Chang_2018_2,"Chang, F., & Ibrahim, S. (2017). Perceptions of Community-Dwelling Patients and Their Physicians on OxyContin(R) Discontinuation and the Impact on Chronic Pain Management. Pain Res Manag, 2017, 5402915. https://doi.org/10.1155/2017/5402915",,,,,,,
Chan_2019,"Chan, N. W., Burkhardt, J., & Flyr, M. (2020). The Effects of Recreational Marijuana Legalization and Dispensing On Opioid Mortality [https://doi.org/10.1111/ecin.12819]. Economic Inquiry, 58(2), 589-606. https://doi.org/https://doi.org/10.1111/ecin.12819",,,,,,,
Chen_2016,"Chen, J.-s. (2016). Harm reduction policy in Taiwan: toward a comprehensive understanding of its making and effects. Harm Reduction Journal, 13(1), 11. https://doi.org/10.1186/s12954-016-0101-6",,,,,,,
Chen_2018,"Cheng, H. G., & Coplan, P. M. (2018). Incidence of nonmedical use of OxyContin and other prescription opioid pain relievers before and after the introduction of OxyContin with abuse deterrent properties. Postgrad Med, 130(6), 568–574. https://doi.org/10.1080/00325481.2018.1495541",,,,,,,
Chen_2019,"Chen, Q., Hsia, H. L., Overman, R., Bryan, W., Pepin, M., Mariano, E. R., Mudumbai, S. C., Buchheit, T., Krishnamoorthy, V., Good, C. B., Brookhart, M. A., & Raghunathan, K. (2019). Impact of an Opioid Safety Initiative on Patients Undergoing Total Knee Arthroplasty: A Time Series Analysis. Anesthesiology, 131(2), 369–380. https://doi.org/10.1097/aln.0000000000002771",,,,,,,
Cherny_2010,"Cherny, N. I., Baselga, J., de Conno, F., & Radbruch, L. (2010). Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: A report from the ESMO/EAPC Opioid Policy Initiative. Ann Oncol, 21(3), 615–626. https://doi.org/10.1093/annonc/mdp581",,,,,,,
Cheurprakobkit_2000,"Cheurprakobkit, S. (2000). The drug situation in Thailand: The role of government and the police. Drug and Alcohol Review, 19(1), 17–26.",,,,,,,
Chihuri_2019,"Chihuri, S., & Li, G. (2019). State marijuana laws and opioid overdose mortality. Inj Epidemiol, 6, 38. https://doi.org/10.1186/s40621-019-0213-z",,,,,,,
Chilcoat_2016,"Chilcoat, H. D., Coplan, P. M., Harikrishnan, V., & Alexander, L. (2016). Decreased diversion by doctor-shopping for a reformulated extended release oxycodone product (OxyContin). Drug Alcohol Depend, 165, 221–228. https://doi.org/10.1016/j.drugalcdep.2016.06.009",,,,,,,
Chiu_2018,"Chiu, A. S., Jean, R. A., Hoag, J. R., Freedman-Weiss, M., Healy, J. M., & Pei, K. Y. (2018). Association of Lowering Default Pill Counts in Electronic Medical Record Systems With Postoperative Opioid Prescribing. JAMA Surg, 153(11), 1012–1019. https://doi.org/10.1001/jamasurg.2018.2083",,,,,,,
Christopher_2015,"Christopher, P. P., Pinals, D. A., Stayton, T., Sanders, K., & Blumberg, L. (2015). Nature and Utilization of Civil Commitment for Substance Abuse in the United States. J Am Acad Psychiatry Law, 43(3), 313–320.",,,,,,,
Chumpitazi_2017,"Chumpitazi, C. E., Rees, C. A., Camp, E. A., & Bernhardt, M. B. (2017). Decreased Opioid Prescribing in a Pediatric Emergency Department After the Rescheduling of Hydrocodone. Journal of Emergency Medicine, 52(4), 547–553.",,,,,,,
Chun_2007,"Chun, J., Guydish, J. R., Sorensen, J. L., Haug, N. A., Andrews, S., & Nelson, L. (2007). Outcomes in a Sample of Opiod-Dependent Clients Treated Under California’s Proposition 36. Journal of Drug Issues, 37(3), 699–715.",,,,,,,
Chu_2015,"Chu, Y.-W. L. (2015). Do Medical Marijuana Laws Increase Hard-Drug Use? Journal of Law & Economics, 58(2), 481–517.",,,,,,,
Cicero_2015,"Cicero, T. J., & Ellis, M. S. (2015). Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin. JAMA Psychiatry, 72(5), 424–430.",,,,,,,
Cicero_2019,"Cicero, T. J., Mendoza, M., Cattaneo, M., Dart, R. C., Mardekian, J., Polson, M., Roland, C. L., Schnoll, S. H., Webster, L. R., & Park, P. W. (2019). Real-world misuse, abuse, and dependence of abuse-deterrent versus non-abuse-deterrent extended-release morphine in Medicaid non-cancer patients. Postgrad Med, 131(3), 225–229. https://doi.org/10.1080/00325481.2019.1585688",,,,,,,
Clark_2014,"Clark, R. E., Baxter, J. D., Barton, B. A., Aweh, G., & al, et. (2014). The Impact of Prior Authorization on Buprenorphine Dose, Relapse Rates, and Cost for Massachusetts Medicaid Beneficiaries with Opioid Dependence. Health Services Research, 49(6), 1964–1979.",,,,,,,
Cleary_2013,"Cleary, J., De Lima, L., Eisenchlas, J., Radbruch, L., Torode, J., & Cherny, N. I. (2013). Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Latin America and the Caribbean: A report from the Global Opioid Policy Initiative (GOPI). Annals of Oncology, 24, xi41–xi50.",,,,,,,
Cleary_2013_2,"Cleary, J., Powell, R. A., Munene, G., Mwangi-Powell, F. N., Luyirika, E., Kiyange, F., Merriman, A., Scholten, W., Radbruch, L., Torode, J., & Cherny, N. I. (2013). Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Africa: A report from the Global Opioid Policy Initiative (GOPI). Annals of Oncology, 24. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed15&AN=370402997",,,,,,,
Cleary_2013_3,"Cleary, J., Radbruch, L., Torode, J., & Cherny, N. I. (2013). Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Asia: A report from the Global Opioid Policy Initiative (GOPI). Ann Oncol, 24 Suppl 11, xi24-32. https://doi.org/10.1093/annonc/mdt500",,,,,,,
Cleary_2013_4,"Cleary, J., Simha, N., Panieri, A., Scholten, W., Radbruch, L., Torode, J., & Cherny, N. I. (2013). Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in India: A report from the Global Opioid Policy Initiative (GOPI). Ann Oncol, 24 Suppl 11, xi33-40. https://doi.org/10.1093/annonc/mdt501",,,,,,,
Cleary_2013_5,"Cleary, J., Silbermann, M., Scholten, W., Radbruch, L., Torode, J., & Cherny, N. I. (2013). Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: A report from the Global Opioid Policy Initiative (GOPI). Ann Oncol, 24 Suppl 11, xi51-9. https://doi.org/10.1093/annonc/mdt503",,,,,,,
Cochella_2011,"Cochella, S., & Bateman, K. (2011). Provider detailing: An intervention to decrease prescription opioid deaths in Utah. Pain Med, 12 Suppl 2, S73-6. https://doi.org/10.1111/j.1526-4637.2011.01125.x",,,,,,,
Cochran_2017,"Cochran, G., Gordon, A. J., Gellad, W. F., Chang, C. H., Lo-Ciganic, W. H., Lobo, C., Cole, E., Frazier, W., Zheng, P., Kelley, D., & Donohue, J. M. (2017). Medicaid prior authorization and opioid medication abuse and overdose. American Journal of Managed Care, 23(5), e164–e171.",,,,,,,
Cooper_2005,"Cooper, H. L. F., Wypij, D., & Krieger, N. (2005). Police drug crackdowns and hospitalisation rates for illicit-injection- related infections in New York City. International Journal of Drug Policy, 16(3), 150–160.",,,,,,,
Cooper_2005_2,"Cooper, H., Moore, L., Gruskin, S., & Krieger, N. (2005). The impact of a police drug crackdown on drug injectors’ ability to practice harm reduction: A qualitative study. Soc Sci Med, 61(3), 673–684. https://doi.org/10.1016/j.socscimed.2004.12.030",,,,,,,
Coplan_2013,"Coplan, P. M., Kale, H., Sandstrom, L., Landau, C., & Chilcoat, H. D. (2013). Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics. Pharmacoepidemiol Drug Saf, 22(12), 1274–1282. https://doi.org/10.1002/pds.3522",,,,,,,
Coplan_2016,"Coplan, P. M., Chilcoat, H. D., Butler, S. F., Sellers, E. M., Kadakia, A., Harikrishnan, V., Haddox, J. D., & Dart, R. C. (2016). The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting. Clin Pharmacol Ther, 100(3), 275–286. https://doi.org/10.1002/cpt.390",,,,,,,
Corcoran_2010,"Corcoran, P., Reulbach, U., Keeley, H. S., Perry, I. J., Hawton, K., & Arensman, E. (2010). Use of analgesics in intentional drug overdose presentations to hospital before and after the withdrawal of distalgesic from the Irish market. BMC Clin Pharmacol, 10, 6. https://doi.org/10.1186/1472-6904-10-6",,,,,,,
Corsaro_2010,"Corsaro, N., Brunson, R. K., & McGarrell, E. F. (2010). Evaluating a policing strategy intended to disrupt an illicit street-level drug market. Evaluation Review, 34(6), 513–548.",,,,,,,
Corsaro_2012,"Corsaro, N., & Brunson, R. K. (2013). Are suppression and deterrence mechanisms enough? Examining the “pulling levers” drug market intervention strategy in Peoria, Illinois, USA. Int J Drug Policy, 24(2), 115–121. https://doi.org/10.1016/j.drugpo.2012.12.006",,,,,,,
Corsaro_2013,"Corsaro, Nicholas, Hunt, E. D., Hipple, N. K., & McGarrell, E. F. (2012). The Impact of Drug Market Pulling Levers Policing on Neighborhood Violence. Criminology & Public Policy, 11(2), 167–199. https://doi.org/10.1111/j.1745-9133.2012.00798.x",,,,,,,
Costa Storti_2009,"Costa Storti, C., & De Grauwe, P. (2009). The cocaine and heroin markets in the era of globalisation and drug reduction policies. International Journal of Drug Policy, 20(6), 488–496.",,,,,,,
Cotti_2014,"Cotti, C. D., & Haley, M. R. (2014). Estimating the effectiveness of a misdemeanor drug diversion program using propensity score matching and survival analyses. The Social Science Journal, 51(4), 638–644. https://doi.org/10.1016/j.soscij.2014.07.007",,,,,,,
Courtwright_2004,"Courtwright, D. T. (2004). The Controlled Substances Act: How a “big tent” reform became a punitive drug law. Drug and Alcohol Dependence, 76(1), 9–15.",,,,,,,
Cowell_2004,"Cowell, A. J., Broner, N., & Dupont, R. (2004). The Cost-Effectiveness of Criminal Justice Diversion Programs for People with Serious Mental Illness Co-Occurring with Substance Abuse: Four Case Studies. Journal of Contemporary Criminal Justice, 20(3), 292–314. https://doi.org/10.1177/1043986204266892",,,,,,,
Crabtree_2019,"Crabtree, A., Rose, C., Chong, M., & Smolina, K. (2019). Effects of the new prescribing standards in British Columbia on consumption of opioids and benzodiazepines and z drugs. Can Fam Physician, 65(5), e231–e237.",,,,,,,
Csete_2013,"Csete, J., & Catania, H. (2013). Methadone treatment providers’ views of drug court policy and practice: A case study of New York State. Harm Reduction Journal, 10, 35.",,,,,,,
Cunningham_2008,"Cunningham, J. K., & Liu, L.-M. (2008). Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment. Social Science & Medicine, 66(7), 1463–1473.",,,,,,,
Danovich_2019,"Danovich, D., Greenstein, J., Chacko, J., Hahn, B., Ardolic, B., Ilyaguyev, B., & Berwald, N. (2019). Effect of New York State Electronic Prescribing Mandate on Opioid Prescribing Patterns. J Emerg Med, 57(2), 156–161. https://doi.org/10.1016/j.jemermed.2019.03.052",,,,,,,
Dart_2018,"Dart, R. C., Iwanicki, J. L., Dasgupta, N., Cicero, T. J., & Schnoll, S. H. (2017). Do abuse deterrent opioid formulations work? J Opioid Manag, 13(6), 365–378. https://doi.org/10.5055/jom.2017.0415",,,,,,,
Dave_2018,"Dave, D., Deza, M., & Horn, B. P. (2018). Prescription Drug Monitoring Programs, Opioid Abuse, and Crime (Working Paper No. 24975). National Bureau of Economic Research. http://www.nber.org/papers/w24975",,,,,,,
Davis_2006,"Davis, C. S., Burris, S., Kraut-Becher, J., Lynch, K. G., & Metzger, D. (2005). Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA. Am J Public Health, 95(2), 233–236. https://doi.org/10.2105/ajph.2003.033563",,,,,,,
Davis_2014_1,"Davis, Corey S., Pierce, M., & Dasgupta, N. (2014). Evolution and Convergence of State Laws Governing Controlled Substance Prescription Monitoring Programs, 1998-2011. American Journal of Public Health, 104(8), 1389–1395.",,,,,,,
Davis_2014_2,"Davis, C. S., Southwell, J. K., Niehaus, V. R., Walley, A. Y., & Dailey, M. W. (2014). Emergency medical services naloxone access: A national systematic legal review. Academic Emergency Medicine, 21(10), 1173–1177.",,,,,,,
Davis_2015,"Davis, C. S., & Carr, D. (2015). Legal changes to increase access to naloxone for opioid overdose reversal in the United States. Drug & Alcohol Dependence, 157, 112–120.",,,,,,,
Davis_2015_2,"Davis, C. S., Carr, D., Southwell, J. K., & Beletsky, L. (2015). Engaging Law Enforcement in Overdose Reversal Initiatives: Authorization and Liability for Naloxone Administration. American Journal of Public Health, 105(8), 1530–1537.",,,,,,,
Davis_2016,"Davis, C. S., & Carr, D. (2016). Physician continuing education to reduce opioid misuse, abuse, and overdose: Many opportunities, few requirements. Drug & Alcohol Dependence, 163, 100–107.",,,,,,,
Davis_2017,"Davis, C., & Carr, D. (2017). State legal innovations to encourage naloxone dispensing. J Am Pharm Assoc (2003), 57(2s), S180-s184. https://doi.org/10.1016/j.japh.2016.11.007",,,,,,,
Davis_2019,"Davis, C. S., Lieberman, A. J., Hernandez-Delgado, H., & Suba, C. (2019). Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: A national systematic legal review. Drug Alcohol Depend, 194, 166–172. https://doi.org/10.1016/j.drugalcdep.2018.09.022",,,,,,,
Davis_2019_2,"Davis, C. S., Piper, B. J., Gertner, A. K., & Rotter, J. S. (2020). Opioid Prescribing Laws Are Not Associated with Short-term Declines in Prescription Opioid Distribution. Pain Medicine, 21(3), 532-537. https://doi.org/10.1093/pm/pnz159",,,,,,,
Deacon_2016,"Deacon, R. M., Nielsen, S., Leung, S., Rivas, G., Cubitt, T., Monds, L. A., Ezard, N., Larance, B., & Lintzeris, N. (2016). Alprazolam use and related harm among opioid substitution treatment clients—12 months follow up after regulatory rescheduling. International Journal of Drug Policy, 36, 104–111.",,,,,,,
DeBeck_2017,"DeBeck, K., Cheng, T., Montaner, J. S., Beyrer, C., Elliott, R., Sherman, S., Wood, E., & Baral, S. (2017). HIV and the criminalisation of drug use among people who inject drugs: A systematic review. Lancet HIV, 4(8), e357–e374. https://doi.org/10.1016/s2352-3018(17)30073-5",,,,,,,
DeFulio_2013,"DeFulio, A., Stitzer, M., Roll, J., Petry, N., Nuzzo, P., Schwartz, R. P., & Stabile, P. (2013). Criminal justice referral and incentives in outpatient substance abuse treatment. Journal of Substance Abuse Treatment, 45(1), 70–75.",,,,,,,
Degenhardt_2015,"Degenhardt, L., Bruno, R., Ali, R., Lintzeris, N., Farrell, M., & Larance, B. (2015). The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study. Drug Alcohol Depend, 151, 56–67. https://doi.org/10.1016/j.drugalcdep.2015.02.038",,,,,,,
Deiana_2019,"Deiana, C., & Giua, L. (2019). The intended and unintended effects of opioid policies on prescription opioids and crime (SSRN Scholarly Paper ID 3445962). Social Science Research Network. https://papers.ssrn.com/abstract=3445962",,,,,,,
Delcher_2015,"Delcher, C., Wagenaar, A. C., Goldberger, B. A., Cook, R. L., & Maldonado-Molina, M. M. (2015). Abrupt decline in oxycodone-caused mortality after implementation of Florida’s Prescription Drug Monitoring Program. Drug & Alcohol Dependence, 150, 63–68.",,,,,,,
Delcher_2017,"Delcher, C., Chen, G., Wang, Y., Slavova, S., & Goldberger, B. A. (2017). Fatal poisonings involving propoxyphene before and after voluntary withdrawal from the United States’ market: An analysis from the state of Florida. Forensic Sci Int, 280, 228–232. https://doi.org/10.1016/j.forsciint.2017.10.008",,,,,,,
De Lima_2001,"De Lima, L., & al, et. (2001). Legislation analysis according to WHO and INCB criteria on opioid availability: A comparative study of 5 countries and the state of Texas. Health Policy, 56, 99–110.",,,,,,,
DeSimone_2005,"DeSimone, J. (2005). Needle exchange programs and drug injection behavior. Journal of Policy Analysis and Management, 24(3), 559–577.",,,,,,,
De Wree_2009,"De Wree, E., Pauwels, L., Colman, C., & De Ruyver, B. (2009). Alternative sanctions for drug users: Fruitless efforts or miracle solution? Crime, Law and Social Change, 52(5), 513. https://doi.org/10.1007/s10611-009-9206-0",,,,,,,
Dhalla_2009,"Dhalla, I. A., Mamdani, M. M., Sivilotti, M. L. A., Kopp, A., Qureshi, O., & Juurlink, D. N. (2009). Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. Canadian Medical Association Journal, 181(12), 891. https://doi.org/10.1503/cmaj.090784",,,,,,,
Dhanda_2018,"Dhanda, A., O’Connor, S. S., McGuire, H., Knox, E., & Ruth, E. (2018). Patterns of opioid use during initial buprenorphine/naloxone treatment in relation to changes in opioid management laws in Kentucky. Am J Addict, 27(7), 560–566. https://doi.org/10.1111/ajad.12767",,,,,,,
Dick_2015,"Dick, A. W., Pacula, R. L., Gordon, A. J., Sorbero, M., Burns, R. M., Leslie, D., & Stein, B. D. (2015). Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11. Health Affairs, 34(6), 1028–1034.",,,,,,,
Dillender_2018,"Dillender, M. (2018). What happens when the insurer can say no? Assessing prior authorization as a tool to prevent high-risk prescriptions and to lower costs. Journal of Public Economics, 165, 170–200. https://doi.org/10.1016/j.jpubeco.2018.07.006",,,,,,,
Dineen_2016,"Dineen, K. K. (2016). Addressing Prescription Opioid Abuse Concerns in Context: Synchronizing Policy Solutions to Multiple Complex Public Health Problems Contributed Articles. Law & Psychology Review, 40, 1–80.",,,,,,,
Divino_2017,"Divino, V., Cepeda, M. S., Coplan, P., Maziere, J. Y., Yuan, Y., & Wade, R. L. (2017). Assessing the impact of the extended-release/long-acting opioid an-algesics risk evaluation and mitigation strategies on opioid prescrip-tion volume. J Opioid Manag, 13(3), 157–168. https://doi.org/10.5055/jom.2017.0383",,,,,,,
Dolan_2015,"Dolan, K., Worth, H., & Wilson, D. (2015). Compulsory treatment of drug users in Asia: Designed to torture? International Journal of Prisoner Health, 11(4), 255–268.",,,,,,,
Doleac_2019,"Doleac, J. L., & Mukherjee, A. (2019). The moral hazard of lifesaving innovations: Naloxone access, opioid abuse, and crime (SSRN Scholarly Paper ID 3135264). Social Science Research Network. https://papers.ssrn.com/abstract=3135264",,,,,,,
Dorf_2000,"Dorf, M. C., & Sabel, C. F. (2000). Drug Treatment Courts and Emergent Experimentalist Government. Vanderbilt Law Review, 53, 829–884.",,,,,,,
Dormuth_2012,"Dormuth, C. R., Miller, T. A., Huang, A., Mamdani, M. M., & Juurlink, D. N. (2012). Effect of a centralized prescription network on inappropriate prescriptions for opioid analgesics and benzodiazepines. Cmaj, 184(16), E852-6. https://doi.org/10.1503/cmaj.120465",,,,,,,
Dowell_2016,"Dowell, D., Kun, Z., Noonan, R. K., & Hockenberry, J. M. (2016). Mandatory Provider Review And Pain Clinic Laws Reduce The Amounts Of Opioids Prescribed And Overdose Death Rates. Health Affairs, 35(10), 1876–1883.",,,,,,,
Dow_2019,"Dow, W. H., Godoy, A., A., L. C., & Reich, M. (2018). Can Economic Policies Reduce Deaths of Despair? (National Bureau of Economic Research Working Paper Series). National Bureau of Economic Research. https://doi.org/10.3386/w25787",,,,,,,
Dray_2008,"Dray, A., Mazerolle, L., Perez, P., & Ritter, A. (2008). Policing Australia’s “heroin drought”: Using an agent-based model to simulate alternative outcomes. Journal of Experimental Criminology, 4(3), 267–287.",,,,,,,
Driscoll_2017,"Driscoll, D. T. (2017). Solving the Problem of Problem-Solving Justice: Rebalancing Federal Court Investment in Reentry and Pretrial Diversion Programs Notes. Minn. L. Rev., 102, 1381–1412.",,,,,,,
Drucker_2013,"Drucker, E. (2012). Drug Law, Mass Incarceration, and Public Health Symposium: A Step Forward: Creating a Just Drug Policy for the United States. Oregon Law Review, 91, 1097–1128.",,,,,,,
Drug Policy Alliance_2017,Drug Policy Alliance. (2017). An Overdose Death Is Not Murder: Why Drug-Induced Homicide Laws Are Counterproductive and Inhumane. Drug Policy Alliance.,,,,,,,
Dublin_2019,"Dublin, S., Walker, R. L., Shortreed, S. M., Ludman, E. J., Sherman, K. J., Hansen, R. N., Thakral, M., Saunders, K., Parchman, M. L., & Von Korff, M. (2019). Impact of initiatives to reduce prescription opioid risks on medically attended injuries in people using chronic opioid therapy. Pharmacoepidemiol Drug Saf, 28(1), 90–96. https://doi.org/10.1002/pds.4678",,,,,,,
Ducharme_2008,"Ducharme, L. J., & Abraham, A. J. (2008). State policy influence on the early diffusion of buprenorphine in community treatment programs. Substance Abuse Treatment, Prevention, and Policy, 3(1), 17. https://doi.org/10.1186/1747-597X-3-17",,,,,,,
Duppong_2019,"Duppong, T., Amato, A., Silverman, M., Eskin, B., & Allegra, J. R. (2020). Emergency department opioid prescriptions decreased after legislation in New Jersey. The American Journal of Emergency Medicine, 38(6), 1134-1136. https://doi.org/10.1016/j.ajem.2019.158394",,,,,,,
Durning_2005,"Durning, K. (2004). No Pain No Gain?!Who Will Make the Greatest Sacrifices in Curbing Opioid Analgesic Diversion and Abuse? Kentucky Law Journal, 93(1), 199–241.",,,,,,,
Dutko_2010,"Dutko, A. (2009). Florida’s Fight against Prescription Drug Abuse: Prescription Drug Monitoring Program Health Law Issue: Notes and Comments. Nova L. Rev., 34, 739–764.",,,,,,,
Dzotsenidze_2018,"Dzotsenidze, P., Lekashvili, T., Chikhladze, N., Jorbenadze, M., Abesadze, I., & Kordzaia, D. (2018). Impact of ambiguous and restrictive regulations on opioid-prescribing practice in Georgia. Journal of Pain & Symptom Management, 29, 29.",,,,,,,
ECDC_2013,"Control, E. C. for D. P. and, & Union, P. O. of the E. (2013b). Prisoners: Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 progress report. https://publications.europa.eu/en/publication-detail/-/publication/053e1665-721f-4929-9700-62c96fde157d/language-en/format-PDF",,,,,,,
ECDC_2015,"Control, E. C. for D. P. and, & Union, P. O. of the E. (2013a). People who inject drugs: Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 progress report. https://publications.europa.eu/en/publication-detail/-/publication/6c6ced7d-c1b7-4350-8bf0-eada98cc3827/language-en/format-PDF",,,,,,,
Edwards_2000,"Edwards, T. (2000). The Theory and Practice of Compulsory Drug Treatment in the Criminal Justice System: The Wisconsin Experiment. Wisconsin Law Review, 2000, 283–368.",,,,,,,
Egan_2004,"Egan, K. (2014). The Overdose Prevention Act: A Small Step when New Jersey Needs a Giant Leap. Rutgers Journal of Law and Public Policy, 12, 1–37.",,,,,,,
EMCDDA_2002,European Monitoring Centre for Drugs and Addiction(2002). Annual report on the state of the drugs problem in the European Union and Norway 2002. https://publications.europa.eu/en/publication-detail/-/publication/031eaff7-c299-43f5-94ff-feeec70fecdf/language-en/format-PDF,,,,,,,
EMCDDA_2003,European Monitoring Centre for Drugs and Drug Addiction. (2003). 2003 Annual report on the state of the drugs problem in the European Union and Norway. https://publications.europa.eu/en/publication-detail/-/publication/2642fc04-cba8-4a6d-98c2-2264e42f433a/language-en/format-PDF,,,,,,,
EMCDDA_2005,European Monitoring Centre for Drugs and Drug Addiction. (2005). Annual report 2005 Selected issues. https://publications.europa.eu/en/publication-detail/-/publication/4b21f37d-e6b6-400f-9b90-cef200344a99/language-en/format-PDF,,,,,,,
EMCDDA_2015,European Monitoring Centre for Drugs and Drug Addiction. . (2015a). Alternatives to punishment for drug-using offenders. https://publications.europa.eu/en/publication-detail/-/publication/8c963225-da5f-4d64-852b-6cdebc0d5f68/language-en/format-PDF,,,,,,,
EMCDDA_2015_2,European Monitoring Centre for Drugs and Drug Addiction. . (2015b). Drugs policy and the city in Europe. https://publications.europa.eu/en/publication-detail/-/publication/398fc8e3-a257-4344-ae5e-a1537349827e/language-en/format-PDF,,,,,,,
Erfanian_2019,"Erfanian, E., Grossman, D., & Collins, A. R. (2019). The Impact of Naloxone Access Laws on Opioid Overdose Deaths in the U.S. The Review of Regional Studies, 49(1), 45–72. ABI/INFORM Collection.",,,,,,,
Erickson_2005,"Erickson, P. G., & Callaghan, R. C. (2005). The probable impacts of the removal of the addiction disability benefit in Ontario. Can J Commun Ment Health, 24(2), 99–108. https://doi.org/10.7870/cjcmh-2005-0017",,,,,,,
Ernst_2014,"Ernst, B. (2014). A Simple Concept in a Complicated World: Actual Causation, Mixed-Drug Deaths and the Eighth Circuit’s Opinion in United States v. Burrage. Boston College Law Review, 55(6). https://lawdigitalcommons.bc.edu/bclr/vol55/iss6/2/",,,,,,,
Espelt_2017,"Espelt, A., Villalbi, J. R., Bosque-Prous, M., Pares-Badell, O., Mari-Dell’Olmo, M., & Brugal, M. T. (2017). The impact of harm reduction programs and police interventions on the number of syringes collected from public spaces. A time series analysis in Barcelona, 2004-2014. Int J Drug Policy, 50, 11–18. https://doi.org/10.1016/j.drugpo.2017.07.033",,,,,,,
Ettner_2016,"Ettner, S. L., J, M. H., Thalmayer, A., Ong, M. K., Xu, H., Bresolin, M. J., Wells, K. B., Tseng, C. H., & Azocar, F. (2016). The Mental Health Parity and Addiction Equity Act evaluation study: Impact on specialty behavioral health utilization and expenditures among “carve-out” enrollees. J Health Econ, 50, 131–143. https://doi.org/10.1016/j.jhealeco.2016.09.009",,,,,,,
Evans_2014,"Evans, E., Li, L., Urada, D., & Anglin, M. D. (2014). Comparative Effectiveness of California’s Proposition 36 and Drug Court Programs Before and After Propensity Score Matching. Crime Delinq, 60(6), 909–938. https://doi.org/10.1177/0011128710382342",,,,,,,
Evans_2018,"Evans, W. N., Lieber, E., & Power, P. (2018). How the Reformulation of OxyContin Ignited the Heroin Epidemic. National Bureau of Economic Research Working Paper Series. https://doi.org/10.3386/w24475",,,,,,,
Fairbarin_2015,"Fairbairn, N., Hayashi, K., Ti, L., Kaplan, K., Suwannawong, P., Wood, E., & Kerr, T. (2015). Compulsory drug detention and injection drug use cessation and relapse in Bangkok, Thailand. Drug & Alcohol Review, 34(1), 74–81.",,,,,,,
Falcato_2001,"Falcato, L., Stohler, R., Farl, D.-M., M, K., Eichenberger, A., Eich, D., & Rossler, W. (2001). Closure of an open drug scene—A case register-based analysis of the impact on the demand for methadone maintenance treatment. Addiction, 96(4), 623–628.",,,,,,,
Farrell_2005,"Farrell, G., & Thorne, J. (2005). Where have all the flowers gone?: Evaluation of the Taliban crackdown against opium poppy cultivation in Afghanistan. International Journal of Drug Policy, 16(2), 81–91. https://doi.org/10.1016/j.drugpo.2004.07.007",,,,,,,
Faryar_2017,"Faryar, K. A., Freeman, C. L., Persaud, A. K., Furmanek, S. P., Guinn, B. E., Mattingly, W. A., Wiemken, T. L., Buckner, K. A., & Huecker, M. R. (2017). The Effects of Kentucky’s Comprehensive Opioid Legislation on Patients Presenting with Prescription Opioid or Heroin Abuse to One Urban Emergency Department. Journal of Emergency Medicine, 53(6), 805–814.",,,,,,,
Faryar_2019,"Faryar, K. A., Webb, A. N., Bhandari, B., Price, T. G., & Bosse, G. M. (2019). Trending gabapentin exposures in Kentucky after legislation requiring use of the state prescription drug monitoring program for all opioid prescriptions. Clinical Toxicology, 57(6), 398-403. https://doi.org/10.1080/15563650.2018.1538518",,,,,,,
Feder_2017,"Feder, K. A., Mojtabai, R., Krawczyk, N., Young, A. S., Kealhofer, M., Tormohlen, K. N., & Crum, R. M. (2017). Trends in insurance coverage and treatment among persons with opioid use disorders following the Affordable Care Act. Drug Alcohol Depend, 179, 271–274. https://doi.org/10.1016/j.drugalcdep.2017.07.015",,,,,,,
Felix_2017,"Felix, S., & Portugal, P. (2017). Drug decriminalization and the price of illicit drugs. International Journal of Drug Policy, 39, 121–129.",,,,,,,
Felix_2017a,"Félix, S., Portugal, P., & Tavares, A. (2017). Going after the addiction, not the addicted: The impact of drug decriminalization in Portugal. IZA Institute of Labor Economics Discussion Paper Series.",,,,,,,
Fernandez_2018,"Fernandez, J., Thornton, J. D., Rege, S., Lewing, B., Bapat, S., Xu, Q., & Fleming, M. L. (2018). Prescribers’ perceptions on the impact of hydrocodone rescheduling on geriatric pain management: A qualitative study. J Opioid Manag, 14(5), 317–326. https://doi.org/10.5055/jom.2018.0464",,,,,,,
Ferrara_2012,"Ferrara, M. M. (2012). The Disparate Treatment of Addiction-Assistance Medications and Opiate Pain Medications under the Law: Permitting the Proliferation of Opiates and Limiting Access to Treatment Comment. Seton Hall L. Rev., 42, 741–768.",,,,,,,
Filies-Away_2014,"Flies-Away, J. T., & Garrow, C. E. (2013). Healing to Wellness Courts: Therapeutic Jurisprudence + Indian Tribes and Human Rights Accountability. Michigan State Law Review, 2013, 403–450.",,,,,,,
Fink_2018,"Fink, D. S., Schleimer, J. P., Sarvet, A., Grover, K. K., Delcher, C., Castillo-Carniglia, A., Kim, J. H., Rivera-Aguirre, A. E., Henry, S. G., Martins, S. S., & Cerda, M. (2018). Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses: A Systematic Review. Ann Intern Med, 168(11), 783–790. https://doi.org/10.7326/m17-3074",,,,,,,
Finley_2017,"Finley, E. P., Garcia, A., Rosen, K., McGeary, D., Pugh, M. J., & Potter, J. S. (2017). Evaluating the impact of prescription drug monitoring program implementation: A scoping review. BMC Health Services Research, 17(1), 420.",,,,,,,
Fiscella_2004,"Fiscella, K., Pless, N., Meldrum, S., & Fiscella, P. (2004). Benign neglect or neglected abuse: Drug and alcohol withdrawal in U.S. jails. Journal of Law, Medicine & Ethics, 32(1), 129–136.",,,,,,,
Fischer_2013,"Fischer, B., Ialomiteanu, A., Kurdyak, P., Mann, R. E., & Rehm, J. (2013). Reductions in non-medical prescription opioid use among adults in Ontario, Canada: Are recent policy interventions working? Substance Abuse Treatment, Prevention, & Policy, 8, 7.",,,,,,,
Fisher_2012,"Fisher, J. E., Zhang, Y., Sketris, I., Johnston, G., & Burge, F. (2012). The effect of an educational intervention on meperidine use in Nova Scotia, Canada: A time series analysis. Pharmacoepidemiol Drug Saf, 21(2), 177–183. https://doi.org/10.1002/pds.2259",,,,,,,
Fishman_2004,"Fishman, S. M., Papazian, J. S., Gonzalez, S., Riches, P. S., & Gilson, A. (2004). Regulating opioid prescribing through prescription monitoring programs: Balancing drug diversion and treatment of pain. Pain Medicine, 5(3), 309–324.",,,,,,,
Fitzgerald_2004,"Fitzgerald, J., Dovey, K., Dietze, P., & Rumbold, G. (2004). Health outcomes and quasi-supervised settings for street injecting drug use. International Journal of Drug Policy, 15(4), 247–257.",,,,,,,
Fitzpatrick_2012,"Fitzpatrick, E. (2011). Cochran v. Commonwealth: Revising Whether Kentucky Should Charge, Commit, or Cure Pregnant Substance Abusers Note. U. Louisville L. Rev., 50, 551–576.",,,,,,,
Fleming_2019,"Fleming, M. L., Driver, L., Sansgiry, S. S., Abughosh, S. M., Wanat, M. A., Varisco, T. J., Pickard, T., Reeve, K., & Todd, K. H. (2019). Drug Enforcement Administration Rescheduling of Hydrocodone Combination Products Is Associated With Changes in Physician Pain Management Prescribing Preferences. J Pain Palliat Care Pharmacother, 33(1–2), 22–31. https://doi.org/10.1080/15360288.2019.1615027",,,,,,,
Fornili_2017,"Fornili, K. S., & Fogger, S. A. (2017). Nurse Practitioner Prescriptive Authority for Buprenorphine: From DATA 2000 to CARA 2016. Journal of Addictions Nursing, 28(1), 43–48.",,,,,,,
Franklin_2012,"Franklin, G. M., Mai, J., Turner, J., Sullivan, M., Wickizer, T., & Fulton-Kehoe, D. (2012). Bending the prescription opioid dosing and mortality curves: Impact of the Washington State opioid dosing guideline. American Journal of Industrial Medicine, 55(4), 325–331.",,,,,,,
Freeman_2005,"Freeman, K., Jones, C. G., Weatherburn, D. J., Rutter, S., Spooner, C. J., & Donnelly, N. (2005). The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime. Drug & Alcohol Review, 24(2), 173–184.",,,,,,,
Freeman_2015,"Freeman, Patricia R., Goodin, A., Troske, S., & Talbert, J. (2015). Kentucky House Bill 1 Impact Evaluation. Institute for Pharmaceutical Outcomes & Policy.",,,,,,,
Freeman_2018,"Freeman, P. R., Hankosky, E. R., Lofwall, M. R., & Talbert, J. C. (2018). The changing landscape of naloxone availability in the United States, 2011—2017. Drug Alcohol Depend, 191, 361–364. https://doi.org/10.1016/j.drugalcdep.2018.07.017",,,,,,,
Friedman_2006,"Friedman, S. R., Cooper, H. L., Tempalski, B., Keem, M., Friedman, R., Flom, P. L., & Des Jarlais, D. C. (2006). Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS, 20(1), 93–99.",,,,,,,
Friedman_2017,"Friedman, S., Xu, H., Harwood, J. M., Azocar, F., Hurley, B., & Ettner, S. L. (2017). The Mental Health Parity and Addiction Equity Act evaluation study: Impact on specialty behavioral healthcare utilization and spending among enrollees with substance use disorders. J Subst Abuse Treat, 80, 67–78. https://doi.org/10.1016/j.jsat.2017.06.006",,,,,,,
Friedman_2018,"Friedman, S. A., Azocar, F., Xu, H., & Ettner, S. L. (2018). The Mental Health Parity and Addiction Equity Act (MHPAEA) evaluation study: Did parity differentially affect substance use disorder and mental health benefits offered by behavioral healthcare carve-out and carve-in plans? Drug Alcohol Depend, 190, 151–158. https://doi.org/10.1016/j.drugalcdep.2018.06.008",,,,,,,
Furlan_2018,"Furlan, A. D., Carnide, N., Irvin, E., Van Eerd, D., Munhall, C., Kim, J., Li, C. M. F., Hamad, A., Mahood, Q., & MacDonald, S. (2018). A systematic review of strategies to improve appropriate use of opioids and to reduce opioid use disorder and deaths from prescription opioids. Canadian Journal of Pain, 2(1), 218–235. https://doi.org/10.1080/24740527.2018.1479842",,,,,,,
Fu_2013,"Fu, J. J., Zaller, N. D., Yokell, M. A., Bazazi, A. R., & Rich, J. D. (2013). Forced withdrawal from methadone maintenance therapy in criminal justice settings: A critical treatment barrier in the United States. Journal of Substance Abuse Treatment, 44(5), 502–505.",,,,,,,
Garcia_2014,"Garcia, M. M., Angelini, M. C., Thomas, T., Lenz, K., & Jeffrey, P. (2014). Implementation of an opioid management initiative by a state Medicaid program. Journal of Managed Care & Specialty Pharmacy, 20(5), 447–454.",,,,,,,
Garcia_2016,"Garcia, M. C., Dodek, A. B., Kowalski, T., Fallon, J., Lee, S. H., Iademarco, M. F., Auerbach, J., & Bohm, M. K. (2016). Declines in Opioid Prescribing After a Private Insurer Policy Change—Massachusetts, 2011-2015. MMWR Morb Mortal Wkly Rep, 65(41), 1125–1131. https://doi.org/10.15585/mmwr.mm6541a1",,,,,,,
Garcia_2019,"Garcia, M. M., Lenz, K., Greenwood, B. C., Angelini, M. C., Thompson, T., Clements, K. M., Mauro, R. P., & Jeffrey, P. L. (2019). Impact of Sequential Opioid Dose Reduction Interventions in a State Medicaid Program Between 2002 and 2017. J Pain, 20(8), 876–884. https://doi.org/10.1016/j.jpain.2019.01.008",,,,,,,
Garg_2013,"Garg, R. K., Fulton-Kehoe, D., Turner, J. A., Bauer, A. M., Wickizer, T., Sullivan, M. D., & Franklin, G. M. (2013). Changes in opioid prescribing for Washington workers’ compensation claimants after implementation of an opioid dosing guideline for chronic noncancer pain: 2004 to 2010. J Pain, 14(12), 1620–1628. https://doi.org/10.1016/j.jpain.2013.08.001",,,,,,,
Garin_2018,"Garin, J., Pohl, V., & Smith, R. A. (2018). The effect of medical cannabis dispensaries on opioid and heroin overdose mortality (SSRN Scholarly Paper ID 3270101). Social Science Research Network. https://papers.ssrn.com/abstract=3270101",,,,,,,
Gaubert_2009,"Gaubert, S., Vie, M., Damase-Michel, C., Pathak, A., & Montastruc, J. L. (2009). Dextropropoxyphene withdrawal from a French university hospital: Impact on analgesic drug consumption. Fundam Clin Pharmacol, 23(2), 247–252. https://doi.org/10.1111/j.1472-8206.2008.00661.x",,,,,,,
Gau_2017,"Gau, J. M., & Brooke, E. J. (2017). An Assessment of the Impact of a Multipronged Approach to Reducing Problematic Pain Clinics in Florida. Journal of Drug Issues, 47(2), 185–204.",,,,,,,
Gertner_2018,"Gertner, A. K., Domino, M. E., & Davis, C. S. (2018). Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from Medicaid. Drug Alcohol Depend, 190, 37–41. https://doi.org/10.1016/j.drugalcdep.2018.05.014",,,,,,,
Ghobadi_2018,"Ghobadi, A., Van Winkle, P. J., Menchine, M., Chen, Q., Huang, B. Z., & Sharp, A. L. (2018). Reduction of Parenteral Opioid Use in Community Emergency Departments Following Implementation of Treatment Guidelines [https://doi.org/10.1111/acem.13395]. Academic Emergency Medicine, 25(8), 901-910. https://doi.org/https://doi.org/10.1111/acem.13395",,,,,,,
Gillespie_2017,"Gillespie, A. M. (2017). Prosecuting Women Based on Drug Abuse during Pregnancy, Protecting Unborn Children, and Examining the Prosecutorial Standards in the Commonwealth of Virginia and How those Standards Apply. Appalachian Journal of Law, 17(1), 151.",,,,,,,
Gilson_2012,"Gilson, A. M., Fishman, S. M., Wilsey, B. L., Casamalhuapa, C., & Baxi, H. (2012). Time series analysis of California’s prescription monitoring program: Impact on prescribing and multiple provider episodes. J Pain, 13(2), 103–111. https://doi.org/10.1016/j.jpain.2011.09.006",,,,,,,
Giuntella_2018,"Gihleb, R., Giuntella, O., & Zhang, N. (2018). The Effects of Mandatory Prescription Drug Monitoring Programs on Foster Care Admissions. IZA Discussion Paper Series. https://www.iza.org/publications/dp/11470/the-effects-of-mandatory-prescription-drug-monitoring-programs-on-foster-care-admissions",,,,,,,
Goldberg_2005,"Goldberg, K., Simel, D., & Oddone, E. (2005). Effect of an Opioid Management System on Opioid Prescribing and Unscheduled Visits in a Large Primary Care Clinic. Journal of Clinical Outcomes Management, 12.",,,,,,,
Golichenko_2013,"Golichenko, M., & Sarang, A. (2013). Atmospheric pressure: Russian drug policy as a driver for violations of the UN Convention against Torture and the International Covenant on Economic, Social and Cultural Rights. Health Hum Rights, 15(1), E135-43.",,,,,,,
Gomes_2012,"Gomes, T., Paterson, J. M., Juurlink, D. N., Dhalla, I. A., & Mamdani, M. M. (2012). Reformulation of controlled-release oxycodone and pharmacy dispensing patterns near the US-Canada border. Open Medicine?: A Peer-Reviewed, Independent, Open-Access Journal, 6(4), e141-5.",,,,,,,
Gomes_2014,"Gomes, T., Jain, S., Paterson, J. M., Sketris, I., Caetano, P., & Henry, D. (2018). Trends and uptake of new formulations of controlled-release oxycodone in Canada. Pharmacoepidemiol Drug Saf, 27(5), 520–525. https://doi.org/10.1002/pds.4390",,,,,,,
Gomes_2015,"Gomes, T., Paterson, J. M., Mukati, M., & Henry, D. (2015). Retrospective analysis of trends in dispensing long-acting non-tamper-resistant oxycodone near the Canada-United States border. CMAJ Open, 3(2), E231-5. https://doi.org/10.9778/cmajo.20140103",,,,,,,
Gomes_2017,"Gomes, T., Mastorakos, A., Paterson, J. M., Sketris, I., Caetano, P., Greaves, S., & Henry, D. (2017). Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: A time series analysis. CMAJ Open, 5(4), E800-e807. https://doi.org/10.9778/cmajo.20170104",,,,,,,
Gomes_2018,"Gomes, Tara, Juurlink, D., Zhan, Y., Camacho, X., Paterson, J. M., Singh, S., Dhalla, I., Sproule, B., & Mamdani, M. (2014). Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: A time series analysis. CMAJ Open, 2(4), E256–E261.",,,,,,,
Goncalves_2015,"Goncalves, R., Lourenco, A., & Silva, S. N. (2015). A social cost perspective in the wake of the Portuguese strategy for the fight against drugs. Int J Drug Policy, 26(2), 199–209. https://doi.org/10.1016/j.drugpo.2014.08.017",,,,,,,
Gonzalez_2012,"Gonzalez, A. M., 3rd, & Kolbasovsky, A. (2012). Impact of a managed controlled-opioid prescription monitoring program on care coordination. Am J Manag Care, 18(9), 516–524.",,,,,,,
Goodman_2008,"Goodman, K. student author. (2008). Prosecution of Physicians as Drug Traffickers: The United States’ Failed Protection of Legitimate Opioid Prescription Under the Controlled Substances Act and South Australia’s Alternative Regulatory Approach. Columbia Journal of Transnational Law, 47(1), 210–244.",,,,,,,
Goodwin_2014,"Goodwin, M. (2014). Fetal Protection Laws: Moral Panic and the New Constitutional Battlefront. California Law Review, 102, 781–876.",,,,,,,
Gordon_2016,"Gordon, A., Gordon, A., & J, ra. (2016). Does It Fit—A Look at Addiction, Buprenorphine and the Legislation Trying to Make It Work. Journal of Health & Biomedical Law, 12, 1–28.",,,,,,,
Graddy_2017,"Graddy, R., & Rastegar, D. A. (2017). Impact of a Mandated Change in Buprenorphine Formulation. Journal of Addiction Medicine, 11(6), 435–439.",,,,,,,
Grant_2017,"Grant, T. M., Graham, J. C., Carlini, B. H., Ernst, C. C., & Brown, N. N. (2018). Use of Marijuana and Other Substances Among Pregnant and Parenting Women With Substance Use Disorders: Changes in Washington State After Marijuana Legalization. Journal of Studies on Alcohol & Drugs, 79(1), 88–95.",,,,,,,
Grecu_2019,"Grecu, A. M., Dave, D. M., & Saffer, H. (2019). Mandatory Access Prescription Drug Monitoring Programs and Prescription Drug Abuse. Journal of Policy Analysis and Management, 38(1), 181–209. https://doi.org/10.1002/pam.22098",,,,,,,
Greenwald_2009,"Greenwald, G. (2009). Drug Decriminalization in Portugal: Lessons for Creating Fair and Successful Drug Policies. CATO Institute. https://www.cato.org/sites/cato.org/files/pubs/pdf/greenwald_whitepaper.pdf",,,,,,,
Green_2006,"Green, B. L., Rockhill, A., & Furrer, C. (2006). Understanding patterns of substance abuse treatment for women involved with child welfare: The influence of the Adoption and Safe Families Act (ASFA). American Journal of Drug and Alcohol Abuse, 32(2), 149–176.",,,,,,,
Green_2012,"Green, T. C., Mann, M. R., Bowman, S. E., Zaller, N., Soto, X., Gadea, J., Cordy, C., Kelly, P., & Friedmann, P. D. (2012). How Does Use of a Prescription Monitoring Program Change Medical Practice? Pain Medicine, 13(10), 1314–1323.",,,,,,,
Grogan_2016,"Grogan, C. M., Andrews, C., Abraham, A., Humphreys, K., Pollack, H. A., Smith, B. T., & Friedmann, P. D. (2016). Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications. Health Aff (Millwood), 35(12), 2289–2296. https://doi.org/10.1377/hlthaff.2016.0623",,,,,,,
Gutheil_2016,"Gutheil, M., Liger, Q., Heetman, A., Eager, J., & Bourgeon, S. (2016). A review and assessment of EU drug policy. European Parliament. https://publications.europa.eu/en/publication-detail/-/publication/be1c6a73-c03d-11e6-a6db-01aa75ed71a1/language-en/format-PDF",,,,,,,
Habbouche_2018,"Habbouche, J., Lee, J., Steiger, R., Dupree, J. M., Khalsa, C., Englesbe, M., Brummett, C., & Waljee, J. (2018). Association of Hydrocodone Schedule Change With Opioid Prescriptions Following Surgery. JAMA Surg, 153(12), 1111–1119. https://doi.org/10.1001/jamasurg.2018.2651",,,,,,,
Haegerich_2014,"Haegerich, T. M., Paulozzi, L. J., Manns, B. J., & Jones, C. M. (2014). What we know, and don’t know, about the impact of state policy and systems-level interventions on prescription drug overdose. Drug & Alcohol Dependence, 145, 34–47.",,,,,,,
Haegerich_2019,"Haegerich, T. M., Jones, C. M., Cote, P. O., Robinson, A., & Ross, L. (2019). Evidence for state, community and systems-level prevention strategies to address the opioid crisis. Drug Alcohol Depend, 204, 107563. https://doi.org/10.1016/j.drugalcdep.2019.107563",,,,,,,
Haffajee_2018,"Haffajee, R. L., Mello, M. M., Zhang, F., Zaslavsky, A. M., Larochelle, M. R., & Wharam, J. F. (2018). Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages. Health Aff (Millwood), 37(6), 964–974. https://doi.org/10.1377/hlthaff.2017.1321",,,,,,,
Hammett_2014,"Hammett, T. M., Phan, S., Gaggin, J., Case, P., Zaller, N., Lutnick, A., Kral, A. H., Fedorova, E. V., Heimer, R., Small, W., Pollini, R., Beletsky, L., Latkin, C., & Des Jarlais, D. C. (2014). Pharmacies as providers of expanded health services for people who inject drugs: A review of laws, policies, and barriers in six countries. BMC Health Services Research, 14, 261.",,,,,,,
Hampton_2011,"Hampton, A. S., Conner, B. T., Albert, D., Anglin, M. D., Urada, D., & Longshore, D. (2011). Pathways to treatment retention for individuals legally coerced to substance use treatment: The interaction of hope and treatment motivation. Drug and Alcohol Dependence, 118(2), 400–407.",,,,,,,
Hansen_2017,"Hansen, R. N., Walker, R. L., Shortreed, S. M., Dublin, S., Saunders, K., Ludman, E. J., & Von Korff, M. (2016). Impact of an opioid risk reduction initiative on motor vehicle crash risk among chronic opioid therapy patients. Pharmacoepidemiology and Drug Safety, 32nd International Conference on Pharmacoepidemiology and Therapeutic Risk Management. Ireland. 25 (Supplement 3) (pp 312).",,,,,,,
Hardjasa_2018,"Hardjasa, C. (2008). Liberty or Death: Federalism, the DEA, and the War on the Suffering Note. Geo. J.L. & Pub. Pol’y, 6, 669–692.",,,,,,,
Harrison_2019,"Harrison, M. L., & Walsh, T. L. (2019). The effect of a more strict 2014 DEA schedule designation for hydrocodone products on opioid prescription rates in the United States. Clin Toxicol (Phila), 57(11), 1064–1072. https://doi.org/10.1080/15563650.2019.1574976",,,,,,,
Hartung_2004,"Hartung, D. M., Touchette, D. R., Ketchum, K. L., Haxby, D. G., & Goldberg, B. W. (2004). Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population. Clin Ther, 26(9), 1518–1532. https://doi.org/10.1016/j.clinthera.2004.09.013",,,,,,,
Hartung_2017,"Hartung, D. M., Kim, H., Ahmed, S. M., Middleton, L., Keast, S., Deyo, R. A., Zhang, K., & McConnell, K. J. (2018). Effect of a high dosage opioid prior authorization policy on prescription opioid use, misuse, and overdose outcomes. Substance abuse, 39(2), 239–246. https://doi.org/10.1080/08897077.2017.1389798",,,,,,,
Hartung_2018,"Hartung, D. M., Alley, L., Leichtling, G., Korthuis, P. T., & Hildebran, C. (2018). A statewide effort to reduce high-dose opioid prescribing through coordinated care organizations. Addict Behav, 86, 32–39. https://doi.org/10.1016/j.addbeh.2018.04.020",,,,,,,
Havens_2014,"Havens, J. R., Leukefeld, C. G., DeVeaugh-Geiss, A. M., Coplan, P., & Chilcoat, H. D. (2014). The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers. Drug Alcohol Depend, 139, 9–17. https://doi.org/10.1016/j.drugalcdep.2014.02.018",,,,,,,
Hawton_2009,"Hawton, K., Bergen, H., Simkin, S., Brock, A., Griffiths, C., Romeri, E., Smith, K. L., Kapur, N., & Gunnell, D. (2009). Effect of withdrawal of co-proxamol on prescribing and deaths from drug poisoning in England and Wales: Time series analysis. BMJ, 338, b2270. https://doi.org/10.1136/bmj.b2270",,,,,,,
Hawton_2011,"Hawton, K., Bergen, H., Waters, K., Murphy, E., Cooper, J., & Kapur, N. (2011). Impact of withdrawal of the analgesic Co-proxamol on nonfatal self-poisoning in the UK. Crisis: Journal of Crisis Intervention & Suicide, 32(2), 81–87.",,,,,,,
Hawton_2012,"Hawton, K., Bergen, H., Simkin, S., Wells, C., Kapur, N., & Gunnell, D. (2012). Six-year follow-up of impact of co-proxamol withdrawal in England and Wales on prescribing and deaths: Time-series study. PLoS Med, 9(5), e1001213. https://doi.org/10.1371/journal.pmed.1001213",,,,,,,
Hayashi_2013,"Hayashi, K., Nosyk, B., Ti, L., Suwannawong, P., Kaplan, K., Wood, E., & Kerr, T. (2013). Increasing availability of illicit drugs among people who inject drugs in Bangkok, Thailand. Drug & Alcohol Dependence, 132(1), 251–256.",,,,,,,
Hayes_2015,"Hayes, C. J., Hudson, T. J., Phillips, M. M., Bursac, Z., Williams, J. S., Austin, M. A., Edlund, M. J., & Martin, B. C. (2015). The influence of propoxyphene withdrawal on opioid use in veterans. Pharmacoepidemiology & Drug Safety, 24(11), 1180–1188.",,,,,,,
Haynes_2016,"Haynes, A., Kleinschmidt, K., Forrester, M. B., & Young, A. (2016). Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone. Clin Toxicol (Phila), 54(5), 434–440. https://doi.org/10.3109/15563650.2016.1148720",,,,,,,
Hedrich_2012,"Hedrich, D., Alves, P., Farrell, M., Stover, H., Moller, L., & Mayet, S. (2012). The effectiveness of opioid maintenance treatment in prison settings: A systematic review. Addiction, 107(3), 501–517. https://doi.org/10.1111/j.1360-0443.2011.03676.x",,,,,,,
Heins_2019,"Heins, S. E., Frey, K. P., Alexander, G. C., & Castillo, R. C. (2020). Reducing High-Dose Opioid Prescribing: State-Level Morphine Equivalent Daily Dose Policies, 2007–2017. Pain Medicine, 21(2), 308-316. https://doi.org/10.1093/pm/pnz038",,,,,,,
Henderson_2016,"Henderson, A. (2015). Portuguese defiance: Analyzing the strenuous relationship between drug decriminalization and international law (SSRN Scholarly Paper ID 2843336). Social Science Research Network. https://papers.ssrn.com/abstract=2843336",,,,,,,
Hewlett_2013,"Hewlett, L., & Wermeling, D. P. (2013). Survey of naloxone legal status in opioid overdose prevention and treatment. Journal of Opioid Management, 9(5), 369–377.",,,,,,,
Hoffman_2017,"Hoffman, L. A., Lewis, B., & Nixon, S. J. (2017). Opioid Misuse Trends in Treatment Seeking Populations: Revised Prescription Opioid Policy and Temporally Corresponding Changes. Subst Use Misuse, 52(14), 1850–1858. https://doi.org/10.1080/10826084.2017.1316291",,,,,,,
Homenko_2009,"Homenko, H. (2012). Rehabilitating opioid regulation: A prescription for the FDA’s next proposal of an opioid risk evaluation and mitigation strategy (REMS). Health Matrix, 22(1), 273–313.",,,,,,,
Hopwood_2003,"Hopwood, M., Southgate, E., Kippax, S., Bammer, G., Isaac-Toua, G., & MacDonald, M. (2003). The injection of methadone syrup in New South Wales: Patterns of use and increased harm after partial banning of injecting equipment. Australian & New Zealand Journal of Public Health, 27(5), 551–555.",,,,,,,
Hora_2008,"Hora, P. F., & Stalcup, T. (2007). Drug Treatment Courts in the Twenty-First Century: The Evolution of the Revolution in Problem-Solving Courts. Georgia Law Review, 42, 717–812.",,,,,,,
Horgan_2008,"Horgan, C. M., Reif, S., Hodgkin, D., Garnick, D. W., & Merrick, E. L. (2008). Availability of addiction medications in private health plans. Journal of Substance Abuse Treatment, 34(2), 147–156.",,,,,,,
Houborg_2014b,"Houborg, E., Frank, V. A., & Bjerge, B. (2014). From Zero Tolerance to Non-Enforcement: Creating a New Space for Drug Policing in Copenhagen, Denmark. Contemporary Drug Problems, 41(2), 261–291. https://doi.org/10.1177/009145091404100206",,,,,,,
Hough_2003,"Hough, M., Clancy, A., McSweeney, T., & Turnbull, P. J. (2003). Impact of Drug Treatment and Testing Orders on Offending: Two-Year Reconviction Results. National Criminal Justice Reference Service. https://www.ncjrs.gov/App/Publications/abstract.aspx?ID=203278",,,,,,,
Hser_2003,"Hser, Y. I., Teruya, C., Evans, E. A., Longshore, D., Grella, C., & Farabee, D. (2003). Treating drug-abusing offenders. Initial findings from a five-county study on the impact of California’s Proposition 36 on the treatment system and patient outcomes. Evaluation Review, 27(5), 479–505.",,,,,,,
Hser_2007,"Hser, Y. I., Teruya, C., Brown, A. H., Huang, D., Evans, E., & Anglin, M. D. (2007). Impact of California’s Proposition 36 on the drug treatment system: Treatment capacity and displacement. Am J Public Health, 97(1), 104–109. https://doi.org/10.2105/ajph.2005.069336",,,,,,,
Huey_2019,"Huey, L. (2019). What is Known About the Impacts of Supervised Injection Sites on Community Safety and Wellbeing? A Systematic Review. Sociology Publications.",,,,,,,
Hughes_2007,"Hughes, Caitlin, & Stevens, A. (2007). The Effects of Decriminalization of Drug Use in Portugal. The Effects of Decriminalization of Drug Use in Portugal.",,,,,,,
Hughes_2018,"Hughes, C., & Stevens, A. (2018). Review of approaches taken in Ireland and in other jurisdictions to simple possession drug offences. Irish Department of Justice and Equality. http://www.justice.ie/en/JELR/ANNEXE_I_-_Hughes_Stevens_Hulme_Cassidy_-_2018_-_Review_of_approaches_taken_in_Ireland_and_in_other_jurisdictions_to_simple_possession_drug_offences.pdf/Files/ANNEXE_I_-_Hughes_Stevens_Hulme_Cassidy_-_2018_-_Review_of_approaches_taken_in_Ireland_and_in_other_jurisdictions_to_simple_possession_drug_offences.pdf",,,,,,,
Husain_2014,"Husain, S. A., Brown, M. S., & Maurer, M. A. (2014). Do national drug control laws ensure the availability of opioids for medical and scientific purposes? Bulletin of the World Health Organization, 92(2), 108–116.",,,,,,,
Hwang_2015,"Hwang, C. S., Chang, H. Y., & Alexander, G. C. (2015). Impact of abuse-deterrent OxyContin on prescription opioid utilization. Pharmacoepidemiol Drug Saf, 24(2), 197–204. https://doi.org/10.1002/pds.3723",,,,,,,
Inciardi_2003,"Inciardi, James A. (2003). The Irrational Politics of American Drug Policy: Implications for Criminal Law and the Management of Drug-Involved Offenders Commentaries. Ohio St. J. Crim. L., 1, 273–288.",,,,,,,
Inciardi_2009,"Inciardi, J. A., Surratt, H. L., Stivers, Y., & Cicero, T. J. (2009). FDA approvals of generic drugs: Impact on the diversion of opioid analgesics with a potential for abuse. Journal of Opioid Management, 5(2), 81–87.",,,,,,,
Irvine_2019,"Irvine, M. A., Kuo, M., Buxton, J. A., Balshaw, R., Otterstatter, M., Macdougall, L., Milloy, M. J., Bharmal, A., Henry, B., Tyndall, M., Coombs, D., & Gilbert, M. (2019). Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic. Addiction, 114(9), 1602–1613. https://doi.org/10.1111/add.14664",,,,,,,
Irwin_2017,"Irwin, A., Jozaghi, E., Weir, B. W., Allen, S. T., Lindsay, A., & Sherman, S. G. (2017). Mitigating the heroin crisis in Baltimore, MD, USA: A cost-benefit analysis of a hypothetical supervised injection facility. Harm Reduction Journal, 14. http://ezproxy.library.ubc.ca/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=psyh&AN=2017-22977-001&site=ehost-live&scope=site Amos@LawEnforcementAction.org",,,,,,,
Israelsson_2011,"Israelsson, Magnus. (2011). Welfare, Temperance and Compulsory Commitment to Care for Persons with Substance Misuse Problems: A Comparative Study of 38 European Countries. (Cover story). European Addiction Research, 17(6), 329–341.",,,,,,,
Israelsson_2012_2,"Israelsson, M., & Gerdner, A. (2012). Compulsory commitment to care of substance misusers: International trends during 25 Years. Eur Addict Res, 18(6), 302–321. https://doi.org/10.1159/000341716",,,,,,,
Israelsson_2015,"Israelsson, M., Nordlof, K., & Gerdner, A. (2015). European laws on compulsory commitment to care of persons suffering from substance use disorders or misuse problems- a comparative review from a human and civil rights perspective. Subst Abuse Treat Prev Policy, 10, 34. https://doi.org/10.1186/s13011-015-0029-y",,,,,,,
Jauncey_2018,"Jauncey, M., Livingston, M., Salmon, A. M., & Dietze, P. (2018). The impact of OxyContin reformulation at the Sydney Medically Supervised Injecting Centre: Pros and cons. Int J Drug Policy, 53, 17–22. https://doi.org/10.1016/j.drugpo.2017.11.025",,,,,,,
Johnson_2006,"Johnson, B. D., Golub, A., Deren, S., Des Jarlais, D. C., Fuller, C., & Vlahov, D. (2006). The nonimpact of the expanded syringe access program upon heroin use, injection behaviours, and crime indicators in New York City and State. Justice Research and Policy, 8(1), 27–49.",,,,,,,
Johnson_2011,"Johnson, E. M., Porucznik, C. A., Anderson, J. W., & Rolfs, R. T. (2011). State-level strategies for reducing prescription drug overdose deaths: Utah’s prescription safety program. Pain Med, 12 Suppl 2, S66-72. https://doi.org/10.1111/j.1526-4637.2011.01126.x",,,,,,,
Johnson_2014,"Johnson, H., Paulozzi, L., Porucznik, C., Mack, K., & Herter, B. (2014). Decline in drug overdose deaths after state policy changes—Florida, 2010-2012. MMWR. Morbidity and Mortality Weekly Report, 63(26), 569–574.",,,,,,,
Jozaghi_2013,"Jozaghi, E., & Andresen, M. M. A. (2013). Should North America’s first and only supervised injection facility (InSite) be expanded in British Columbia, Canada? Harm Reduction Journal, 10(1). http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=emed15&AN=52450021",,,,,,,
Junod_2018,"Junod, V., Wolff, H., Scholten, W., Novet, B., Greifinger, R., Dickson, C., & Simon, O. (2018). Methadone versus torture: The perspective of the European court of Human Rights. Heroin Addiction and Related Clinical Problems, 20(1), 31–36.",,,,,,,
Kaestner_2019,"Kaestner, R., & Ziedan, E. (2019). Mortality and Socioeconomic Consequences of Prescription Opioids: Evidence from State Policies. NBER Working Papers. https://www.nber.org/papers/w26135",,,,,,,
Kahler_2017,"Kahler, Z. P., Musey, P. I., Schaffer, J. T., Johnson, A. N., Strachan, C. C., & Shufflebarger, C. M. (2017). Effect Of A “No Superuser Opioid Prescription” Policy On ED Visits And Statewide Opioid Prescription. The Western Journal of Emergency Medicine, 18(5), 894–902.",,,,,,,
Kampschmidt_2015,"Kampschmidt, E. D. (2015). Prosecuting Women for Drug Use during Pregnancy: The Criminal Justice System Should Step out and the Affordable Care Act Should Step up Notes. Health Matrix, 25, 487–512.",,,,,,,
Kattan_2016,"Kattan, J. A., Tuazon, E., Paone, D., Dowell, D., Vo, L., Starrels, J. L., Jones, C. M., & Kunins, H. V. (2016). Public Health Detailing-A Successful Strategy to Promote Judicious Opioid Analgesic Prescribing. Am J Public Health, 106(8), 1430–1438. https://doi.org/10.2105/ajph.2016.303274",,,,,,,
Katz_2009,"Katz, J. G. (2009). Heroin Maintenance Treatment: Its Effectiveness and the Legislative Changes Necessary to Implement It in the U.S. Note. J. Contemp. Health L. & Pol’y, 26, 300–342.",,,,,,,
Kaufman_2019,"Kaufman, D., Nihal, A., Leppo, J., Staples, K., McCall, K., & Piper, B. (2019). Opioid mortality following implementation of medical marijuana programs (1999-2017) in the United States. https://doi.org/10.1101/670059",,,,,,,
Keast_2016,"Keast, S. L., Owora, A., Nesser, N., & Farmer, K. (2016). Evaluation of Abuse-Deterrent or Tamper-Resistant Opioid Formulations on Overall Health Care Expenditures in a State Medicaid Program. J Manag Care Spec Pharm, 22(4), 347–356. https://doi.org/10.18553/jmcp.2016.22.4.347",,,,,,,
Keast_2017,"Keast, S. L., Kim, H., Deyo, R. A., Middleton, L., McConnell, K. J., Zhang, K., Ahmed, S. M., Nesser, N., & Hartung, D. M. (2018). Effects of a Prior Authorization Policy for Extended-release/Long-acting Opioids on Utilization and Outcomes in a State Medicaid Program. Addiction, 20, 20.",,,,,,,
Keast_2018,"Keast, S. L., Pham, T., Teel, A., & Nesser, N. J. (2017). Incremental Effect of the Addition of Prescriber Restrictions on a State Medicaid’s Pharmacy-Only Patient Review and Restriction Program. Journal of Managed Care & Specialty Pharmacy, 23(8), 875–883.",,,,,,,
Keene_2007,"Keene, J., Stenner, K., Connor, M., & Fenley, S. (2007). A case-study of substitute opiate prescribing for drug-using offenders. Drugs: Education, Prevention & Policy, 14(5), 443–456.",,,,,,,
Kennedy-Hendrick_2016,"Kennedy-Hendricks, A., Richey, M., McGinty, E. E., Stuart, E. A., Barry, C. L., & Webster, D. W. (2016). Opioid Overdose Deaths and Florida’s Crackdown on Pill Mills. American Journal of Public Health, 106(2), 291–297.",,,,,,,
Kennedy_2017,"Kennedy, M. C., Karamouzian, M., & Kerr, T. (2017). Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: A Systematic Review. Curr HIV/AIDS Rep, 14(5), 161–183. https://doi.org/10.1007/s11904-017-0363-y",,,,,,,
Kennedy_2019,"Kennedy, C., Duggan, E., Bennett, K., & Williams, D. J. (2019). Rates of reported codeine-related poisonings and codeine prescribing following new national guidance in Ireland. Pharmacoepidemiol Drug Saf, 28(1), 106–111. https://doi.org/10.1002/pds.4725",,,,,,,
Kerr_2006,"Kerr, T., Stoltz, J. A., Tyndall, M., Li, K., Zhang, R., Montaner, J., & Wood, E. (2006). Impact of a medically supervised safer injection facility on community drug use patterns: A before and after study. British Medical Journal, 332(7535), 220–222.",,,,,,,
Khobrani_2019,"Khobrani, M., Perona, S., & Patanwala, A. E. (2019). Effect of a legislative mandate on opioid prescribing for back pain in the emergency department. Am J Emerg Med. https://doi.org/10.1016/j.ajem.2019.02.031",,,,,,,
Khruakham_2016,"Khruakham, S., & Lee, J. (2016). A preliminary evaluation on the national drug intervention in Thailand: A time series analysis of crime report. The Police Journal, 89(3), 187–197. https://doi.org/10.1177/0032258X16656325",,,,,,,
Kilby_2015,"Kilby, A. (2015). Opioids for the masses: Welfare tradeoffs in the regulation of narcotic pain medications. Job Market Paper. http://economics.mit.edu/grad/akilby/research",,,,,,,
Kim_2016,"Kim, J. H., Santaella-Tenorio, J., Mauro, C., Wrobel, J., CerdÃ, M., Keyes, K. M., Hasin, D., Martins, S. S., & Guohua, L. (2016). State Medical Marijuana Laws and the Prevalence of Opioids Detected Among Fatally Injured Drivers. American Journal of Public Health, 106(11), 2032–2037.",,,,,,,
Kinnard_2014,"Kinnard, E. N., Howe, C. J., Kerr, T., Skjodt Hass, V., & Marshall, B. D. (2014). Self-reported changes in drug use behaviors and syringe disposal methods following the opening of a supervised injecting facility in Copenhagen, Denmark. Harm Reduct J, 11(1), 29. https://doi.org/10.1186/1477-7517-11-29",,,,,,,
Kinner_2013,"Kinner, S. A., Moore, E., Spittal, M. J., & Indig, D. (2013). Opiate substitution treatment to reduce in-prison drug injection: A natural experiment. International Journal of Drug Policy, 24(5), 460–463.",,,,,,,
Kinsman_2018,"Kinsman, J. M., & Robinson, K. (2018). National Systematic Legal Review of State Policies on Emergency Medical Services Licensure Levels’ Authority to Administer Opioid Antagonists. Prehosp Emerg Care, 22(5), 650–654. https://doi.org/10.1080/10903127.2018.1439129",,,,,,,
Kline_2019,"Kline, T. V., Savage, R. L., Greenslade, J. H., Lock, C. L., Pattullo, C., & Bell, A. J. (2019). Affecting emergency department oxycodone discharge prescribing: An educational intervention. Emerg Med Australas, 31(4), 580–586. https://doi.org/10.1111/1742-6723.13261",,,,,,,
Knudsen_2015,"Knudsen, H. K. (2015). The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level Analysis. J Stud Alcohol Drugs, 76(4), 644–654. https://doi.org/10.15288/jsad.2015.76.644",,,,,,,
Knudsen_2015a,"Knudsen, H. K., Lofwall, M. R., Havens, J. R., & Walsh, S. L. (2015). States’ implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence. Drug Alcohol Depend, 157, 36–43. https://doi.org/10.1016/j.drugalcdep.2015.09.032",,,,,,,
Knudsen_2017,"Knudsen, H. K., & Studts, J. L. (2017). Perceived Impacts of the Affordable Care Act: Perspectives of Buprenorphine Prescribers. J Psychoactive Drugs, 49(2), 111–121. https://doi.org/10.1080/02791072.2017.1295335",,,,,,,
Knudsen_2019,"Knudsen, H. K., Lofwall, M. R., Walsh, S. L., & Havens, J. R. (2019). Impact of health reform on health insurance status among persons who use opioids in eastern Kentucky: A prospective cohort analysis. Int J Drug Policy, 70, 8–14. https://doi.org/10.1016/j.drugpo.2019.04.008",,,,,,,
Kopf_2014,"Kopf, S. (2014). Slaying the Dragon: How the Law Can Help Rehab a Country in Crisis Comment. Pace L. Rev., 35, 739–760.",,,,,,,
Korn_2016,"Korn, A. E. (2016). Detoxing the Child Welfare System. Virginia Journal of Social Policy & the Law, 23, 293–350.",,,,,,,
Kozhimannil_2019,"Kozhimannil, K. B., Dowd, W. N., Ali, M. M., Novak, P., & Chen, J. (2019). Substance use disorder treatment admissions and state-level prenatal substance use policies: Evidence from a national treatment database. Addict Behav, 90, 272–277. https://doi.org/10.1016/j.addbeh.2018.11.019",,,,,,,
Krakauer_2015,"Krakauer, E. L., Nguyen, T. P., Husain, S. A., Nguyen, T. H., Joranson, D. E., Luong, N. K., & Maurer, M. A. (2015). Toward safe accessibility of opioid pain medicines in Vietnam and other developing countries: A balanced policy method. J Pain Symptom Manage, 49(5), 916–922. https://doi.org/10.1016/j.jpainsymman.2014.10.012",,,,,,,
Kramer_2015,"Kramer, T. (2017). The Current State of Counternarcotics Policy and Drug Reform Debates in Myanmar. Journal of Drug Policy Analysis, 10(1), 721–800.",,,,,,,
Kropp_2019,"Kropp, A. K., Nichols, S. D., Chung, D. Y., McCall, K. L., & Piper, B. J. (2019). Prescription Opioid Distribution After the Legalization of Recreational Marijuana in Colorado, 2007-2017. BioRxiv, 702811. https://doi.org/10.1101/702811",,,,,,,
Kruithof_2017,"Kruithof, K., Davies, M., Disley, E., Strang, L., & Ito, K. (2016). Study on alternatives to coercive sanctions as response to drug law offences and drug-related crimes. Publications Office of the European Union. https://publications.europa.eu/en/publication-detail/-/publication/6e9f22b4-aa5a-11e6-aab7-01aa75ed71a1/language-en/format-PDF",,,,,,,
Kumar_2019,"Kumar, V. M., Agboola, F., Synnott, P. G., Segel, C., Webb, M., Ollendorf, D. A., Banken, R., & Chapman, R. H. (2019). Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model. Value Health, 22(4), 416–422. https://doi.org/10.1016/j.jval.2018.12.005",,,,,,,
Kuo_2018,"Kuo, Y. F., Raji, M. A., Liaw, V., Baillargeon, J., & Goodwin, J. S. (2018). Opioid Prescriptions in Older Medicare Beneficiaries After the 2014 Federal Rescheduling of Hydrocodone Products. J Am Geriatr Soc, 66(5), 945–953. https://doi.org/10.1111/jgs.15332",,,,,,,
Kushel_2017,"Kuschel, L. M., & Mort, J. M. (2017). Impact of the Hydrocodone Schedule Change on Opioid Prescription Patterns in South Dakota. S D Med, 70(10), 449–455.",,,,,,,
Kwok_2017,"Kwok, H., Khuu, W., Fern, es, K., Martins, D., Tadrous, M., Singh, S., Juurlink, D. N., & Gomes, T. (2017). Impact of Unrestricted Access to Pregabalin on the Use of Opioids and Other CNS-Active Medications: A Cross-Sectional Time Series Analysis. Pain Medicine, 18(6), 1019–1026.",,,,,,,
Ladd_2017,"Ladd, E., Sweeney, C. F., Guarino, A., & Hoyt, A. (2019). Opioid Prescribing by Nurse Practitioners in Medicare Part D: Impact of State Scope of Practice Legislation. Medical Care Research and Review, 76(3), 337–353. https://doi.org/10.1177/1077558717725604",,,,,,,
Lambdin_2018,"Lambdin, B. H., Davis, C. S., Wheeler, E., Tueller, S., & Kral, A. H. (2018). Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States. Drug Alcohol Depend, 188, 370–376. https://doi.org/10.1016/j.drugalcdep.2018.04.004",,,,,,,
Larance_2015,"Larance, B., Dietze, P., Ali, R., Lintzeris, N., White, N., Jenkinson, R., & Degenhardt, L. (2015). The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations. Drug Alcohol Rev, 34(6), 603–610. https://doi.org/10.1111/dar.12277",,,,,,,
Larance_2015_2,"Larance, B., Mattick, R., Ali, R., Lintzeris, N., Jenkinson, R., White, N., Kihas, I., Cassidy, R., & Degenhardt, L. (2016). Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia. Drug Alcohol Rev, 35(1), 83–91. https://doi.org/10.1111/dar.12344",,,,,,,
Larance_2018,"Larance, B., Dobbins, T., Peacock, A., Ali, R., Bruno, R., Lintzeris, N., Farrell, M., & Degenhardt, L. (2018). The effect of a potentially tamper-resistant oxycodone formulation on opioid use and harm: Main findings of the National Opioid Medications Abuse Deterrence (NOMAD) study. The Lancet. Psychiatry, 5(2), 155–166.",,,,,,,
Larkin_2016,"Larkin, P. J., Jr. (2015). Swift, Certain, and Fair Punishment: 24/7 Sobriety and Hope: Creative Approaches to Alcohol- and Illicit Drug-Using Offenders Criminal Law. Journal of Criminal Law and Criminology, 105, 39–94.",,,,,,,
Larochelle_2015,"Larochelle, M. R., Zhang, F., Ross-Degnan, D., & Wharam, J. F. (2015). Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal of propoxyphene. JAMA Intern Med, 175(6), 978–987. https://doi.org/10.1001/jamainternmed.2015.0914",,,,,,,
Lasnier_2010,"Lasnier, B., Brochu, S., Boyd, N., & Fischer, B. (2010). A heroin prescription trial: Case studies from Montreal and Vancouver on crime and disorder in the surrounding neighbourhoods. International Journal of Drug Policy, 21(1), 28–35.",,,,,,,
Latimore_2017,"Latimore, A. D., & Bergstein, R. S. (2017). “Caught with a body” yet protected by law? Calling 911 for opioid overdose in the context of the Good Samaritan Law. International Journal of Drug Policy, 50, 82–89.",,,,,,,
Laws_2005,"Laws, K. E., D’Ambrosio, R., & Deck, D. D. (2005). Impact of changes in financing on publicly funded methadone maintenance treatment: A comparison between Oregon and Washington. Journal of Maintenance in the Addictions, 3(2), 65–78.",,,,,,,
Levy_2008,"Levy, S. D. (2008). The Collateral Consequences of Seeking Order Through Disorder: New York’s Narcotics Eviction Program. Harvard Civil Rights - Civil Liberties Law Review, 43(2), 539.",,,,,,,
Liang_2018,"Liang, D., Bao, Y., Wallace, M., Grant, I., & Shi, Y. (2018). Medical cannabis legalization and opioid prescriptions: Evidence on US Medicaid enrollees during 1993-2014. Addiction, 113(11), 2060–2070. https://doi.org/10.1111/add.14382",,,,,,,
Liang_2019,"Liang, D., & Shi, Y. (2019a). Prescription drug monitoring programs and drug overdose deaths involving benzodiazepines and prescription opioids. Drug Alcohol Rev, 38(5), 494–502. https://doi.org/10.1111/dar.12959",,,,,,,
Liang_2019_2,"Liang, D., & Shi, Y. (2019b). The Associations of Neighborhood Availability of Marijuana Dispensaries and DATA-2000 Waivered Providers with Hospital Stays Related to Opioids. Subst Use Misuse, 1–11. https://doi.org/10.1080/10826084.2019.1650775",,,,,,,
Lilley_2013,"Lilley, D. R. (2013). Drug Courts and Community Crime Rates: A Nationwide Analysis of Jurisdiction-Level Outcomes. Journal of Criminology, 2013, 571760. https://doi.org/10.1155/2013/571760",,,,,,,
Lilley_2016,"Lilley, D. R. (2017). Did Drug Courts Lead to Increased Arrest and Punishment of Minor Drug Offenses? Justice Quarterly, 34(4), 674–698. https://doi.org/10.1080/07418825.2016.1219760",,,,,,,
Lilley_2019,"Lilley, D. R., Stewart, M. C., & Tucker-Gail, K. (2020). Drug Courts and Net-Widening in U.S. Cities: A Reanalysis Using Propensity Score Matching. Criminal Justice Policy Review, 31(2), 287–308. https://doi.org/10.1177/0887403419828045",,,,,,,
Lin_2017,"Lin, L. A., Bohnert, A. S. B., Kerns, R. D., Clay, M. A., Ganoczy, D., & Ilgen, M. A. (2017). Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans. Pain, 158(5), 833–839.",,,,,,,
Lin_2017_2,"Lin, D. H., Lucas, E., Murimi, I. B., Jackson, K., Baier, M., Frattaroli, S., Gielen, A. C., Moyo, P., Simoni-Wastila, L., & Alexander, G. C. (2017). Physician attitudes and experiences with Maryland’s prescription drug monitoring program (PDMP). Addiction, 112(2), 311–319. https://doi.org/10.1111/add.13620",,,,,,,
Lin_2018,"Lin, H.-C., Wang, Z., Boyd, C., Simoni-Wastila, L., & Buu, A. (2018). Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain. Addictive Behaviors, 76, 348–354.",,,,,,,
Lin_2019,"Lin, H. C., Wang, Z., Simoni-Wastila, L., Boyd, C., & Buu, A. (2019). Interstate data sharing of prescription drug monitoring programs and associated opioid prescriptions among patients with non-cancer chronic pain. Prev Med, 118, 59–65. https://doi.org/10.1016/j.ypmed.2018.10.011",,,,,,,
Liu_2019,"Liu, Y., Baker, O., Schuur, J. D., & Weiner, S. G. (2020). Effects of Rescheduling Hydrocodone on Opioid Prescribing in Ohio. Pain Medicine, 21(9), 1863-1870. https://doi.org/10.1093/pm/pnz210",,,,,,,
Livingstone_2017,"Livingston, M. D., Barnett, T. E., Delcher, C., & Wagenaar, A. C. (2017). Recreational Cannabis Legalization and Opioid-Related Deaths in Colorado, 2000-2015. American Journal of Public Health, 107(11), 1827–1829.",,,,,,,
Li_2014,"Li, G., Brady, J. E., Lang, B. H., Giglio, J., Wunsch, H., & DiMaggio, C. (2014). Prescription drug monitoring and drug overdose mortality. Injury epidemiology, 1(1), 9. https://doi.org/10.1186/2197-1714-1-9",,,,,,,
Lloyd_2017,"Lloyd, C., Stover, H., Zurhold, H., & Hunt, N. (2017). Similar problems, divergent responses: Drug consumption room policies in the UK and Germany. Journal of Substance Use, 22(1), 66–70.",,,,,,,
Lofgren_2011,"Lofgren, A. (2011). A Sign of Things to Come? Drug Policy Reforms in Arizona, Californina and New York. Legislation and Public Policy, 14, 733–804.",,,,,,,
Logan_2001,"Logan, T. K., Hoyt, W., & Leukefeld, C. (2001). Kentucky Drug Court Outcome Evaluation: Behavior, Costs, & Avoided Costs to Society. Center on Drug and Alcohol Research, University of Kentucky. http://www.cdar.uky.edu/CoerciveControl/docs/outcome%20report%20final.pdf",,,,,,,
Lollar_2017,"Lollar, C. E. (2017). Criminalizing Pregnancy. Indiana Law Journal, 92(3), 947–1005.",,,,,,,
Loong_2019,"Loong, D., Bonato, S., Barnsley, J., & Dewa, C. S. (2019). The Effectiveness of Mental Health Courts in Reducing Recidivism and Police Contact: A Systematic Review. Community Ment Health J, 55(7), 1073–1098. https://doi.org/10.1007/s10597-019-00421-9",,,,,,,
Losby_2016,"Losby, J. L., Hyatt, J. D., Kanter, M. H., Baldwin, G., & Matsuoka, D. (2017). Safer and more appropriate opioid prescribing: A large healthcare system’s comprehensive approach. Journal of Evaluation in Clinical Practice, 23(6), 1173–1179.",,,,,,,
Lo_2018,"Lo, S. Y., Winston-McPherson, G. N., Starosta, A. J., Sullivan, M. D., Baird, G. S., Hoofnagle, A. N., & Greene, D. N. (2019). Cannabis Legalization Does Not Influence Patient Compliance with Opioid Therapy. Am J Med, 132(3), 347–353. https://doi.org/10.1016/j.amjmed.2018.11.002",,,,,,,
Lucas_2017,"Lucas, P., & Walsh, Z. (2017). Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients. Int J Drug Policy, 42, 30–35. https://doi.org/10.1016/j.drugpo.2017.01.011",,,,,,,
Luyt_2007,"Luyt, W. F. M. (2007). Harm Reduction, Substance Abuse and Methadone Maintenance in Scottish Prisons. European Journal of Crime, Criminal Law & Criminal Justice, 15(2), 205–226.",,,,,,,
Lyapustina_2016,"Lyapustina, T., Rutkow, L., Chang, H. Y., Daubresse, M., Ramji, A. F., Faul, M., Stuart, E. A., & Alexander, G. C. (2016). Effect of a ""pill mill"" law on opioid prescribing and utilization: The case of Texas. Drug and alcohol dependence, 159, 190–197. https://doi.org/10.1016/j.drugalcdep.2015.12.025",,,,,,,
Macdonald_2001a,"Macdonald, S., Bois, C., Br, s, B., Dempsey, D., Erickson, P., Marsh, D., Meredith, S., Shain, M., Skinner, W., & Chiu, A. (2001). Drug testing and mandatory treatment for welfare recipients. International Journal of Drug Policy, 12(3), 249–257.",,,,,,,
MacDonald_2019,"McDonald, D. C., Carlson, K. E., & Jalbert, S. K. (2019). An Experimental Test of the Effectiveness of Unsolicited Reporting by a Prescription Drug Monitoring Program in Reducing Inappropriate Acquisition of Opioids. Pain Med, 20(5), 944–954. https://doi.org/10.1093/pm/pny095",,,,,,,
MacLean_2018,"MacLean, C. D., Fujii, M., Ahern, T. P., Holoch, P., Russell, R., Hodges, A., & Moore, J. (2019). Impact of Policy Interventions on Postoperative Opioid Prescribing. Pain Med, 20(6), 1212–1218. https://doi.org/10.1093/pm/pny215",,,,,,,
MacLean_2018_2,"Maclean, J. C., & Saloner, B. (2019). The Effect of Public Insurance Expansions on Substance Use Disorder Treatment: Evidence from the Affordable Care Act. Journal of Policy Analysis and Management, 38(2), 366–393. https://doi.org/10.1002/pam.22112",,,,,,,
Majtabai_2018,"Mojtabai, R., Feder, K. A., Kealhofer, M., Krawczyk, N., Storr, C., Tormohlen, K. N., Young, A. S., Olfson, M., & Crum, R. M. (2018). State variations in Medicaid enrollment and utilization of substance use services: Results from a National Longitudinal Study. J Subst Abuse Treat, 89, 75–86. https://doi.org/10.1016/j.jsat.2018.04.002",,,,,,,
Malkin_2001,"Malkin, I. (2001). Establishing Supervised Injecting Facilities: A Responsible Way to Help Minimise Harm. Melbourne University Law Review, 25, 680–756.",,,,,,,
Mallatt_2017,"Mallatt, J. (2018). The Effect of Prescription Drug Monitoring Programs on Opioid Prescriptions and Heroin Crime Rates (SSRN Scholarly Paper ID 3050692). Social Science Research Network. https://papers.ssrn.com/abstract=3050692",,,,,,,
Mallatt_2019,"Mallatt, J. (2019b). Individual Effects of Prescription Drug Monitoring Programs: How Prescriber Information Targets Misusers while Preserving Access for Treatment of Legitimate Pain (SSRN Scholarly Paper ID 3411199). Social Science Research Network. https://papers.ssrn.com/abstract=3411199",,,,,,,
Mallatt_2019_2,"Mallatt, J. (2020). Policy-induced Substitution to Illicit Drugs and Implications for Law Enforcement Activity (SSRN Scholarly Paper ID 3418615). Social Science Research Network. https://papers.ssrn.com/abstract=3418615",,,,,,,
Mallya_2013,"Mallya, A., Purnell, A. L., Svrakic, D. M., Lovell, A. M., Freedl, E., K., Gott, B. M., Sayuk, G. S., Cicero, T. J., Brawer, P. A., Trafton, J. A., Scherrer, J. F., & Lustman, P. J. (2013). Witnessed versus unwitnessed random urine tests in the treatment of opioid dependence. American Journal on Addictions, 22(2), 175–177.",,,,,,,
Mandiberg_2014,"Mandiberg, S. F., & Harris, R. L. (2014). Alcohol- and Drug-Free Housing: A Key Strategy in Breaking the Cycle of Addiction and Recidivism. McGeorge Law Review, 46(4), 843–895.",,,,,,,
Margolis_2009,"Margolis, J. M., Johnston, S. S., Chu, B. C., Onukwugha, E., Hvidsten, K., Alvir, J., Rossi, J. G., & Mullins, C. D. (2009). Effects of a Medicaid prior authorization policy for pregabalin. Am J Manag Care, 15(10), e95-102.",,,,,,,
Margolis_2010,"Margolis, J. M., Cao, Z., Onukwugha, E., Sanchez, R. J., Alvir, J., Joshi, A. V., & Mullins, C. D. (2010). Healthcare utilization and cost effects of prior authorization for pregabalin in commercial health plans. Am J Manag Care, 16(6), 447–456.",,,,,,,
Marotta_2016,"Marotta, P. L., & McCullagh, C. A. (2016). A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011. International Journal of Drug Policy, 32, 3–10.",,,,,,,
Marshall_2011,"Marshall, B. D., Milloy, M. J., Wood, E., Montaner, J. S., & Kerr, T. (2011). Reduction in overdose mortality after the opening of North America’s first medically supervised safer injecting facility: A retrospective population-based study. Lancet, 377(9775), 1429–1437. https://doi.org/10.1016/s0140-6736(10)62353-7",,,,,,,
Martello_2018,"Martello, J., Cassidy, B., & Mitchell, A. (2018). Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program. J Addict Nurs, 29(3), 196–202. https://doi.org/10.1097/jan.0000000000000236",,,,,,,
Martinez_2007,"Martinez, A. N., Bluthenthal, R. N., Lorvick, J., Anderson, R., Flynn, N., & Kral, A. H. (2007). The impact of legalizing syringe exchange programs on arrests among injection drug users in California. J Urban Health, 84(3), 423–435. https://doi.org/10.1007/s11524-006-9139-1",,,,,,,
Martin_2018,"Martin, J., Cunliffe, J., Décary-Hétu, D., & Aldridge, J. (2018). Effect of restricting the legal supply of prescription opioids on buying through online illicit marketplaces: Interrupted time series analysis. BMJ, 361, k2270. https://doi.org/10.1136/bmj.k2270",,,,,,,
Maughan_2015,"Maughan, B. C., Bachhuber, M. A., Mitra, N., & Starrels, J. L. (2015). Prescription monitoring programs and emergency department visits involving opioids, 2004-2011. Drug Alcohol Depend, 156, 282–288. https://doi.org/10.1016/j.drugalcdep.2015.09.024",,,,,,,
Mazerolle_2006,"Mazerolle, L., Soole, D. W., & Rombouts, S. (2006). Street-level drug law enforcement: A meta-analytical review?. Journal of Experimental Criminology, 2(4), 409–435. https://doi.org/10.1007/s11292-006-9017-6",,,,,,,
McAuley_2015,"McAuley, A., Aucott, L., & Matheson, C. (2015). Exploring the life-saving potential of naloxone: A systematic review and descriptive meta-analysis of take home naloxone (THN) programmes for opioid users. International Journal of Drug Policy, 26(12), 1183–1188.",,,,,,,
McAuley_2017,"McAuley, A., Bouttell, J., Barnsdale, L., Mackay, D., Lewsey, J., Hunter, C., & Robinson, M. (2017). Evaluating the impact of a national naloxone programme on ambulance attendance at overdose incidents: A controlled time-series analysis. Addiction, 112(2), 301–308.",,,,,,,
McCary_2019,"McCarty, D., Gu, Y., McIlveen, J. W., & Lind, B. K. (2019). Medicaid expansion and treatment for opioid use disorders in Oregon: An interrupted time-series analysis. Addict Sci Clin Pract, 14(1), 31. https://doi.org/10.1186/s13722-019-0160-6",,,,,,,
McClellan_2018,"McClure, A. M. (2018). Illegitimate Overprescription: How Burrage v. United States Is Hindering Punishment of Physicians and Bolstering the Opioid Epidemic. Notre Dame Law Review, 93(4), 1747–1770.",,,,,,,
McClure_2019,"McClellan, C., Lambdin, B. H., Ali, M. M., Mutter, R., Davis, C. S., Wheeler, E., Pemberton, M., & Kral, A. H. (2018). Opioid-overdose laws association with opioid use and overdose mortality. Addictive Behaviors, 19, 19.",,,,,,,
McConnell_2012,"McConnell, K. J., Ridgely, M. S., & McCarty, D. (2012). What Oregon’s parity law can tell us about the federal Mental Health Parity and Addiction Equity Act and spending on substance abuse treatment services. Drug Alcohol Depend, 124(3), 340–346. https://doi.org/10.1016/j.drugalcdep.2012.02.006",,,,,,,
McConnell_2012_2,"McConnell, K. J., Gast, S. H., Ridgely, M. S., Wallace, N., Jacuzzi, N., Rieckmann, T., McFarland, B. H., & McCarty, D. (2012). Behavioral health insurance parity: Does Oregon’s experience presage the national experience with the Mental Health Parity and Addiction Equity Act? Am J Psychiatry, 169(1), 31–38. https://doi.org/10.1176/appi.ajp.2011.11020320",,,,,,,
McFarland_2005,"McFarl, H, B., Deck, D. D., McCamant, L. E., Gabriel, R. M., & Bigelow, D. A. (2005). Outcomes for Medicaid Clients With Substance Abuse Problems Before and After Managed Care. The Journal of Behavioral Health Services & Research, 32(4), 351–367.",,,,,,,
McGerald_2009,"McGerald, G., Dvorkin, R., Levy, D., Lovell-Rose, S., & Sharma, A. (2009). Prescriptions for schedule II opioids and benzodiazepines increase after the introduction of computer-generated prescriptions. Academic Emergency Medicine, 16(6), 508–512.",,,,,,,
McGinty_2015,"McGinty, E. E., Busch, S. H., Stuart, E. A., Huskamp, H. A., Gibson, T. B., Goldman, H. H., & Barry, C. L. (2015). Federal parity law associated with increased probability of using out-of-network substance use disorder treatment services. Health Aff (Millwood), 34(8), 1331–1339. https://doi.org/10.1377/hlthaff.2014.1384",,,,,,,
McInerney_2019,"McInerney, M. (2019). Medicaid Expansion and the Opioid Epidemic: How does increasing health insurance impact the crisis? [Doctoral Dissertation, University of Connecticut - Storrs]",,,,,,,
McKenna_2017,"McKenna, R. M. (2017). Treatment use, sources of payment, and financial barriers to treatment among individuals with opioid use disorder following the national implementation of the ACA. Drug Alcohol Depend, 179, 87–92. https://doi.org/10.1016/j.drugalcdep.2017.06.028",,,,,,,
McKenzie_2005,"McKenzie, M., Macalino, G., McClung, C., Shield, D. C., & Rich, J. D. (2005). Opiate replacement therapy at time of release from incarceration: Project MOD, a pilot program. Journal of Opioid Management, 1(3), 147–151.",,,,,,,
McMichael_2018,"McMichael, B., van Horn, R. L., & Viscusi, W. K. (2019). The Impact of Cannabis Access Laws in Opioid Prescribing (Research Briefs in Economic Policy). CATO Institute.",,,,,,,
McMichael_2018_2,"McMichael, B. (2018). Scope-of-Practice Laws and Patient Safety: Evidence from the Opioid Crisis. McMichael, B. J. (2018). Scope-of-practice laws and patient safety: Evidence from the opioid crisis (SSRN Scholarly Paper ID 3300365). Social Science Research Network. https://papers.ssrn.com/abstract=3300365",,,,,,,
McSweeny_2007,"McSweeney, T., Stevens, A., Hunt, N., & Turnbull, P. J. (2007). Twisting arms or a helping hand? Assessing the impact of ‘coerced’ and comparable ‘voluntary’ drug treatment options. British Journal of Criminology, 47(3), 470–490.",,,,,,,
Meara_2016,"Meara, E., Horwitz, J. R., Powell, W., McClell, Lynn, Weiping, Z., O’Malley, A. J., Morden, N. E., & Zhou, W. (2016). State Legal Restrictions and Prescription-Opioid Use among Disabled Adults. New England Journal of Medicine, 375(1), 44–53.",,,,,,,
Meinhofer_2018,"Meinhofer, A., & Witman, A. E. (2018). The role of health insurance on treatment for opioid use disorders: Evidence from the Affordable Care Act Medicaid expansion. J Health Econ, 60, 177–197. https://doi.org/10.1016/j.jhealeco.2018.06.004",,,,,,,
Meinhofer_2019,"Meinhofer, Angélica, Witman, A., Murphy, S. M., & Bao, Y. (2019). Medical marijuana laws are associated with increases in substance use treatment admissions by pregnant women. Addiction, 114(9), 1593–1601. https://doi.org/10.1111/add.14661",,,,,,,
Meisenberg_2018,"Meisenberg, B. R., Grover, J., Campbell, C., & Korpon, D. (2018). Assessment of Opioid Prescribing Practices Before and After Implementation of a Health System Intervention to Reduce Opioid Overprescribing. JAMA Netw Open, 1(5), e182908. https://doi.org/10.1001/jamanetworkopen.2018.2908",,,,,,,
Merlo_2011,"Merlo, L. J., Greene, W. M., & Pomm, R. (2011). Mandatory naltrexone treatment prevents relapse among opiate-dependent anesthesiologists returning to practice. Journal of Addiction Medicine, 5(4), 279–283.",,,,,,,
Meyerson_2018,"Meyerson, B. E., Agley, J. D., Davis, A., Jayawardene, W., Hoss, A., Shannon, D. J., Ryder, P. T., Ritchie, K., & Gassman, R. (2018). Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016. Drug Alcohol Depend, 188, 187–192. https://doi.org/10.1016/j.drugalcdep.2018.03.032",,,,,,,
Michels_2007,"Michels, I., Fang, Y. X., Zhao, D., Zhao, L. Y., & Lu, L. (2007). Comparison of drug abuse in Germany and China. Acta Pharmacologica Sinica, 28(10), 1505–1518.",,,,,,,
Miller_2004,"Miller, C. L., Schechter, M. T., Wood, E., Spittal, P. M., Li, K., Laliberte, N., Montaner, J. S., & Hogg, R. S. (2004). The potential health and economic impact of implementing a medically prescribed heroin program among Canadian injection drug users. International Journal of Drug Policy, 15(4), 259–263.",,,,,,,
Miller_2016,"Miller, J. S. (2016). Increasing Access to Naloxone: Overcoming Societal Challenges to Reduce Opioid Overdose Fatalities. Albany Law Journal of Science & Technology, 26, 77–110.",,,,,,,
Milloy_2008,"Milloy, M. J., Kerr, T., Tyndall, M., Montaner, J., & Wood, E. (2008). Estimated drug overdose deaths averted by North America’s first medically-supervised safer injection facility. PLoS One, 3(10), e3351. https://doi.org/10.1371/journal.pone.0003351",,,,,,,
Minhee_2019,"Minhee, C., & Calandrillo, S. (2018). The cure for america’s opioid crisis? End the war on drugs (SSRN Scholarly Paper ID 3245489). Social Science Research Network. https://papers.ssrn.com/abstract=3245489",,,,,,,
Miron_2003,"Miron, J. A. (2003). The Effect of Drug Prohibition on Drug Prices: Evidence from the Markets for Cocaine and Heroin. The Review of Economics and Statistics, 85(3), 522–530.",,,,,,,
Mitchell_2012,"Mitchell, O., Wilson, D. B., Eggers, A., & MacKenzie, D. L. (2012a). Drug courts’ effects on criminal offending for juveniles and adults. Campbell Systematic Reviews, 4. https://doi.org/10.4073/csr.2012.4",,,,,,,
Mitchell_2012_2,"Mitchell, O., Wilson, D. B., Eggers, A., & MacKenzie, D. L. (2012b). Assessing the effectiveness of drug courts on recidivism: A meta-analytic review of traditional and non-traditional drug courts. Journal of Criminal Justice, 40(1), 60–71. https://doi.org/10.1016/j.jcrimjus.2011.11.009",,,,,,,
Mohammadi_2018,"Mohammadi, Z. (2018). The Effects of Prescription Drug Monitoring Programs on the Opioid Abuse Epidemic. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3107826",,,,,,,
Mojtabai_2019,"Mojtabai, R., Mauro, C., Wall, M. M., Barry, C. L., & Olfson, M. (2019a). Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities. Health Aff (Millwood), 38(1), 14–23. https://doi.org/10.1377/hlthaff.2018.05162",,,,,,,
Mojtabai_2019b,"Mojtabai, R., Mauro, C., Wall, M. M., Barry, C. L., & Olfson, M. (2019b). The Affordable Care Act and Opioid Agonist Therapy for Opioid Use Disorder. Psychiatr Serv, 70(7), 617–620. https://doi.org/10.1176/appi.ps.201900025",,,,,,,
Monaghan_2013,"Monaghan, M., & Wincup, E. (2013). Work and the journey to recovery: Exploring the implications of welfare reform for methadone maintenance clients. Int J Drug Policy, 24(6), e81-6. https://doi.org/10.1016/j.drugpo.2013.08.006",,,,,,,
Moore_2007,"Moore, T. J., Ritter, A., & Caulkins, J. P. (2007). The costs and consequences of three policy options for reducing heroin dependency. Drug & Alcohol Review, 26(4), 369–378.",,,,,,,
Morden_2008,"Morden, N. E., Zerzan, J. T., Rue, T. C., Heagerty, P. J., Roughead, E. E., Soumerai, S. B., Ross-Degnan, D., & Sullivan, S. D. (2008). Medicaid prior authorization and controlled-release oxycodone. Med Care, 46(6), 573–580. https://doi.org/10.1097/MLR.0b013e31816493fb",,,,,,,
Morgan_2015,"Horgan, C. M., Hodgkin, D., Stewart, M. T., Quinn, A., Merrick, E. L., Reif, S., Garnick, D. W., & Creedon, T. B. (2016). Health Plans’ Early Response to Federal Parity Legislation for Mental Health and Addiction Services. Psychiatr Serv, 67(2), 162–168. https://doi.org/10.1176/appi.ps.201400575",,,,,,,
Moride_2019,"Moride, Y., Lemieux-Uresandi, D., Castillon, G., de Moura, C. S., Pilote, L., Faure, M., & Bernartsky, S. (2019). A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids. Pain Physician, 22(3), 229–240.",,,,,,,
Morse_2011,"Morse, J. S., Stockbridge, H., Egan, K. B., Mai, J., Wickizer, T., & Franklin, G. M. (2011). Primary care survey of the value and effectiveness of the Washington State Opioid Dosing Guideline. J Opioid Manag, 7(6), 427–433. https://doi.org/10.5055/jom.2011.0083",,,,,,,
Mospan_2018,"Mospan, G., Gillette, C., Chaplin, M., & Bush, M. (2019). Do more opioid policies reduce opioid dispensing in traditional medicaid?: A national analysis. Res Social Adm Pharm, 15(8), 1000–1006. https://doi.org/10.1016/j.sapharm.2018.12.004",,,,,,,
Moyo_2017,"Moyo, P., Simoni-Wastila, L., Griffin, B. A., Onukwugha, E., Harrington, D., Alexander, G. C., & Palumbo, F. (2017). Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States. Addiction (Abingdon, England), 112(10), 1784–1796. https://doi.org/10.1111/add.13860
",,,,,,,
Moyo_2019,"Moyo, P., Simoni-Wastila, L., Griffin, B. A., Harrington, D., Alexander, G. C., Palumbo, F., & Onukwugha, E. (2019). Prescription drug monitoring programs: Assessing the association between “best practices” and opioid use in Medicare. Health Serv Res, 54(5), 1045–1054. https://doi.org/10.1111/1475-6773.13197",,,,,,,
Mulcahy_2017,"Mulcahy, A. W., Hollands, S., Duffy, E. L., Strong, A., & Barbara O. Wynn. (2017). Modeling the Economic Impact of a California Workers’ Compensation Formulary. State of California Department of Industrial Relations. https://www.rand.org/pubs/research_reports/RR1971.html",,,,,,,
Mulrooney_2017,"Mulrooney, J. J., II, & Legel, K. E. (2017). Current Navigation Points in Drug Diversion Law: Hidden Rocks in Shallow, Murky, Drug-Infested Waters. Marquette Law Review, 101, 333–452.",,,,,,,
Murimi_2019,"Murimi, I. B., Chang, H. Y., Bicket, M., Jones, C. M., & Alexander, G. C. (2019). Using trajectory models to assess the effect of hydrocodone upscheduling among chronic hydrocodone users. Pharmacoepidemiol Drug Saf, 28(1), 70–79. https://doi.org/10.1002/pds.4639",,,,,,,
Murphy_2017,"Murphy, S. M., Howell, D., McPherson, S., Grohs, R., Roll, J., & Neven, D. (2017a). A Randomized Controlled Trial of a Citywide Emergency Department Care-Coordination Program to Reduce Prescription Opioid-Related Visits: An Economic Evaluation. J Emerg Med, 53(2), 186–194. https://doi.org/10.1016/j.jemermed.2017.02.014",,,,,,,
Musselwhite_2010,"Musselwhite, E. M. (2010). One Tough Pill to Swallow: A Call to Revise North Carolina’s Drug Trafficking Laws concerning Prescription Painkillers Comment. Campbell L. Rev., 33, 451–476.",,,,,,,
Myer_2018,"Myer, A. J., & Belisle, L. (2018). Highs and Lows: An Interrupted Time-Series Evaluation of the Impact of North America’s Only Supervised Injection Facility on Crime. Journal of Drug Issues, 48(1), 36–49.",,,,,,,
Nagar_2015,"Nagar, V. R., Springer, J. E., & Salles, S. (2015). Increased Incidence of Spinal Abscess and Substance Abuse after Implementation of State Mandated Prescription Drug Legislation. Pain Medicine, 16(10), 2031–2035.",,,,,,,
Nam_2017,"Nam, Y. H., Shea, D. G., Shi, Y., & Moran, J. R. (2017). State prescription drug monitoring programs and fatal drug overdoses. Am J Manag Care, 23(5), 297–303.",,,,,,,
Naumann_2018,"Naumann, R. B., Marshall, S. W., Lund, J. L., Gottfredson, N. C., Ringwalt, C. L., & Skinner, A. C. (2018). Evaluating short- and long-term impacts of a Medicaid “lock-in” program on opioid and benzodiazepine prescriptions dispensed to beneficiaries. Drug Alcohol Depend, 182, 112–119. https://doi.org/10.1016/j.drugalcdep.2017.10.001",,,,,,,
Naumann_2018_2,"Naumann, R. B., Marshall, S. W., Gottfredson, N. C., Lund, J. L., Ringwalt, C. L., & Skinner, A. C. (2019). Trajectories of dispensed prescription opioids among beneficiaries enrolled in a Medicaid controlled substance “lock-in” program. Pharmacoepidemiol Drug Saf, 28(1), 16–24. https://doi.org/10.1002/pds.4445",,,,,,,
Naumann_2019,"Naumann, R. B., Roberts, A. W., Marshall, S. W., & Skinner, A. C. (2019). Evaluation of a Medicaid Lock-in Program: Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk. Med Care, 57(3), 213–217. https://doi.org/10.1097/mlr.0000000000001058",,,,,,,
Neven_2016,"Neven, D., Paulozzi, L., Howell, D., McPherson, S., Murphy, S. M., Grohs, B., Marsh, L., Lederhos, C., & Roll, J. (2016). A Randomized Controlled Trial of a Citywide Emergency Department Care Coordination Program to Reduce Prescription Opioid Related Emergency Department Visits. The Journal of Emergency Medicine, 51(5), 498–507. https://doi.org/10.1016/j.jemermed.2016.06.057
",,,,,,,
Nguyen_2018,"Nguyen, H., & Parker, B. R. (2018). Assessing the effectiveness of New York’s 911 Good Samaritan Law-Evidence from a natural experiment. Int J Drug Policy, 58, 149–156. https://doi.org/10.1016/j.drugpo.2018.05.013",,,,,,,
Nicosia_2017,"Nicosia, N., MacDonald, J. M., & Pacula, R. L. (2017). Does Mandatory Diversion to Drug Treatment Eliminate Racial Disparities in the Incarceration of Drug Offenders? An Examination of California’s Proposition 36. Journal of Quantitative Criminology, 33(1), 179–205. https://doi.org/10.1007/s10940-016-9293-x",,,,,,,
Niv_2009,"Niv, N., Hamilton, A., & Hser, Y. I. (2009). Impact of court-mandated substance abuse treatment on clinical decision making. J Behav Health Serv Res, 36(4), 505–516. https://doi.org/10.1007/s11414-008-9129-z",,,,,,,
Nordt_2009,"Nordt, C., & Stohler, R. (2009). Low-threshold methadone treatment, heroin price, police activity and incidence of heroin use: The Zurich experience. International Journal of Drug Policy, 20(6), 497–501.",,,,,,,
Nordt_2010,"Nordt, C., & Stohler, R. (2010). Combined effects of law enforcement and substitution treatment on heroin mortality. Drug & Alcohol Review, 29(5), 540–545.",,,,,,,
Northrup_2019,"Northrup, T. F., Carroll, K., Suchting, R., Villarreal, Y. R., Zare, M., & Stotts, A. L. (2019). The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System. J Am Board Fam Med, 32(3), 362–374. https://doi.org/10.3122/jabfm.2019.03.180356",,,,,,,
Novak_2012,"Novak, A. (2012). Legislative note: The abolition of the death penalty for drug offenses in The Gambia. Commonwealth Law Bulletin, 38(1), 63–67.",,,,,,,
Obadia_2001,"Obadia, Y., e, Perrin, V., Feroni, I., Vlahov, D., & Moatti, J.-P. (2001). Injecting misuse of buprenorphine among French drug users. Addiction, 96(2), 267–272.",,,,,,,
Obrien_2013,"O’Brien, J. (2012). A Review and Evaluation of Indiana’s INSPECT System and Governing Legislation: Maximizing Potential Impact on Public Health Note. Ind. Health L. Rev., 10, 701–740.",,,,,,,
OConner_2011,"O’Connor, A. B. (2011). Nurse practitioners’ inability to prescribe buprenorphine: Limitations of the Drug Addiction Treatment Act of 2000. Journal of the American Academy of Nurse Practitioners, 23(10), 542–545.",,,,,,,
OConnor_2019,"O’Connor, C. (2019). A GUIDING HAND OR A SLAP ON THE WRIST: CAN DRUG COURTS BE THE SOLUTION TO MATERNAL OPIOID USE? JOURNAL OF CRIMINAL LAW & CRIMINOLOGY, 109(1), 103–136.",,,,,,,
Oehler_2016,"Oehler, E. C., Day, R. L., Robinson, D. B., & Brown, L. H. (2016). Has the rescheduling of hydrocodone changed ED prescribing practices? American Journal of Emergency Medicine, 34(12), 2388–2391.",,,,,,,
Olfson_2018,"Olfson, M., Wall, M., Barry, C. L., Mauro, C., & Mojtabai, R. (2018). Impact Of Medicaid Expansion On Coverage And Treatment Of Low-Income Adults With Substance Use Disorders. Health Aff (Millwood), 37(8), 1208–1215. https://doi.org/10.1377/hlthaff.2018.0124",,,,,,,
Olsen_2006,"Olsen, H. (2006). A happy compromise? Public injection rooms in Norway—Admission criteria and client responses. Drug Users and Spaces for Legitimate Action. NAD Publication, 49, 183–204.",,,,,,,
Olson_2019,"Olson, J., Chen, P.-H. A., White, M., Brennan, N., & Gong, N. (2020). State Drug Policy Effectiveness: Comparative Policy Analysis of Drug Overdose Mortality. ArXiv:1909.01936 [Cs, Econ, Stat]. http://arxiv.org/abs/1909.01936",,,,,,,
Osborn_2017,"Osborn, S. R., Yu, J., Williams, B., Vasilyadis, M., & Blackmore, C. C. (2017). Changes in Provider Prescribing Patterns After Implementation of an Emergency Department Prescription Opioid Policy. Journal of Emergency Medicine, 52(4), 538–546.",,,,,,,
Ozluk_2017,"Ozluk, P. (2017). The effects of medical marijuana laws on utilization of prescribed opioids and other prescription drugs (SSRN Scholarly Paper ID 3056791). Social Science Research Network. https://papers.ssrn.com/abstract=3056791",,,,,,,
Page_2018,"Page, J., Traver, R., Patel, S., & Saliba, C. (2018). Implementation of a Proactive Pilot Health Plan-Driven Opioid Tapering Program to Decrease Chronic Opioid Use for Conditions of the Back and Spine in a Medicaid Population. J Manag Care Spec Pharm, 24(3), 191–196. https://doi.org/10.18553/jmcp.2018.24.3.191",,,,,,,
Palmateer_2014,"Palmateer, N. E., Taylor, A., Goldberg, D. J., Munro, A., Aitken, C., Shepherd, S. J., McAllister, G., Gunson, R., & Hutchinson, S. J. (2014). Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions. PLoS ONE [Electronic Resource], 9(8), e104515.",,,,,,,
Paone_2015,"Paone, D., Tuazon, E., Kattan, J., Nolan, M. L., O’Brien, D. B., Dowell, D., Farley, T. A., & Kunins, H. V. (2015). Decrease in rate of opioid analgesic overdose deaths—Staten Island, New York City, 2011-2013. MMWR. Morbidity and Mortality Weekly Report, 64(18), 491–494.",,,,,,,
Pardo_2017,"Pardo, B. (2017). Do more robust prescription drug monitoring programs reduce prescription opioid overdose? Addiction, 112(10), 1773–1783.",,,,,,,
Park_2019,"Park, C. (2019). Impact of prescription opioid access restrictions on alcohol-induced mortality in kentucky. MPA/MPP Capstone Projects. https://uknowledge.uky.edu/mpampp_etds/325",,,,,,,
Parsons_2014,"Parsons, J., Wei, Q., Rinaldi, J., Henrichson, C., Sandwick, T., Wendel, T., Druker, E., Ostermann, M., DeWitt, S., & Clear, T. (2015). A Natural Experiment in Reform: Analyzing Drug Policy Change In New York City. https://www.ncjrs.gov/pdffiles1/nij/grants/248524.pdf",,,,,,,
Patrick_2016,"Patrick, S. W., Fry, C. E., Jones, T. F., & Buntin, M. B. (2016). Implementation Of Prescription Drug Monitoring Programs Associated With Reductions In Opioid-Related Death Rates. Health Affairs, 35(7), 1324–1332.",,,,,,,
Paulozzi_2011,"Paulozzi, L. J., Kilbourne, E. M., & Desai, H. A. (2011). Prescription Drug Monitoring Programs and Death Rates from Drug Overdose. Pain Medicine, 12(5), 747–754.",,,,,,,
Pauly_2018,"Pauly, N. J., Slavova, S., Delcher, C., Freeman, P. R., & Talbert, J. (2018). Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings. Drug & Alcohol Dependence, 184, 26–32.",,,,,,,
Peacock_2015,"Peacock, A., Degenhardt, L., Hordern, A., Larance, B., Cama, E., White, N., Kihas, I., & Bruno, R. (2015). Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulation. Int J Drug Policy, 26(12), 1265–1272. https://doi.org/10.1016/j.drugpo.2015.05.023",,,,,,,
Peakcock_2015,"Peacock, A., Degenhardt, L., Larance, B., Cama, E., Lintzeris, N., Ali, R., & Bruno, R. (2015). A typology of people who tamper with pharmaceutical opioids: Responses to introduction of a tamper-resistant formulation of controlled-release oxycodone. Pharmacoepidemiol Drug Saf, 24(12), 1321–1333. https://doi.org/10.1002/pds.3883",,,,,,,
Pearson_2015,"Pearson, C. F., Burton, C., Harhaj, C., & Graziano, J. A. (2015). Opioid Abuse and the Development of Abuse-Deterrent Drugs: Trends and Coverage in the Medicare Part D Program. Avalere.",,,,,,,
Pedersen_2011,"Pedersen, M. U., Hesse, M., & Bloomfield, K. (2011). Abstinence-orientated residential rehabilitation of opioid users in Denmark: Do changes in national treatment policies affect treatment outcome? Scandinavian Journal of Public Health, 39(6), 582–589.",,,,,,,
Penm_2017,"Penm, J., MacKinnon, N. J., Boone, J. M., Ciaccia, A., McNamee, C., & Winstanley, E. L. (2017). Strategies and policies to address the opioid epidemic: A case study of Ohio. Journal of the American Pharmacists Association: JAPhA, 57(2), S148–S153.",,,,,,,
Perez-Munoz_2017,"Pérez-Muñoz, C. (2017). What is Wrong with Testing Welfare Recipients for Drug Use? Political Studies, 65(4), 912–929. https://doi.org/10.1177/0032321717692166",,,,,,,
Perngmark_2007,"Perngmark, P., Vanichseni, S., & Celentano, D. D. (2006). The Thai “War-on-Drugs” Policy: Impact on Southern Thai Drug Injectors. Thai Journal of Nursing Research, 10(4), 242–251.",,,,,,,
Perry_2009,"Perry, A., E, a, Darwin, Z., Godfrey, C., McDougall, C., Lunn, J., Glanville, J., & Coulton, S. (2009). The effectiveness of interventions for drug-using offenders in the courts, secure establishments and the community: A systematic review. Substance Use & Misuse, 44(3), 374–400.",,,,,,,
Peterson_2019,"Peterson, M., Rich, J., Macmadu, A., Truong, A. Q., Green, T. C., Beletsky, L., Pognon, K., & Brinkley-Rubinstein, L. (2019). “One guy goes to jail, two people are ready to take his spot”: Perspectives on drug-induced homicide laws among incarcerated individuals. International Journal of Drug Policy, 70, 47–53. https://doi.org/10.1016/j.drugpo.2019.05.001",,,,,,,
Phillips_2017,"Phillips, E., & Gazmararian, J. (2017). Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality. Journal of Opioid Management, 13(4), 229–239.",,,,,,,
Pinkerton_2010,"Pinkerton, S. D. (2010). Is Vancouver Canada’s supervised injection facility cost-saving? Addiction, 105(8), 1429–1436. https://doi.org/10.1111/j.1360-0443.2010.02977.x",,,,,,,
Pitt_2018,"Pitt, A. L., Humphreys, K., & Brandeau, M. L. (2018). Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic. American Journal of Public Health, 108(10), 1394-1400. https://doi.org/10.2105/AJPH.2018.304590",,,,,,,
Pohl_2018,"Pohl, R. V. (2018). Time trends matter: The case of medical cannabis laws and opioid overdose mortality (No. 87237; MPRA Paper). University Library of Munich, Germany. https://ideas.repec.org/p/pra/mprapa/87237.html",,,,,,,
Pombo_2016,"Pombo, S., & da Costa, N. F. (2016). Heroin addiction patterns of treatment-seeking patients, 1992-2013: Comparison between pre-and post-drug policy reform in Portugal. Heroin Addiction and Related Clinical Problems, 18(6), 51–60.",,,,,,,
Ponnapalli_2018,"Ponnapalli, A., Grando, A., Murcko, A., & Wertheim, P. (2018). Systematic Literature Review of Prescription Drug Monitoring Programs. AMIA Annu Symp Proc, 2018, 1478–1487.",,,,,,,
Popovici_2018,"Popovici, I., Maclean, J. C., Hijazi, B., & Radakrishnan, S. (2018). The effect of state laws designed to prevent nonmedical prescription opioid use on overdose deaths and treatment. Health Economics, 27(2), 294–305.",,,,,,,
Popovici_2018_2,"Popovici, I., Maclean, J. C., & French, M. T. (2017). Health insurance and traffic fatalities: The effects of substance use disorder parity laws (No. w23388). National Bureau of Economic Research. https://doi.org/10.3386/w23388",,,,,,,
Potier_2014,"Potier, C., Laprevote, V., Dubois-Arber, F., Cottencin, O., & Rolland, B. (2014). Supervised injection services: What has been demonstrated? A systematic literature review. Drug Alcohol Depend, 145, 48–68. https://doi.org/10.1016/j.drugalcdep.2014.10.012",,,,,,,
Powell_2011,"Powell, C., Christie, M., Bankart, J., Bamber, D., & Unell, I. (2011). Drug treatment outcomes in the criminal justice system: What non-self-report measures of outcome can tell us. Addiction Research & Theory, 19(2), 148–160. https://doi.org/10.3109/16066359.2010.530709",,,,,,,
Powell_2016,"Powell, David, Pacula, R. L., & Taylor, E. A. (2020). How Increasing Medical Access to Opioids Contributes to the Opioid Epidemic: Evidence from Medicare Part D. Journal of Health Economics, 71, 52.",,,,,,,
Powell_2018,"Powell, D., Pacula, R. L., & Jacobson, M. (2018). Do medical marijuana laws reduce addictions and deaths related to pain killers? Journal of Health Economics, 58, 29–42.",,,,,,,
Pradel_2009,"Pradel, V., Frauger, E., Thirion, X., Ronfle, E., Lapierre, V., Masut, A., Coudert, C., Blin, O., & Micallef, J. (2009). Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine. Pharmacoepidemiology and Drug Safety, 18(1), 36–43.",,,,,,,
Rafful_2018,"Rafful, C., Orozco, R., Rangel, G., Davidson, P., Werb, D., Beletsky, L., & Strathdee, S. A. (2018). Increased non-fatal overdose risk associated with involuntary drug treatment in a longitudinal study with people who inject drugs. Addiction, 113(6), 1056–1063. https://doi.org/10.1111/add.14159",,,,,,,
Raji_2017,"Raji, M. A., Kuo, Y. F., Chen, N. W., Hasan, H., Wilkes, D. M., & Goodwin, J. S. (2017). Impact of Laws Regulating Pain Clinics on Opioid Prescribing and Opioid-Related Toxicity among Texas Medicare Part D Beneficiaries. Journal of Pharmacy Technology, 33(2), 60–65.",,,,,,,
Raji_2018,"Raji, M. A., Kuo, Y. F., Adhikari, D., Baillargeon, J., & Goodwin, J. S. (2017). Decline in opioid prescribing after federal rescheduling of hydrocodone products. Pharmacoepidemiology & Drug Safety, 21, 21.",,,,,,,
Ranapurwala_2019,"Ranapurwala, S. I., Carnahan, R. M., Brown, G., Hinman, J., & Casteel, C. (2018). Impact of Iowa’s Prescription Monitoring Program on Opioid Pain Reliever Prescribing Patterns: An Interrupted Time Series Study 2003–2014. Pain Medicine, 20(2), 290–300. https://doi.org/10.1093/pm/pny029",,,,,,,
Rasubala_2015,"Rasubala, L., Pernapati, L., Velasquez, X., Burk, J., & Ren, Y. F. (2015). Impact of a Mandatory Prescription Drug Monitoring Program on Prescription of Opioid Analgesics by Dentists. PLoS ONE [Electronic Resource], 10(8), e0135957.",,,,,,,
Rees_2019,"Rees, D., Sabia, J., Argys, L., Latshaw, J., & Dave, D. (2017). With a little help from my friends: The effects of naloxone access and good samaritan laws on opioid-related deaths (No. w23171; p. w23171). National Bureau of Economic Research. https://doi.org/10.3386/w23171",,,,,,,
Reifler_2012,"Reifler, L. M., Droz, D., Bailey, J. E., Schnoll, S. H., Fant, R., Dart, R. C., & Bucher Bartelson, B. (2012). Do prescription monitoring programs impact state trends in opioid abuse/misuse? Pain Medicine, 13(3), 434–442.",,,,,,,
Reisman_2009,"Reisman, R. M., Shenoy, P. J., Atherly, A. J., & Flowers, C. R. (2009). Prescription opioid usage and abuse relationships: An evaluation of state prescription drug monitoring program efficacy. Subst Abuse, 3, 41–51. https://doi.org/10.4137/sart.s2345",,,,,,,
Reitan_2016,"Reitan, T. (2016). Commitment without confinement. Outpatient compulsory care for substance abuse, and severe mental disorder in Sweden. Int J Law Psychiatry, 45, 60–69. https://doi.org/10.1016/j.ijlp.2016.02.011",,,,,,,
Rengifo_2010,"Rengifo, A. F., & Stemen, D. (2013). The Impact of Drug Treatment on Recidivism: Do Mandatory Programs Make a Difference? Evidence From Kansas’s Senate Bill 123. Crime & Delinquency, 59(6), 930–950. https://doi.org/10.1177/0011128709348447",,,,,,,
Reset_2018,"Reset, A., Skurtveit, S., Furu, K., & Skovlund, E. (2018). Effect of the market withdrawal of dextropropoxyphene on use of other prescribed analgesics. Scand J Pain, 18(4), 667–674. https://doi.org/10.1515/sjpain-2018-0103",,,,,,,
Resiak_2016,"Resiak, D., Mpofu, E., & Athanasou, J. (2016). Drug Treatment Policy in the Criminal Justice System: A Scoping Literature Review. American Journal of Criminal Justice?: AJCJ, 41(1), 3–13.",,,,,,,
Rhodes_2015,"Rhodes, T., Guise, A., Ndimbii, J., Strathdee, S., Ngugi, E., Platt, L., Kurth, A., Clel, C., & Vickerman, P. (2015). Is the promise of methadone Kenya’s solution to managing HIV and addiction? A mixed-method mathematical modelling and qualitative study. BMJ Open, 5(3), e007198.",,,,,,,
Rich_2015,"Rich, J. D., McKenzie, M., Larney, S., Wong, J. B., Tran, L., Clarke, J., Noska, A., Reddy, M., & Zaller, N. (2015). Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: A randomised, open-label trial. The Lancet, 386(9991), 350–359. https://doi.org/10.1016/S0140-6736(14)62338-2",,,,,,,
Riggs_2017,"Riggs, C. S., Billups, S. J., Flores, S., Patel, R. J., Heilmann, R. M., & Milchak, J. L. (2017). Opioid Use for Pain Management After Implementation of a Medicaid Short-Acting Opioid Quantity Limit. J Manag Care Spec Pharm, 23(3), 346–354. https://doi.org/10.18553/jmcp.2017.23.3.346",,,,,,,
Rinaldo_2013,"Rinaldo, S. G., & Rinaldo, D. W. (2013). Availability without accessibility? State Medicaid coverage and authorization requirements for opioid dependence medications. Advancing Access to Addiction Medications: Implications for Opioid Addiction Treatment, 9–71.",,,,,,,
Ringwalt_2015,"Ringwalt, C., Garrettson, M., & Alexandridis, A. (2015). The effects of North Carolina’s prescription drug monitoring program on the prescribing behaviors of the state’s providers. J Prim Prev, 36(2), 131–137. https://doi.org/10.1007/s10935-014-0381-0",,,,,,,
Ritter_2005,"Ritter, A., & Natale, R. D. I. (2005). The relationship between take-away methadone policies and methadone diversion. Drug and Alcohol Review, 24(4), 347–352.",,,,,,,
Roberts_2014,"Roberts, A. W., & Skinner, A. C. (2014). Assessing the present state and potential of Medicaid controlled substance lock-in programs. J Manag Care Spec Pharm, 20(5), 439–46c. https://doi.org/10.18553/jmcp.2014.20.5.439",,,,,,,
Roberts_2016,"Roberts, A. W., Farley, J. F., Holmes, G. M., Oramasionwu, C. U., Ringwalt, C., Sleath, B., & Skinner, A. C. (2016). Controlled Substance Lock-In Programs: Examining An Unintended Consequence Of A Prescription Drug Abuse Policy. Health Affairs, 35(10), 1884–1892.",,,,,,,
Robinson_2010,"Robinson, D. L. (2009). Bridging the Gaps: Improved Legislation to Prohibit the Abuse of Prescription Drugs in Virginia Student Notes & Comments. Appalachian J.L., 9, 281–306.",,,,,,,
Robles_2001,"Robles, E., Miller, F. B., Gilmore-Thomas, K. K., & McMillan, D. E. (2001). Implementation of a clinic policy of client-regulated methadone dosing. Journal of Substance Abuse Treatment, 20(3), 225–230; discussion 231.",,,,,,,
Romelsjo_2010,"Romelsjö, A., Engdahl, B., Stenbacka, M., Fugelstad, A., Davstad, I., Leifman, A., & Thiblin, I. (2010). Were the changes to Sweden’s maintenance treatment policy 2000-06 related to changes in opiate-related mortality and morbidity? Addiction, 105(9), 1625–1632.",,,,,,,
Rosenblum_2002,"Rosenblum, L. (2001). Mandating Effective Treatment for Drug Offenders Note. Hastings L.J., 53, 1217–1244.",,,,,,,
Rossiter_2014,"Rossiter, L. F., Kirson, N. Y., Shei, A., White, A. G., Birnbaum, H. G., Ben-Joseph, R., & Michna, E. (2014). Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US. J Med Econ, 17(4), 279–287. https://doi.org/10.3111/13696998.2014.897628",,,,,,,
Rousseau_2017,"Rousseau, L., & Nordan, I. E. (2017). Tug V. Mingo: Let the Plantiffs Sue - Opioid Addiction, The Wrongful Conduct Rule, and the Culpability Exception. Thomas M. Cooley Law Review, 34(1), 33.",,,,,,,
Rudolph_2011,"Rudolph, S. S., Jehu, G., Nielsen, S. L., Nielsen, K., Siersma, V., & Rasmussen, L. S. (2011). Prehospital treatment of opioid overdose in Copenhagen—Is it safe to discharge on-scene? Resuscitation, 82(11), 1414–1418. https://doi.org/10.1016/j.resuscitation.2011.06.027",,,,,,,
Russoniello_2012,"Russoniello, K. (2012). The Devil (and Drugs) in the Details: Portugal’s Focus on Public Health as a Model for Decriminalization of Drugs in Mexico Note. Yale J. Health Pol’y L. & Ethics, 12, 371–432.",,,,,,,
Rutkow_2015,"Rutkow, L., Chang, H. Y., Daubresse, M., Webster, D. W., Stuart, E. A., Alex, & er, G. C. (2015). Effect of Florida’s Prescription Drug Monitoring Program and pill mill laws on opioid prescribing and use. JAMA Internal Medicine, 175(10), 1642–1649.",,,,,,,
Sacks_2019,"Sacks, D. W., Hollingsworth, A., Nguyen, T. D., & Simon, K. I. (2019). Can policy affect initiation of addictive substance use? Evidence from opioid prescribing (No. w25974). National Bureau of Economic Research. https://doi.org/10.3386/w25974",,,,,,,
Salmon_2009,"Salmon, A. M., van Beek, I., Amin, J., Kaldor, J., & Maher, L. (2010). The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. Addiction, 105(4), 676–683. https://doi.org/10.1111/j.1360-0443.2009.02837.x",,,,,,,
Saloner_2016,"Saloner, B., Stoller, K. B., & Barry, C. L. (2016). Medicaid Coverage for Methadone Maintenance and Use of Opioid Agonist Therapy in Specialty Addiction Treatment. Psychiatric Services, 67(6), 676–679.",,,,,,,
Saloner_2017,"Saloner, B., Akosa Antwi, Y., Maclean, J. C., & Cook, B. (2018). Access to Health Insurance and Utilization of Substance Use Disorder Treatment: Evidence from the Affordable Care Act Dependent Coverage Provision. Health Econ, 27(1), 50–75. https://doi.org/10.1002/hec.3482",,,,,,,
Saloner_2018,"Saloner, B., Levin, J., Chang, H. Y., Jones, C., & Alexander, G. C. (2018). Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion. JAMA Network Open, 1(4), e181588. https://doi.org/10.1001/jamanetworkopen.2018.1588",,,,,,,
Sander_2016,"Sander, G., Scandurra, A., Kamenska, A., MacNamara, C., Kalpaki, C., Bessa, C. F., Laso, G. N., Parisi, G., Varley, L., Wolny, M., Moudatsou, M., Pontes, N. H., Mannix-McNamara, P., Libianchi, S., & Antypas, T. (2016). Overview of harm reduction in prisons in seven European countries. Harm Reduction Journal, 13(1), 28. https://doi.org/10.1186/s12954-016-0118-x",,,,,,,
Sandlilands_2008,"Sandilands, E. A., & Bateman, D. N. (2008). Co-proxamol withdrawal has reduced suicide from drugs in Scotland. Br J Clin Pharmacol, 66(2), 290–293. https://doi.org/10.1111/j.1365-2125.2008.03206.x",,,,,,,
Sankey_2016,"Sankey, C., Setnik, B., Harsanyi, Z., Michalko, K., Yang, Z., & Geoffroy, P. (2016). Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients. J Opioid Manag, 12(2), 149–159. https://doi.org/10.5055/jom.2016.0327",,,,,,,
Sanmartin_2019,"Sanmartin, M. X., Ali, M. M., & Lynch, S. (2019). Foster care admissions and state-level criminal justice-focused prenatal substance use policies. Children and Youth Services Review, 102, 102–107. https://doi.org/10.1016/j.childyouth.2019.03.050",,,,,,,
Santistevan_2018,"Santistevan, J. R., Sharp, B. R., Hamedani, A. G., Fruhan, S., Lee, A. W., & Patterson, B. W. (2018). By Default: The Effect of Prepopulated Prescription Quantities on Opioid Prescribing in the Emergency Department. West J Emerg Med, 19(2), 392–397. https://doi.org/10.5811/westjem.2017.10.33798",,,,,,,
Saulle_2017,"Saulle, R., Vecchi, S., & Gowing, L. (2017). Supervised dosing with a long-acting opioid medication in the management of opioid dependence. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD011983.pub2",,,,,,,
Saunders_2014,"Saunders, K. W., Shortreed, S., Thielke, S., Turner, J. A., LeResche, L., Beck, R., & Von Korff, M. (2015). Evaluation of Health Plan Interventions to Influence Chronic Opioid Therapy Prescribing. Clin J Pain, 31(9), 820–829. https://doi.org/10.1097/ajp.0000000000000159",,,,,,,
Schackman_2006,"Schackman, B. R., Merrill, J. O., McCarty, D., Levi, J., & Lubinski, C. (2006). Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care. Clinical Infectious Diseases, 43, S247-53.",,,,,,,
Schaffer_2018,"Schaffer, Andrea L., Buckley, N. A., Degenhardt, L., Larance, B., Cairns, R., Dobbins, T. A., & Pearson, S.-A. (2018). Person-level changes in oxycodone use after the introduction of a tamper-resistant formulation in Australia. Canadian Medical Association Journal, 190(12), E355. https://doi.org/10.1503/cmaj.170666",,,,,,,
Schaffer_2019,"Schaffer, A. L., Karanges, E. A., Buckley, N. A., Wilson, A., Degenhardt, L., Larance, B., & Pearson, S. A. (2019). Increases in controlled-release oxycodone utilisation following the subsidy of oxycodone with naloxone formulations: An Australian population-based study. Pharmacoepidemiol Drug Safety, 28(1), 97–105. https://doi.org/10.1002/pds.4683",,,,,,,
Schill_2018,"Schill, N. (2018). The Fatal Shortcomings of Our Good Samaritan Overdose Statutes and Proposed Model Statute. Equal Rights & Social Justice, 25(1), 123–159.",,,,,,,
Schultz_2016,"Schultz, S., Chamberlain, C., Vulcan, M., Rana, H., Patel, B., Alex, & er, J. C. (2016). Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center. Journal of Opioid Management, 12(2), 119–122.",,,,,,,
Schwartz_2013,"Schwartz, R. P., Gryczynski, J., O’Grady, K. E., Sharfstein, J. M., Warren, G., Olsen, Y., Mitchell, S. G., & Jaffe, J. H. (2013). Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. American Journal of Public Health, 103(5), 917–922.",,,,,,,
Seago_2016,"Seago, S., Hayek, A., Pruszynski, J., & Newman, M. G. (2016). Change in prescription habits after federal rescheduling of hydrocodone combination products. Baylor University Medical Center Proceedings, 29(3), 268–270.",,,,,,,
Sears_2009,"Sears, C., Davis, T., Guydish, J., & Gleghorn, A. (2009). Investigating the effects of San Francisco’s treatment on demand initiative on a publicly-funded substance abuse treatment system: A time series analysis. Journal of Psychoactive Drugs, 41(3), 297–304.",,,,,,,
Sears_2019,"Sears, J. M., Fulton-Kehoe, D., Schulman, B. A., Hogg-Johnson, S., & Franklin, G. M. (2019). Opioid Overdose Hospitalization Trajectories in States With and Without Opioid-Dosing Guidelines. Public Health Rep, 134(5), 567–576. https://doi.org/10.1177/0033354919864362",,,,,,,
Sellars_2013,"Sellers, E. M., Perrino, P. J., Colucci, S. V., & Harris, S. C. (2013). Attractiveness of reformulated OxyContin(R) tablets: Assessing comparative preferences and tampering potential. J Psychopharmacol, 27(9), 808–816. https://doi.org/10.1177/0269881113493364",,,,,,,
Sessler_2014,"Sessler, N. E., Downing, J. M., Kale, H., Chilcoat, H. D., Baumgartner, T. F., & Coplan, P. M. (2014). Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation. Pharmacoepidemiol Drug Saf, 23(12), 1238–1246. https://doi.org/10.1002/pds.3658",,,,,,,
Severtson_2013,"Severtson, S. G., Bartelson, B. B., Davis, J. M., Munoz, A., Schneider, M. F., Chilcoat, H., Coplan, P. M., Surratt, H., & Dart, R. C. (2013). Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release oxycodone in 2010. J Pain, 14(10), 1122–1130. https://doi.org/10.1016/j.jpain.2013.04.011",,,,,,,
Severtson_2016,"Severtson, S. G., Ellis, M. S., Kurtz, S. P., Rosenblum, A., Cicero, T. J., Parrino, M. W., Gilbert, M. K., Buttram, M. E., Dasgupta, N., BucherBartelson, B., Green, J. L., & Dart, R. C. (2016). Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone. Drug Alcohol Depend, 168, 219–229. https://doi.org/10.1016/j.drugalcdep.2016.09.018",,,,,,,
Sevigny_2013,"Sevigny, E. L., Fuleihan, B. K., & Ferdik, F. V. (2013). Do drug courts reduce the use of incarceration?: A meta-analysis. Journal of Criminal Justice, 41(6), 416–425. https://doi.org/10.1016/j.jcrimjus.2013.06.005",,,,,,,
Shaffer_2011,"Shaffer, D. K. (2011). Looking Inside the Black Box of Drug Courts: A Meta?Analytic Review. Justice Quarterly, 28(3), 493–521. https://doi.org/10.1080/07418825.2010.525222",,,,,,,
Shah_2019,"Shah, A., Hayes, C. J., Lakkad, M., & Martin, B. C. (2019). Impact of Medical Marijuana Legalization on Opioid Use, Chronic Opioid Use, and High-risk Opioid Use. J Gen Intern Med, 34(8), 1419–1426. https://doi.org/10.1007/s11606-018-4782-2",,,,,,,
Sham_2011,"Sham, M. K. (2010). Down on the Pharm: The Juvenile Prescription Drug Abuse Epidemic and the Necessity of Holding Parents Criminally Liable for Making Drugs Accessible in Their Homes Note. J. Contemp. Health L. & Pol’y, 27, 426–452.",,,,,,,
Sharareh_2019,"Sharareh, N., Sabounchi, S. S., McFarland, M., & Hess, R. (2019). Evidence of Modeling Impact in Development of Policies for Controlling the Opioid Epidemic and Improving Public Health: A Scoping Review. Subst Abuse, 13, 1178221819866211. https://doi.org/10.1177/1178221819866211",,,,,,,
Sharma_2017,"Sharma, E. (2017). Warning- Special Delivery Due in Nine Months... Jailtime: Pregnancy, Drug Abuse, and the Argument Against Criminal Ramifications. Holy Cross Journal of Law and Public Policy, 21, 79–138.",,,,,,,
Sharp_2018,"Sharp, A., Jones, A., Sherwood, J., Kutsa, O., Honermann, B., & Millett, G. (2018). Impact of Medicaid Expansion on Access to Opioid Analgesic Medications and Medication-Assisted Treatment. Am J Public Health, 108(5), 642–648. https://doi.org/10.2105/ajph.2018.304338",,,,,,,
Shearer_2007,"Shearer, J., Wodak, A. D., & Dolan, K. A. (2007). Evaluation of a prison-based naltrexone program. International Journal of Prisoner Health, 3(3), 214–224.",,,,,,,
Shepherd_2014,"Shepherd, J. (2014). Combating the prescription painkiller epidemic: A national prescription drug reporting program. American Journal of Law & Medicine, 40(1), 85–112.",,,,,,,
Shi_2017,"Shi, Y. (2017). Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever. Drug & Alcohol Dependence, 173, 144–150.",,,,,,,
Shi_2019,"Shi, Y., Liang, D., Bao, Y., An, R., Wallace, M. S., & Grant, I. (2019). Recreational marijuana legalization and prescription opioids received by Medicaid enrollees. Drug Alcohol Depend, 194, 13–19. https://doi.org/10.1016/j.drugalcdep.2018.09.016",,,,,,,
Shover_2019,"Shover, C. L., Davis, C. S., Gordon, S. C., & Humphreys, K. (2019). Association between medical cannabis laws and opioid overdose mortality has reversed over time. Proc Natl Acad Sci U S A, 116(26), 12624–12626. https://doi.org/10.1073/pnas.1903434116",,,,,,,
Showalter_2018,"Showalter D. (2018). Federal funding for syringe exchange in the US: Explaining a long-term policy failure. The International journal on drug policy, 55, 95–104. https://doi.org/10.1016/j.drugpo.2018.02.006",,,,,,,
Shumway_2018,"Shumway, J. W., Ran, R., McClusky, J., Rafique, Z., Dark, C., Peacock, W. F., Cintron, A., & Ludwig, M. (2018). Impact of rescheduling hydrocodone-combination products in an urban Texas county healthcare system. J Opioid Manag, 14(4), 257–264. https://doi.org/10.5055/jom.2018.0457",,,,,,,
Shumway_2019,"Shumway, W. A. (2019). 2017 Drug Laws in West Virginia: The Wrong Prescription for the State’s Opioid Crisis. Penn State Law Review, 123(2), 559–584.",,,,,,,
Siddiqui_2015,"Siddiqui, S. S., Armenta, R. F., Evans, J. L., Yu, M., Cuevas-Mota, J., Page, K., Davidson, P., & Garfein, R. S. (2015). Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA. International Journal of Drug Policy, 26(11), 1150–1157.",,,,,,,
Simojoki_2008,"Simojoki, K., Vorma, H., & Alho, H. (2008). A retrospective evaluation of patients switched from buprenorphine (Subutex) to the buprenorphine/naloxone combination (Suboxone). Substance abuse treatment, prevention, and policy, 3, 16. https://doi.org/10.1186/1747-597X-3-16",,,,,,,
Simoni-Wastila_2012,"Simoni-Wastila, L., & Qian, J. (2012). Influence of prescription monitoring programs on analgesic utilization by an insured retiree population. Pharmacoepidemiol Drug Saf, 21(12), 1261–1268. https://doi.org/10.1002/pds.3342",,,,,,,
Skinner_2016,"Skinner, A. C., Ringwalt, C., Naumann, R. B., Roberts, A. W., Moss, L. A., Sachdeva, N., Weaver, M. A., & Farley, J. (2016). Reducing Opioid Misuse: Evaluation of a Medicaid Controlled Substance Lock-In Program. J Pain, 17(11), 1150–1155. https://doi.org/10.1016/j.jpain.2016.07.003",,,,,,,
SKodbo_2007,"Skodbo, S., Brown, G., Deacon, S., Cooper, A., Millar, T., Smith, J., & Whitham, K. (2007). The Drug Interventions Programme (DIP): addressing drug use and offending through 'Tough Choices'. https://pdfs.semanticscholar.org/4db8/1511a0087c02388e3d57a3833fbae690058f.pdf",,,,,,,
Skretting_2010,"Skretting, A., & Rosenqvist, P. (2010). Shifting focus in substitution treatment in the Nordic countries. NAT Nordisk Alkohol & Narkotikatidskrift, 27(6), 581–597.",,,,,,,
Smithson_2005,"Smithson, M., McFadden, M., & Mwesigye, S.-E. (2005). Impact of federal drug law enforcement on the supply of heroin in Australia. Addiction, 100(8), 1110–1120.",,,,,,,
Smith_2012,"Smith, K., Bartlett, N., & Wang, N. (2012). A harm reduction paradox: Comparing China’s policies on needle and syringe exchange and methadone maintenance. International Journal of Drug Policy, 23(4), 327–332.",,,,,,,
Smith_2015,"Smith, S. E. (2015). No safe harbors: Examining the shift from voluntary treatment options to criminalization of maternal drug use in Tennessee. The University of Memphis Law Review, 46(1), 203.",,,,,,,
Smyth_2015,"Smyth, B. P., James, P., Cullen, W., & Darker, C. (2015). “So prohibition can work?” Changes in use of novel psychoactive substances among adolescents attending a drug and alcohol treatment service following a legislative ban. International Journal of Drug Policy, 26(9), 887–889.",,,,,,,
Smyth_2019,"Smyth, B. P., Daly, A., Elmusharaf, K., McDonald, C., Clarke, M., Craig, S., & Cullen, W. (2020). Legislation targeting head shops selling new psychoactive substances and changes in drug-related psychiatric admissions: A national database study [https://doi.org/10.1111/eip.12807]. Early Intervention in Psychiatry, 14(1), 53-60. https://doi.org/https://doi.org/10.1111/eip.12807",,,,,,,
Snider_2019,"Snider, J. T., Duncan, M. E., Gore, M. R., Seabury, S., Silverstein, A. R., Tebeka, M. G., & Goldman, D. P. (2019). Association Between State Medicaid Eligibility Thresholds and Deaths Due to Substance Use Disorders. JAMA Netw Open (31026034; Vol. 2). https://doi.org/10.1001/jamanetworkopen.2019.3056",,,,,,,
Socias_2017,"Socias, M. E., Wood, E., McNeil, R., Kerr, T., Dong, H., Shoveller, J., Montaner, J., & Milloy, M. J. (2017). Unintended impacts of regulatory changes to British Columbia Methadone Maintenance Program on addiction and HIV-related outcomes: An interrupted time series analysis. International Journal of Drug Policy, 45, 1–8.",,,,,,,
Sohn_2019,"Sohn, M., Talbert, J. C., Huang, Z., Lofwall, M. R., & Freeman, P. R. (2019). Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States. JAMA Netw Open, 2(6), e196215. https://doi.org/10.1001/jamanetworkopen.2019.6215",,,,,,,
Soni_2018,"Soni, A. (2019). Health insurance, price changes, and the demand for pain relief drugs: Evidence from medicare part d (SSRN Scholarly Paper ID 3268968). Social Science Research Network. https://papers.ssrn.com/abstract=3268968",,,,,,,
Soper_2018,"Soper, R., Appajosyula, S., & Deximo, C. (2018). Decline in Buprenorphine/Naloxone Prescriptions in a State Medicaid Population Following Formulary Conversion from Suboxone to Bunavail. Adv Ther, 35(4), 457–466. https://doi.org/10.1007/s12325-018-0696-y",,,,,,,
Sorensen_2009,"Sorensen, J. L., Guydish, J., Zilavy, P., Davis, T. B., Gleghorn, A., Jacoby, M., & Sears, C. (2007). Access to drug abuse treatment under Treatment on Demand policy in San Francisco. Am J Drug Alcohol Abuse, 33(2), 227–236. https://doi.org/10.1080/00952990601174824",,,,,,,
Spooner_2016,"Fernandes, K., Martins, D., Juurlink, D., Mamdani, M., Paterson, J. M., Spooner, L., Singh, S., & Gomes, T. (2016). High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study. PLoS One, 11(12), e0167479. https://doi.org/10.1371/journal.pone.0167479",,,,,,,
Srubar_2015,"Srubar, B. (2015). BREAKING BAD POLICY: SHIFTING U.S. COUNTER-DRUG POLICY, ELIMINATING SAFE HAVENS, AND FACILITATING INTERNATIONAL COOPERATION. Houston Journal of International Law, 37(1), 197–233.",,,,,,,
Stanos_2012,"Stanos, S. (2012). Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids. Physician & Sportsmedicine, 40(4), 12–20.",,,,,,,
Stark_2002,"Stark, S. E. (2001). Bio-Ethics and Physician Liability: The Liability Effects of Developing Pain Management Standards. St. Thomas Law Review, 14, 601–640.",,,,,,,
Steckler_2019,"Steckler, T. J., Mosher, H. J., Desloover-Koch, Y., & Lund, B. C. (2019). Impact of hydrocodone reclassification on analgesic prescribing in the Veterans Health Administration. Am J Health Syst Pharm, 76(Supplement_2), S61-s67. https://doi.org/10.1093/ajhp/zxy090",,,,,,,
Steffen_2016,"Steffen, B. J. (2016). Battling the Heroin Epidemic with Involuntary Treatment. Journal of Law and Social Deviance, 12, 181–225.",,,,,,,
Stein_2014,"Stein, B. D., Pacula, R. L., Gordon, A. J., Burns, R. M., Leslie, D. L., Sorbero, M. J., Bauhoff, S., Mandell, T., & Dick, A. W. (2015). Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? https://www.rand.org/pubs/external_publications/EP50865.html files/249/EP50865.html",,,,,,,
Stein_2015,"Stein, B. D., Gordon, A. J., Dick, A. W., Burns, R. M., Pacula, R. L., Farmer, C. M., Leslie, D. L., & Sorbero, M. J. (2015). Supply of Buprenorphine Waivered Physicians. https://www.rand.org/pubs/external_publications/EP66172.html files/253/EP66172.html",,,,,,,
Stemen_2012,"Stemen, D., & Rengifo, A. F. (2011). Reconciling the multiple objectives of prison diversion programs for drug offenders: Evidence from Kansas’ Senate Bill 123. Eval Rev, 35(6), 642–672. https://doi.org/10.1177/0193841x12439194",,,,,,,
Stevenson_2002,"Stevenson, D. (2002). Should Addicts Get Welfare—Addiction & (and) SSI/SSDI. Brooklyn Law Review, 68, 185–240.",,,,,,,
Steverson_2009,"Steverson, J. W., & Rieckmann, T. (2009). Legislating for the Provision of Comprehensive Substance Abuse Treatment Programs for Pregnant and Mothering Women. Duke Journal of Gender Law & Policy, 16, 315–346.",,,,,,,
Stoever_2002,"Stoever, H. (2002). Drug substitution treatment and needle exchange programs in German and European prisons. Journal of Drug Issues, 32(2), 573–595.",,,,,,,
Stover_2006,"Stoever, Heino, Casselman, J., & Hennebel, L. (2006). Substitution treatment in European prisons. A study of policies and practices in 18 European countries. International Journal of Prisoner Health, 2. https://doi.org/10.1080/17449200600743396",,,,,,,
Strickler_2019,"Strickler, G. K., Zhang, K., Halpin, J. F., Bohnert, A. S. B., Baldwin, G. T., & Kreiner, P. W. (2019). Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing. Drug Alcohol Depend, 199, 1–9. https://doi.org/10.1016/j.drugalcdep.2019.02.010",,,,,,,
Strike_2005,"Strike, C. J., Urbanoski, K., Fischer, B., Marsh, D. C., & Millson, M. (2005). Policy changes and the methadone maintenance treatment system for opioid dependence in Ontario, 1996 to 2001. Journal of Addictive Diseases, 24(1), 39–51.",,,,,,,
Stucke_2018,"Stucke, R. S., Kelly, J. L., Mathis, K. A., Hill, M. V., & Barth, R. J., Jr. (2018). Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery. JAMA Surg, 153(12), 1105–1110. https://doi.org/10.1001/jamasurg.2018.2666",,,,,,,
Suffoletto_2018,"Suffoletto, B., Lynch, M., Pacella, C. B., Yealy, D. M., & Callaway, C. W. (2018). The Effect of a Statewide Mandatory Prescription Drug Monitoring Program on Opioid Prescribing by Emergency Medicine Providers Across 15 Hospitals in a Single Health System. Journal of Pain, 19(4), 430–438.",,,,,,,
Sullivan_2016,"Sullivan, M. D., Bauer, A. M., Fulton-Kehoe, D., Garg, R. K., Turner, J. A., Wickizer, T., & Franklin, G. M. (2016). Trends in Opioid Dosing Among Washington State Medicaid Patients Before and After Opioid Dosing Guideline Implementation. Journal of Pain, 17(5), 561–568.",,,,,,,
Sung_2011,"Sung, H.-E. (2011). From Diversion to Reentry: Recidivism Risks Among Graduates of an Alternative to Incarceration Program. Criminal Justice Policy Review, 22(2), 219–234. https://doi.org/10.1177/0887403410376588",,,,,,,
Sung_2018,"Sung, A. S. (2019). Drug Use and Punishment: A Public Health Crisis America Can No Longer Ignore. Seattle Journal for Social Justice, 17(2).",,,,,,,
Sun_2017,"Sun, B. C., Lupulescu-Mann, N., Charlesworth, C. J., Kim, H., Hartung, D. M., Deyo, R. A., & John McConnell, K. (2017). Impact of Hospital “Best Practice” Mandates on Prescription Opioid Dispensing After an Emergency Department Visit. Academic Emergency Medicine, 24(8), 905–913.",,,,,,,
Sun_2018,"Sun, B. C., Charlesworth, C. J., Lupulescu-Mann, N., Young, J. I., Kim, H., Hartung, D. M., Deyo, R. A., & McConnell, K. J. (2018). Effect of Automated Prescription Drug Monitoring Program Queries on Emergency Department Opioid Prescribing. Ann Emerg Med, 71(3), 337-347.e6. https://doi.org/10.1016/j.annemergmed.2017.10.023",,,,,,,
Surratt_2014,"Surratt, H. L., O’Grady, C., Kurtz, S. P., Stivers, Y., Cicero, T. J., Dart, R. C., & Chen, M. (2014). Reductions in prescription opioid diversion following recent legislative interventions in Florida. Pharmacoepidemiology & Drug Safety, 23(3), 314–320.",,,,,,,
Swartz_2019,"Swartz, J. A., & Beltran, S. J. (2019). Prescription opioid availability and opioid overdose-related mortality rates in Medicaid expansion and non-expansion states. Addiction, 114(11), 2016–2025. https://doi.org/10.1111/add.14741",,,,,,,
Tadrous_2019,"Tadrous, M., Greaves, S., Martins, D., Nadeem, K., Singh, S., Mamdani, M. M., Juurlink, D. N., & Gomes, T. (2019). Evaluation of the fentanyl patch-for-patch program in Ontario, Canada. Int J Drug Policy, 66, 82–86. https://doi.org/10.1016/j.drugpo.2019.01.025",,,,,,,
Tami_2014,SAMHSA. (2014). Medicaid Coverage and Financing of Medications to Treat Alcohol and Opioid Use Disorders. SAMHSA. https://store.samhsa.gov/product/Medicaid-Coverage-and-Financing-of-Medications-to-Treat-Alcohol-and-Opioid-Use-Disorders/sma14-4854,,,,,,,
Tan_2018,"Tan, W. H., Feaman, S., Milam, L., Garber, V., McAllister, J., Blatnik, J. A., & Brunt, L. M. (2018). Postoperative opioid prescribing practices and the impact of the hydrocodone schedule change. Surgery, 164(4), 879–886. https://doi.org/10.1016/j.surg.2018.06.018",,,,,,,
Tempalski_2008,"Tempalski, B., Cooper, H. L., Friedman, S. R., Des Jarlais, D. C., Brady, J., & Gostnell, K. (2008). Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug. International Journal of Drug Policy, 19, S47-58.",,,,,,,
Tenney_2018,"Tenney, L., McKenzie, L. M., Matus, B., Mueller, K., & Newman, L. S. (2019). Effect of an opioid management program for Colorado workers’ compensation providers on adherence to treatment guidelines for chronic pain. Am J Ind Med, 62(1), 21–29. https://doi.org/10.1002/ajim.22920",,,,,,,
Tesoriero_2009,"Tesoriero, J. M., Battles, H. B., Klein, S. J., Kaufman, E., & Birkhead, G. S. (2009). Expanding access to sterile syringes through pharmacies: Assessment of New York’s Expanded Syringe Access Program. J Am Pharm Assoc (2003), 49(3), 407–416. https://doi.org/10.1331/JAPhA.2009.07127",,,,,,,
The Network for Public Health Law_2018,The Network for Public Health Law. (2018). Legal Interventions To Reduce Overdose Mortality: Naloxone Access And Overdose Good Samaritan Laws. The Network for Pubilc Health Law. https://www.networkforphl.org/_asset/qz5pvn/legal-interventions-to-reduce-overdose.pdf,,,,,,,
Thomas_2013,"Thomas, C. P., Kim, M., Kelleher, S. J., Nikitin, R. V., Kreiner, P. W., McDonald, A., & Carrow, G. M. (2013). Early experience with electronic prescribing of controlled substances in a community setting. J Am Med Inform Assoc, 20(e1), e44-51. https://doi.org/10.1136/amiajnl-2012-001499",,,,,,,
Thongkhamcharoen_2012,"Thongkhamcharoen, R., Phungrassami, T., & Atthakul, N. (2014). Regulation of opioid drugs in thai government hospitals: Thailand national survey 2012. Indian J Palliat Care, 20(1), 6–11. https://doi.org/10.4103/0973-1075.125548",,,,,,,
Townsend_2019,"Townsend, T., Blostein, F., Doan, T., Madson-Olson, S., Galecki, P., & Hutton, D. W. (2020). Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States. International Journal of Drug Policy, 75, 102536. https://doi.org/https://doi.org/10.1016/j.drugpo.2019.07.031",,,,,,,
Tran_2012,"Tran, Bach Xuan, Ohinmaa, A., Duong, A. T., Nguyen, L. T., Vu, P. X., Mills, S., Houston, S., & Jacobs, P. (2012). The cost-effectiveness and budget impact of Vietnam’s methadone maintenance treatment programme in HIV prevention and treatment among injection drug users. Global Public Health: An International Journal for Research, Policy and Practice, 7(10), 1080–1094.",,,,,,,
Tran_2016,"Tran, B. X., Nguyen, L. H., Nong, V. M., Nguyen, C. T., Phan, H. T., & Latkin, C. A. (2016). Behavioral and quality-of-life outcomes in different service models for methadone maintenance treatment in Vietnam. Harm Reduction Journal, 13, 4.",,,,,,,
Tran_2017,"Tran, S., Lavitas, P., Stevens, K., Greenwood, B. C., Clements, K., Alper, C. J., Lenz, K., Price, M., Hydery, T., Arnold, J. L., Takeshita, M., Bacon, R., Peristere, J. P., & Jeffrey, P. L. (2017). The Effect of a Federal Controlled Substance Act Schedule Change on Hydrocodone Combination Products Claims in a Medicaid Population. Journal of Managed Care & Specialty Pharmacy, 23(5), 532–539.",,,,,,,
Turner_2013,"Turner, J. A., Saunders, K., Shortreed, S. M., Rapp, S. E., Thielke, S., LeResche, L., Riddell, K. M., & Von Korff, M. (2014). Chronic opioid therapy risk reduction initiative: Impact on urine drug testing rates and results. J Gen Intern Med, 29(2), 305–311. https://doi.org/10.1007/s11606-013-2651-6",,,,,,,
Twillman_2016,"Twillman, R. K., Gilson, A. M., & Duensing, K. N. (2016). State Policies Regulating the Practice of Pain Management: Statutes, Rules, and Guidelines That Shape Pain Care. Anesthesiol Clin, 34(2), 409–424. https://doi.org/10.1016/j.anclin.2016.01.010",,,,,,,
Tyndall_2002,"Tyndall, M. W., Bruneau, J., Brogly, S., Spittal, P., O’Shaughnessy, M. V., & Schechter, M. T. (2002). Satellite needle distribution among injection drug users: Policy and practice in two canadian cities. J Acquir Immune Defic Syndr, 31(1), 98–105. https://doi.org/10.1097/00126334-200209010-00013",,,,,,,
Unger_2014,"Unger, D. T. (2014). Minding Your Meds: Balancing the Needs for Patient Privacy and Law Enforcement in Prescription Drug Monitoring Programs. West Virginia Law Review, 117, 345–384.",,,,,,,
van Ameijden_2001,"van Ameijden, E. J., & Coutinho, R. A. (2001). Large decline in injecting drug use in Amsterdam, 1986-1998: Explanatory mechanisms and determinants of injecting transitions. Journal of Epidemiology & Community Health, 55(5), 356–363.",,,,,,,
vanBurskirk_2017,"Van Buskirk, J., Bruno, R., Dobbins, T., Breen, C., Burns, L., Naicker, S., Roxburgh, A., & a. (2017). The recovery of online drug markets following law enforcement and other disruptions. Drug and Alcohol Dependence, 173, 159–162.",,,,,,,
vandewalker_2008,"Vanderwalker, I. (2007). Taking the Baby before It’s Born: Termination of the Parental Rights of Women Who Use Illegal Drugs While Pregnant. New York University Review of Law & Social Change, 32, 423–464.",,,,,,,
van Ganse_2018,"Van Ganse, E., Belhassen, M., Ginoux, M., Chrétien, E., Cornu, C., Ecoffey, C., & Aubrun, F. (2018). Use of analgesics in France, following dextropropoxyphene withdrawal. BMC Health Services Research, 18(1), 231. https://doi.org/10.1186/s12913-018-3058-1",,,,,,,
Varisco_2017,"Varisco, T. J., Ogunsanya, M. E., Barner, J. C., & Fleming, M. L. (2017). Pharmacists’ perceptions regarding the impact of hydrocodone rescheduling on prescription volume, workflow management, and patient outcomes. J Am Pharm Assoc (2003), 57(2s), S51-s62. https://doi.org/10.1016/j.japh.2017.01.020",,,,,,,
vonaarburg_2004,"von Aarburg, H. P., & Stauffacher, M. (2004). From law enforcement to care: Changed benefits and harm of heroin use in Switzerland through a shift in drug policy. In T. Decorte & D. Korf (Eds.), European studies on Drugs and Drug Policy: Selected Readgins from the 14th International Conference of the European Society for Social Drug Research (ESSD) (pp. 21–47). VUB University Press.",,,,,,,
Vongchak_2005,"Vongchak, T., Kawichai, S., Sherman, S., Celentano, D. D., Sirisanthana, T., Latkin, C., Wiboonnatakul, K., Srirak, N., Jittiwutikarn, J., & Aramrattana, A. (2005). The influence of Thailand’s 2003 “war on drugs” policy on self-reported drug use among injection drug users in Chiang Mai, Thailand. International Journal of Drug Policy, 16(2), 115–121.",,,,,,,
von Korff_2016,"Von Korff, M., Dublin, S., Walker, R. L., Parchman, M., Shortreed, S. M., Hansen, R. N., & Saunders, K. (2016). The Impact of Opioid Risk Reduction Initiatives on High-Dose Opioid Prescribing for Patients on Chronic Opioid Therapy. Journal of Pain, 17(1), 101–110.",,,,,,,
von Korff_2017,"Von Korff, M., Walker, R. L., Saunders, K., Shortreed, S. M., Thakral, M., Parchman, M., Hansen, R. N., Ludman, E., Sherman, K. J., & Dublin, S. (2017). Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives. Int J Drug Policy, 46, 90–98. https://doi.org/10.1016/j.drugpo.2017.05.053",,,,,,,
von Korff_2019,"Von Korff, M., Saunders, K., Dublin, S., Walker, R. L., Thakral, M., Sherman, K. J., Ludman, E. J., Hansen, R. N., Parchman, M., & Shortreed, S. M. (2019). Impact of Chronic Opioid Therapy Risk Reduction Initiatives on Opioid Overdose. J Pain, 20(1), 108–117. https://doi.org/10.1016/j.jpain.2018.08.003",,,,,,,
Vosburg_2017,"Vosburg, S. K., Haynes, C., Besharat, A., & Green, J. L. (2017). Changes in drug use patterns reported on the web after the introduction of ADF OxyContin: Findings from the Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS) System Web Monitoring Program. Pharmacoepidemiol Drug Saf, 26(9), 1044–1052. https://doi.org/10.1002/pds.4248",,,,,,,
Vranken_2014,"Vranken, M. J., Lisman, J. A., Mantel-Teeuwisse, A. K., Junger, S., Scholten, W., Radbruch, L., Payne, S., & Schutjens, M. H. (2016). Barriers to access to opioid medicines: A review of national legislation and regulations of 11 central and eastern European countries. Lancet Oncology, 17(1), e13-22.",,,,,,,
Vranken_2016,"Vranken, M. J., Mantel-Teeuwisse, A. K., Junger, S., Radbruch, L., Lisman, J., Scholten, W., Payne, S., Lynch, T., & Schutjens, M. H. (2014). Legal barriers in accessing opioid medicines: Results of the ATOME quick scan of national legislation of eastern European countries. Journal of Pain & Symptom Management, 48(6), 1135–1144.",,,,,,,
Vranken_2017,"Vranken, M. J. M., Mantel-Teeuwisse, A. K., Junger, S., Radbruch, L., Scholten, W., Lisman, J. A., Subataite, M., & Schutjens, M. D. B. (2017). Barriers to access to opioid medicines for patients with opioid dependence: A review of legislation and regulations in eleven central and eastern European countries. Addiction, 112(6), 1069–1076.",,,,,,,
Vuong_2018,"Vuong, T., Ritter, A., Shanahan, M., Ali, R., Nguyen, N., Pham, K., Vuong, T. T. A., & Le, G. M. (2018). Outcomes of compulsory detention compared to community-based voluntary methadone maintenance treatment in Vietnam. Journal of Substance Abuse Treatment, 87, 9–15.",,,,,,,
Vyas_2018,"Vyas, M. B., LeBaron, V. T., & Gilson, A. M. (2018). The use of cannabis in response to the opioid crisis: A review of the literature. Nursing Outlook, 66(1), 56–65.",,,,,,,
Waal_2014,"Waal, H., Clausen, T., Gjersing, L., & Gossop, M. (2014). Open drug scenes: Responses of five European cities. BMC Public Health, 14, 853.",,,,,,,
Wade_2017,"Wade, R. L., Chen, C.-C., Ajita, P. D., & Howard, J. C. (2017). Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans. Methodology and Health Care Policy, 5(1), 75–88.",,,,,,,
Wakeland_2013,"Wakeland, W., Nielsen, A., Schmidt, T. D., McCarty, D., Webster, L. R., Fitzgerald, J., & Haddox, J. D. (2013). Modeling the impact of simulated educational interventions on the use and abuse of pharmaceutical opioids in the United States: A report on initial efforts. Health Educ Behav, 40(1 Suppl), 74s–86s. https://doi.org/10.1177/1090198113492767",,,,,,,
Wakeland_2015,"Wakeland, W., Nielsen, A., & Geissert, P. (2015). Dynamic model of nonmedical opioid use trajectories and potential policy interventions. American Journal of Drug & Alcohol Abuse, 41(6), 508–518.",,,,,,,
Waldrop_2017,"Waldrop, M. (2017). A Little less Regulation: Why Federal Pain Management Laws Are Hurting State Efforts to Combat the Opioid Epidemic Student Notes. Mitchell Hamline L. Rev., 43, 881–924.",,,,,,,
Walley_2013,"Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., Ruiz, S., & Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. BMJ, 346, f174. https://doi.org/10.1136/bmj.f174",,,,,,,
Wang_2019,"Wang, L. X. (2020). The complementarity of drug monitoring programs and health it for reducing opioid-related mortality and morbidity (SSRN Scholarly Paper ID 3176809). Social Science Research Network. https://papers.ssrn.com/abstract=3176809",,,,,,,
Wan_2016,"Wan, W. Y., Weatherburn, D., Wardlaw, G., Sarafidis, V., & Sara, G. (2016). Do drug seizures predict drug-related emergency department presentations or arrests for drug use and possession? Int J Drug Policy, 27, 74–81. https://doi.org/10.1016/j.drugpo.2015.09.012",,,,,,,
Warren_2018,"Warren, J. A. (2018). Defining the Opioid Crisis and the Limited Role of the Criminal Justice System Resolving It. The University of Memphis Law Review, 48(4), 1205–1298.",,,,,,,
Weber_2010,"Weber, E. M. (2010). Failure of Physicians to Prescribe Pharmacotherapies for Addiction: Regulatory Restrictions and Physician Resistance Symposium: Obstacles to the Development and Use of Pharmacotherapies for Addiction. Journal of Health Care Law & Policy, 13, 49–76.",,,,,,,
Web_2016,"Werb, D., Kamarulzaman, A., Meacham, M. C., Rafful, C., Fischer, B., Strathdee, S. A., & Wood, E. (2016). The effectiveness of compulsory drug treatment: A systematic review. Int J Drug Policy, 28, 1–9. https://doi.org/10.1016/j.drugpo.2015.12.005",,,,,,,
Wegman_2017,"Wegman, M. P., Altice, F. L., Kaur, S., Rajandaran, V., Osornprasop, S., Wilson, D., Wilson, D. P., & Kamarulzaman, A. (2017). Relapse to opioid use in opioid-dependent individuals released from compulsory drug detention centres compared with those from voluntary methadone treatment centres in Malaysia: A two-arm, prospective observational study. Lancet Glob Health, 5(2), e198–e207. https://doi.org/10.1016/s2214-109x(16)30303-5",,,,,,,
Weimer_2016,"Weimer, M. B., Hartung, D. M., Ahmed, S., & Nicolaidis, C. (2016). A chronic opioid therapy dose reduction policy in primary care. Substance Abuse, 37(1), 141–147.",,,,,,,
Weiner_2017,"Weiner, S. G., Baker, O., Poon, S. J., Rodgers, A. F., Garner, C., Nelson, L. S., & Schuur, J. D. (2017). The Effect of Opioid Prescribing Guidelines on Prescriptions by Emergency Physicians in Ohio. Annals of Emergency Medicine, 70(6), 799-808.e1.",,,,,,,
Weisberg_2016,"Weisberg, A. J., V, & ervort, F. E. (2015). A Liberal Dilemma: Respecting Autonomy While Also Protecting Inchoate Children from Prenatal Substance Abuse Symposium: The Liberal Dilemma in Child Welfare Reform. William & Mary Bill of Rights Journal, 24, 659–708.",,,,,,,
Wen_2013,"Wen, H., Cummings, J. R., Hockenberry, J. M., Gaydos, L. M., & Druss, B. G. (2013). State parity laws and access to treatment for substance use disorder in the United States: Implications for federal parity legislation. JAMA Psychiatry, 70(12), 1355–1362. https://doi.org/10.1001/jamapsychiatry.2013.2169",,,,,,,
Wen_2015,"Wen, H., Hockenberry, J. M., & Cummings, J. R. (2015). The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. J Health Econ, 42, 64–80. https://doi.org/10.1016/j.jhealeco.2015.03.007",,,,,,,
Wen_2017,"Wen, H., Hockenberry, J. M., Borders, T. F., & Druss, B. G. (2017). Impact of medicaid expansion on medicaid-covered utilization of buprenorphine for opioid use disorder treatment. Medical Care, 55(4), 336–341.",,,,,,,
Wen_2017a,"Wen H., Schackman, B. R., Aden, B., on, & Yuhua, B. (2017). States With Prescription Drug Monitoring Mandates Saw A Reduction In Opioids Prescribed To Medicaid Enrollees. Health Affairs, 36(4), 733–741.",,,,,,,
Wen_2018,"Wen, H., & Hockenberry, J. M. (2018). Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees. JAMA Internal Medicine, 2, 02.",,,,,,,
Wen_2019,"Wen, Hefei, Hockenberry, J. M., Jeng, P. J., & Bao, Y. (2019). Prescription Drug Monitoring Program Mandates: Impact On Opioid Prescribing And Related Hospital Use. Health Affairs, 38(9), 1550–1556. https://doi.org/10.1377/hlthaff.2019.00103",,,,,,,
Werb_2013,"Werb, D. A. N. (2013). Heroin Prescription, HIV, and Drug Policy: Emerging Regulatory Frameworks. Oregon Law Review, 91(4), 1213–1225.",,,,,,,
Westanmo_2015,"Westanmo, A., Marshall, P., Jones, E., Burns, K., & Krebs, E. E. (2015). Opioid Dose Reduction in a VA Health Care System—Implementation of a Primary Care Population-Level Initiative. Pain Med, 16(5), 1019–1026. https://doi.org/10.1111/pme.12699",,,,,,,
Wettstein_2019,"Wettstein, G. (2019). Health insurance and opioid deaths: Evidence from the Affordable Care Act young adult provision. Health Economics, 28(5), 666–677. https://doi.org/10.1002/hec.3872",,,,,,,
Whitelaw_2017,"Whitelaw, M. (2017). A Path to Peace in the U.S. Drug War: Why California Should Implement the Portuguese Model for Drug Decriminalization. Loyola of Los Angeles International and Comparative Law Review, 81, 81–113.",,,,,,,
Whitmore_2019,"Whitmore, C. C., White, M. N., Buntin, M. B., Fry, C. E., Calamari, K., & Patrick, S. W. (2019). State laws and policies to reduce opioid-related harm: A qualitative assessment of PDMPs and naloxone programs in ten U.S. States. Prev Med Rep, 13, 249–255. https://doi.org/10.1016/j.pmedr.2018.12.014",,,,,,,
Wickramatilake_2017,"Wickramatilake, S., Zur, J., Mulvaney-Day, N., Klimo, M. C., Selmi, E., & Harwood, H. (2017). How States Are Tackling the Opioid Crisis. Public Health Reports, 132(2), 171–179.",,,,,,,
Williams_2014,"Williams, A. R., Cohen, S., & Ford, E. B. (2014). Statutory definitions of mental illness for involuntary hospitalization as related to substance use disorders. Psychiatr Serv, 65(5), 634–640. https://doi.org/10.1176/appi.ps.201300175",,,,,,,
Wilson_2006,"Wilson, D. B., Mitchell, O., & MacKenzie, D. L. (2006). A systematic review of drug court effects on recidivism. Journal of Experimental Criminology, 2(4), 459–487. https://doi.org/10.1007/s11292-006-9019-4",,,,,,,
Wilson_2018,"Wilson, M. N., Hayden, J. A., Rhodes, E., Robinson, A., & Asbridge, M. (2019). Effectiveness of Prescription Monitoring Programs in Reducing Opioid Prescribing, Dispensing, and Use Outcomes: A Systematic Review. J Pain. https://doi.org/10.1016/j.jpain.2019.04.007",,,,,,,
Wilson_2019,"Wilson, T. M. (2018). LEAD the Way: Using Local Communities as Legal Laboratories to Combat Drug Addiction Commentaries. J. Legal Med., 38, 163–176.",,,,,,,
Winstanley_2018,"Winstanley, E. L., Zhang, Y., Mashni, R., Schnee, S., Penm, J., Boone, J., McNamee, C., & MacKinnon, N. J. (2018). Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing. Drug Alcohol Depend, 188, 169–174. https://doi.org/10.1016/j.drugalcdep.2018.03.036",,,,,,,
Wittouck_2013,"Wittouck, C., Dekkers, A., De Ruyver, B., Vanderplasschen, W., & Vander Laenen, F. (2013). The Impact of Drug Treatment Courts on Recovery: A Systematic Review. The Scientific World Journal, 2013, 12. https://doi.org/10.1155/2013/493679",,,,,,,
Wong_2019,"Wong, S. W., & Lin, H. C. (2019). Medical marijuana legalization and associated illicit drug use and prescription medication misuse among adolescents in the U.S. Addict Behav, 90, 48–54. https://doi.org/10.1016/j.addbeh.2018.10.017",,,,,,,
Woodworth_2013,"Woodworth, E. (2013). Pharmageddon: A Statutory Solution to Curb Ohio’s Prescription Abuse Problem Note. J.L. & Health, 26, 103–142.",,,,,,,
Wood_2003,"Wood, E., Tyndall, M. W., Spittal, P. M., Li, K., Anis, A. H., Hogg, R. S., Montaner, J. S. G., O’Shaughnessy, M. V., & Schechter, M. T. (2003). Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: Investigation of a massive heroin seizure. Cmaj, 168(2), 165–169.",,,,,,,
Wood_2004,"Wood, E., Spittal, P. M., Small, W., Kerr, T., Li, K., Hogg, R. S., Tyndall, M. W., Montaner, J. S. G., & Schechter, M. T. (2004). Displacement of Canada’s largest public illicit drug market in response to a police crackdown. Cmaj, 170(10), 1551–1556.",,,,,,,
Wood_2004_2,"Wood, E., Kerr, T., Small, W., Li, K., Marsh, D. C., Montaner, J. S., & Tyndall, M. W. (2004). Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Cmaj, 171(7), 731–734. https://doi.org/10.1503/cmaj.1040774",,,,,,,
Wood_2006,"Wood, E., Tyndall, M. W., Lai, C., Montaner, J. S., & Kerr, T. (2006). Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. Subst Abuse Treat Prev Policy, 1, 13. https://doi.org/10.1186/1747-597x-1-13",,,,,,,
Worrall_2009,"Worrall, J. L., Hiromoto, S., Merritt, N., Du, D., Jacobson, J. O., & Iguchi, M. Y. (2009). Crime trends and the effect of mandated drug treatment: Evidence from California’s Substance Abuse and Crime Prevention Act. Journal of Criminal Justice, 37(2), 109–113. https://doi.org/10.1016/j.jcrimjus.2009.02.010",,,,,,,
Wright_2017,"Wright, E. R., Kooreman, H. E., & Greene, M. S. (2017). The Early Impact of the Indiana Scheduled Prescription Electronic Collection and Tracking (INSPECT) Program: A Potentially Effective Policy Tool for Reducing Prescription Drug Abuse. Indiana Health Law Review, 14, 112–128.",,,,,,,
Xu_2018,"Xu, J., Davis, C. S., Cruz, M., & Lurie, P. (2018). State naloxone access laws are associated with an increase in the number of naloxone prescriptions dispensed in retail pharmacies. Drug Alcohol Depend, 189, 37–41. https://doi.org/10.1016/j.drugalcdep.2018.04.020",,,,,,,
Yarbrough_2015,"Yarbrough, C., & Bradford, W. D. (2015). Where does it hurt? The impact of prescription drug monitoring programs on pain management in home health care (SSRN Scholarly Paper ID 2671500). Social Science Research Network. https://papers.ssrn.com/abstract=2671500",,,,,,,
Yarbrough_2018,"Yarbrough, C. R. (2018). Prescription Drug Monitoring Programs Produce a Limited Impact on Painkiller Prescribing in Medicare Part D. Health Services Research, 53(2), 671–689.",,,,,,,
Yenikomshian_2019,"Yenikomshian, M. A., White, A. G., Carson, M. E., Jia, Z. B., Mendoza, M. R., & Roland, C. L. (2019). Modeling the potential impact of abuse-deterrent opioids on medical resource utilization. J Med Econ, 22(10), 1073–1079. https://doi.org/10.1080/13696998.2019.1645680",,,,,,,
Young_2017,"Young, L. D., Kreiner, P. W., & Panas, L. (2018). Unsolicited Reporting to Prescribers of Opioid Analgesics by a State Prescription Drug Monitoring Program: An Observational Study with Matched Comparison Group. Pain Med, 19(7), 1396–1407. https://doi.org/10.1093/pm/pnx044",,,,,,,
Zanis_2003,"Zanis, D. A., Mulvaney, F., Coviello, D., Alterman, A. I., Savitz, B., & Thompson, W. (2003). The effectiveness of early parole to substance abuse treatment facilities on 24-month criminal recidivism. Journal of Drug Issues, 33(1), 223–235.",,,,,,,
Zarkin_2005,"Zarkin, Gary A., Dunlap, L. J., Belenko, S., & Dynia, P. A. (2005). A Benefit-Cost Analysis of the Kings County District Attorney’s Office Drug Treatment Alternative to Prison (DTAP) Program. Justice Research and Policy, 7(1), 1–25. https://doi.org/10.3818/JRP.7.1.2005.1",,,,,,,
Zarkin_2011,"Zarkin, G. A., Cowell, A. J., Hicks, K. A., Mills, M. J., Belenko, S., Dunlap, L. J., Houser, K. A., & Keyes, V. (2012). Benefits and costs of substance abuse treatment programs for state prison inmates: Results from a lifetime simulation model. Health Econ, 21(6), 633–652. https://doi.org/10.1002/hec.1735",,,,,,,
Zarkin_2012,"Zarkin, Gary A., Cowell, A. J., Hicks, K. A., Mills, M. J., Belenko, S., Dunlap, L. J., & Keyes, V. (2015). Lifetime Benefits and Costs of Diverting Substance-Abusing Offenders From State Prison. Crime & Delinquency, 61(6), 829–850. https://doi.org/10.1177/0011128712461904",,,,,,,
Zhu_2019,"Zhu, H., & Wu, L. T. (2019). Discharge against medical advice from hospitalizations for substance use disorders: The potential impact of the Affordable Care Act. Drug Alcohol Depend, 197, 115–119. https://doi.org/10.1016/j.drugalcdep.2018.12.032",,,,,,,
Zolin_2019,"Zolin, S. J., Ho, V. P., Young, B. T., Harvey, A. R., Beel, K. T., Tseng, E. S., Brown, L. R., & Claridge, J. A. (2019). Opioid prescribing in minimally injured trauma patients: Effect of a state prescribing limit. Surgery, 166(4), 593–600. https://doi.org/10.1016/j.surg.2019.05.040",,,,,,,
Zurhold_2003,"Zurhold, H., Degkwitz, P., Verthein, U., & Haasen, C. (2003). Drug Consumption Rooms in Hamburg, Germany: Evaluation of the Effects on Harm Reduction and the Reduction of Public Nuisance. Journal of Drug Issues, 33(3), 663–688. https://doi.org/10.1177/002204260303300308",,,,,,,
